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Summary.
As part of an effort to increase our understanding of central metabolic pathways in 
streptomycetes, the TCA cycle enzyme, isocitrate dehydrogenase (IDH), was studied 
from Streptomyces coelicolor. In Eschericia coli grown on acetate as a sole carbon 
source, IDH plays an important role in controlling the flux of carbon between the 
glyoxylate bypass and the TCA cycle. The study of any such control in streptomycetes is 
of interest because these pathways are important in providing energy and precursors for 
both primary and secondary metabolism.
A purification procedure was developed that enabled the isolation of the IDH from 
S.coelicolor. This enzyme was found to be a monomeric protein with a molecular weight 
of around 80,000, quite different to the IDH from E.coli. Based on this information and 
on the immunological properties and N-terminal sequence of the enzyme, it was proposed 
that the S.coelicolor IDH could be grouped with the IDH-II from Vibrio spp. ABE-1, 
into a separate class of enzymes that were named the type II IDHs. Recent 
characterisation of the IDH from Rhodomicrobium vannielii indicates that these 
properties may be common to all type II IDHs.
Determination of the N-terminal sequence of IDH enabled the design and construction 
of an oligonucleotide that was used as a probe specific for the gene encoding IDH (icd 
B). It was used to screen two types of S.coelicolor libraries. One was a plasmid sub­
library constructed from genomic DNA that had been pre-selected to contain a high 
proportion of fragments that contained the icd B gene. The other was a X library 
(constructed in X-GEM11) that represented sequences from the entire S.coelicolor 
genome. Screening of the plasmid library allowed the isolation of a recombinant plasmid 
(called pRT60) that contained a 5kb insert. Partial sequencing and restriction mapping of 
this clone showed that only the first 800bp of icd B had been isolated on this fragment. 
The rest of the DNA fragment contained DNA upstream of icd B. Screening of the X 
library produced a clone (XI) that contained the whole of the icd B gene (c.2.5 kb) plus 
c.6.4 kb of the region downstream of icd B plus c.2 kb of the region upstream of the 
gene.
A 5kb Pst I fragment was subcloned from XI into pBluescript II SK+ to produce 
pRTBl. The insert is likely to contain all of the up and downstream signals required for 
expression in S. coelicolor, as well as the icd B coding region. Further subcloning 
enabled the gene to be isolated on a 2.7 kb E.co RVPima I fragment (pRTB 2 and 3) that 
contained very little up and downstream sequences. None of these plasmids were able to 
complement a mutant of E.coli that was devoid of IDH activity. This was probably due 
to lack of expression as many streptomycete promoters are not recognised by the E. coli
Summary.
DNA-dependent RNA polymerase. Analysis of the DNA sequence upstream of icd B 
revealed no obvious E.coli -like promoters supporting this hypothesis.
The whole of the icd B gene (plus another 197 bp upstream and 137 bp downstream) 
was sequenced using a series of oligonucleotides. Analysis of the predicted protein 
sequence showed that the gene encoded a protein with an N-terminal sequence identical to 
that obtained by Edman degradation of the purified protein. This information, coupled 
with the similarity of the sequence to the N-terminal sequence of the IDH from R. 
vannielii, proves that the gene encoding IDH has been cloned. The codon bias and G+C 
content of icd B is typical of those found for other streptomycete genes. Analysis of the 
codon bias and G+C content also suggested that there is a possible open reading frame id s  
bp upstream andicobp downstream of icd B.
The IDH from E.coli is known to have an amino acid sequence similar to that of the 
isopropylmalate dehydrogenases (IMDHs) from various organisms. Comparison of 
several IMDHs and the IDH from E.coli, with the IDH from S.coelicolor, showed that 
the streptomycete enzyme is significantly different. However closer inspection of the 
sequences revealed a small region of similarity that is present in all of the IMDH and IDH 
sequences available, including the NAD dependent IDH from yeast. This region 
coincides with the region known to bind NADP in the IDH from E.coli, suggesting that 
both NAD and NADP binding sites in IDH and IMDH type enzymes are related. A novel 
consensus sequence is presented that describes some of the conserved residues found 
between the aligned sequences at the proposed NADP binding site.
During this sequence analysis it was noticed that the all of the IDH and IMDH 
sequences, with the exception of the S.coelicolor IDH sequence, show significant 
similarity along their whole length. This is despite the fact that the different enzymes 
differ in subunit organisation and coenzyme specificity. It has therefore been proposed 
that all of the IMDH/IDH type enzymes (except the IDH from S. coelicolor) have 
subunits that are evolutionarily related and that some of these subunits have developed 
specialist functions. Sequence alignments of the IDH from S. coelicolor with other IDHs 
and IMDHs may indicate a distant relationship between this type II enzyme and the 
IMDH/IDH enzymes, although the alignments could be coincidental.
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Chapter li— General Introduction.
1.0 Introduction.
The aim of this chapter is to provide a background to some of the subjects discussed 
in this thesis. Some relevant aspects of streptomycetes are discussed first (section 1.1). 
This is followed by a discussion of the role and control of IDHs from various 
organisms.
During the course of the work described in this thesis, a putative NAD(P)+ binding 
site was discovered in the IDH sequence from S. coelicolor. Similarities to other enzyme 
sequences were identified and used to create a novel NAD(P)+ consensus sequence. 
Section 1.3 is therefore devoted to a dicussion of some of the information known about 
NAD(P)+ binding sites in various enzymes.
The final section in this chapter describes the general aims of this study and the 
strategies employed to achieve them.
JL.1 An introduction to streptomycetes,
This section aims to provide the reader with an insight into some of the more unusual 
features of the genus. It is not meant to be a comprehensive review of the information 
known about streptomycetes but is meant to provide information relevant to the work 
carried out during this study.
1 .1 .1  Some general aspects of streptomycetes,
Streptomyces belongs to the cycxupof bacteria called the actinomycetes. 
These are a group of filamentous soil bacteria that obtain nutrients by the degradation of 
organic material. To do this, they excrete a wide variety of enzymes such as cellulases, 
xylanases, chitinases and lipases (Tomich, 1988a). They also provide an important 
source of other enzymes of commercial interest such as restriction endonucleases and 
amylases.
Starvation causes the substrate mycelia to branch further (see figure 1.1) and produce 
aerial hyphae. These eventually produce chains of spores, with the concomitant lysis of 
the substrate mycelia usually accompanied by the production of antibiotics (Chater, 
1984).
4
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Figure 1.1 Life cycle of streptomycetes.
This idealised diagram summarises the life cycle of S.coelicolor from germination to 
sporuiation. Modified from Chater and Merrick, 1979.
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This ability to undergo both biochemical and morphological changes has stimulated 
interest in streptomycetes as a model for the study of differentiation. Perhaps the most 
extensive research on streptomycetes though is due to their ability to produce a wide 
range of antibiotics, accounting for over 70% of the naturally occurring antibiotics 
discovered so far (Tomich, 1988a).
The advances that have been made in the molecular biology of streptomycetes 
(Hopwood el al., 1985a and Tomich, 1988a and b) have allowed analysis of the biology 
of these organisms at the genetic level. Again, much of the attention has been directed 
toward the genes that control the production of antibiotic synthesis and resistance. For 
many antibiotics all of the genes required for production and resistance are clustered 
together on the chromosome, making it comparatively easy to clone whole biosynthetic 
pathways within a single plasmid construct, by selecting for fragments of DNA that 
confer antibiotic resistance to the host. For instance Malpartida and Hopwood (1984) 
cloned the whole cluster of genes that allow for the production of the polyketide 
antibiotic, actinorhodin, into a naive host which then produced the antibiotic. Introduction 
of only part of the cluster into hosts {eg. S.violaceoruber) that normally produce other 
polyketides led to to the production of the first genetically engineered hybrid antibiotics 
(Hopwood eta l.y 1985b).
S. coelicolor is the best studied streptomycete producing several antibiotics including 
actinorhodin, undecylprodigiosin and methylenomycin. Actinorhodin is an 
isochromanequinone antibiotic that is produced by a polyketide type pathway (see figure 
1.2). Polyketide synthesis shows certain analogies to the synthesis of long chain fatty 
acids which are synthesised by the sequential addition of two-carbon units. The first 
molecule in fatty acid biosynthesis (the starter unit) is always acetyl-CoA whilst the units 
used to extend the chain are always malonyl-CoA (for unbranched fatty acids). The 
condensation of the extender units onto the growing chain results in the loss of carbon 
dioxide resulting in the net incorporation of a two carbon acetyl group. Different 
polyketides can however use different starter and extender units, sometimes using a 
mixture, allowing a greater variety of structures (Sherman et al., 1988).
Another major difference between the two types of synthesis is that the keto groups 
of fatty acids are always fully reduced after the addition of each extender unit. In 
polyketide synthesis these are sometimes only partially reduced or not reduced at all, 
dependent on the polyketide being made. These modifications may occur immediately 
after addition of the extender unit or may be left until chain growth is complete (Sherman 
et al., 1988).
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Figure 1.2 Proposed pathway for the assembly of actinorhodin.
This diagram shows the sequential condensation of acetate units (indicated by the 
letter as C) with a single reduction and dehydrogenation (indicated by the letters R and D 
respectively). From Sherman etal., 1988.
Chapter 1.— General Introduction.
The synthesis of actinorhodin (figure 1.2) provides a good example of polyketide 
synthesis with each individual acetate unit (derived from malonyl-CoA) being added 
sequentially to the growing chain with a total of only one reduction during the synthesis. 
Two of these cyclised "mature chains" are joined together to give the final actinorhodin 
molecule.
1 . 1 . 2  Why study IDH in £, CQelicQfor.!
As described above streptomycetes have become the object of extensive research. 
Understandably, the commercial use of these organisms to produce antibiotics has 
encouraged research into the systems which control and produce antibiotics. However 
little is known about the pathways and systems that produce the basic precursors of 
antibiotic synthesis which will be provided by primary metabolic pathways and may 
become a limiting step in the overproduction of antibiotics.
As described above, polyketides such as actinorhodin are synthesised from the head- 
to-tail condensation of acetate units which are derived from acetyl-CoA. The TCA cycle 
also consumes acetyl-CoA and may therefore compete with antibiotic synthesis for this 
common precursor. Consequently, it is of interest to see if the TCA cycle is regulated in 
some way to control this flux. Indeed, the same factor (A-factor) that stimulates antibiotic 
synthesis (streptomycin) in S.griseus also causes the indirect inhibition of IDH and 
glycolytic enzymes (see section 1.1.4).
Control over the TCA cycle is likely to be even more strict when one considers that 
many industrial fermentations are carried out on media based on oils, such as oil seed 
rape. These oils are likely to metabolised directly to acetyl-CoA for entry into the TCA 
cycle and will therefore require the induction of the glyoxylate bypass as an anaplerotic 
pathway. By analogy to E. co li, the competition for isocitrate is likely to be controlled 
via the control of IDH, adding further complexity to the control of the cycle both before 
and during antibiotic synthesis. This enzyme was therefore an obvious target for study.
S. coelicolor was chosen for these studies because it is genetically the best 
characterised streptomycete allowing for a variety of classical and recombinant DNA 
techniques (Hopwood et al., 1985a) to be used in the study of this enzyme.
1 .1 .3  RNA polymerase and prom oter heterogeneity.
For many genes, from many organisms, promoters can be identified as recognisable 
sequence motifs that conform to a consensus. The sequences are required for the RNA 
polymerase (RNApol) to bind to DNA at the correct position to initiate transcription. In
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E. coli these consensus sequences lie 10 and 35 nucleotides upstream of the 5' end of 
the mRNA and have therefore been called the -10 and -35 sequences respectively 
(Hawley and McClure, 1983).
Initial studies on the promoters from streptomycetes used promoter probe vectors to 
show the presence of promoter activity. Only a few randomly cloned DNA fragments 
from streptomycete DNA could direct transcription (ie. show promoter activity) in E. coli 
whereas many of the DNA fragments from E. coli could direct transcription in 
streptomycetes (Bibb and Cohen, 1982). This suggested that streptomycetes have the 
ability to transcribe genes with E. coli -like promoters, but that most of streptomycete 
promoters are significantly different and cannot be transcribed by E. coli.
This situation is reminiscent of the situation in B.subtilis where genes involved in 
different stages of the life-cycle possess different classes of promoters. These are 
recognised by specific RNA-polymerase (RNApol) holoenzymes whose specificity is 
imposed by the incorporation of one of a number of different sigma (a) factors (Losick 
and Pero, 1981). Varying levels of the different a  factors at different times of the life 
cycle therefore allows preferential transcription of different sets of genes at appropriate 
points in the life-cycle. For instance four of the eight a  factors produced by B.subtilis 
recognise promoters for sporuiation specific genes and are produced only at the onset of 
sporuiation (Errington, 1991, cited in Strohl 1992).
Westpheling et al. (1985) were the first to show directly that there was more than one 
RNApol holoenzyme in S. coelicolor. They found one RNApol that was associated with 
a 35 kDa a  factor (a35) and could transcribe the E. coli -like veg promoters of Bsubtilis. 
The second RNApol had either a a 37 or a 49 associated with it and was found to direct 
transcription from the non-E. coli-like etc promoter from B.subtilis, which is involved in 
sporuiation and motility. The specificity of certain holoenzymes for certain types of 
streptomycete promoters was shown by Buttner et al. (1988). This group found that the 
dag A  gene from S. coelicolor possessed four different promoters and identified three 
different holoenzymes that would transcribe three of them. This suggested that there are 
at least four a  factors in S. coelicolor that can transcribe this one gene. Two of these a  
factors probably correspond to the a 35 and o49 identified by Westpheling et al., (1985). 
The third was a novel 38 kDa a  factor (a38).
Tanaka et al. (1988) have cloned four a  factor genes called hrdA, B, C and D, all of 
which show remarkable sequence similarity to the veg a  factor gene from B.subtilis and 
the o70 gene of E. coli (the "housekeeping" a  factors). The close similarity suggests that 
these factors are different to the a 49 and a 37 factors isolated by Wespheling et al. (which 
recognise etc type promoters) although one of these genes could encode a 35 which
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recognises the veg promoters. Disruption of the genomic copies of the genes hrdC and D 
had no apparent effect on the viability of the organism and no obvious phenotype 
(Buttner et al., 1990). However attempts to disrupt the hrd B mutants were unsuccessful 
indicating that this mutation is lethal and that the a  factor encoded by this gene is therefore 
an absolute requirement for growth.
This shows that there are at least six different factors present in S. coelicolor (hrdk , 
B, C and D and the etc transcribing factors a 37 and a 49; factor a 28 and a 35 could 
possibly be encoded by one of the hrd genes). A seventh a  factor called a whiG has also 
been identified. Mutants that lack a functional owhiG factor are unable to produce mature 
pigmented spores which results in the colonies having a white colour (hence the mutation 
was called whi te) and were unable to produce antibiotics. This sigma factor is therefore 
unnecessary for vegetative growth but is required for the transcription of genes involved 
in both morphological and biochemical differentiation. Cloning and sequencing of a piece 
of DNA that complements this mutation has shown that the gene resembles the motility 
factor (a28) of B.subtilis (Chater et al., 1989).
Unfortunately little is known about which a  factors recognise which promoters in 
streptomycetes. Attempts to classify the different promoters that have been sequenced by 
similarity to each other have only really succeeded in highlighting the diversity of 
promoter sequences present in streptomycetes (Seno and Baltz, 1989). No obvious 
distinctions were found between those promoters from "housekeeping" and primary 
metabolic genes and those involved in differentiation and secondary metabolism.
A more recent review by Strohl (1992) was able to take advantage of the fact that 139 
promoters have now been sequenced from 87 genes. From this study it was shown that 
only 29 of these could be classified as having "£. coli -like promoters" that might be 
recognised by the E. coli housekeeping sigma factor, a 70. This classification required 
that the promoter showed similarity to the consensus sequences TTGACA and TATAAT 
(for the -35 and -10 regions respectively) and that the two sequences were between 16 
and 18 nucleotides apart. Some of these promoters were in fact known to be active in E. 
coli demonstrating the functional significance of this sequence classification. The rest of 
the promoters studied showed a wide diversity of sequences. Some had E. coli like -10 
sequences or -35 sequences but not both, whilst others had both consensus sequences 
but a distance between the two of greater than the 16 and 18 nucleotides. Other 
streptomycete promoters show no obvious sequence similarity to the E. coli -like 
consensus at all. Some promoters show similarities to each other but the functional 
significance of this is not yet known. It was suggested that some of these sequences 
could be involved in providing recognition sites for positive or negative regulators as well
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as providing a recognition site for the RNApol. In fact some of these promoters could 
form secondary structures which could be involved in this sort of regulation.
Another unusual feature of transcription initiation in streptomycetes is the widespread 
use of multiple promoters. Out of the 87 genes studied by Strohl (1992), 27 had more 
than one promoter. Multiple promoters presumably allow transcription of genes by more 
than one RNApol like the situation for dag A (see above). Where multiple promoters 
were found, 13 cases were identified in which a single region of DNA contains 
overlapping divergent promoters. This must form part of some complex regulatory 
system which allows for the coordinated control of more than one gene from the same 
DNA region.
The main conclusion that can be drawn from these studies is that the organisation of 
streptomycete promoters is more complex than in other prokaryotes and that only further 
study will reveal the working of these mechanisms.
1 .1 .4  Control of metabolism bv_ A-factor like molecules.
Another unusual feature of streptomycetes is the control of antibiotic biosynthesis by 
a microbial "pheromone-type" molecule called A-factor (activating factor). In S.griseus 
the afsA+ gene is required for A-factor synthesis. Mutations in this gene render the strain 
unable to sporulate or to produce the antibiotic streptomycin. However, addition of 
purified A-factor to the media in which the mutants were grown restored these functions, 
showing that A-factor is diffusible and indicated the "pheromone-like" action of the factor 
(Kokhlov, 1973).
It has been reported that S.griseus possesses a protein that has the ability to bind A- 
factor (Miyake et al., 1989). In strains incapable of synthesising A-factor, secondary 
mutations were isolated that restored antibiotic synthesis and sporuiation despite the lack 
of A-factor (Miyake et al., 1990). These secondary mutations were found to lack a 
functional A-factor binding protein leading to the conclusion that the binding protein acts 
as a repressor and that A-factor binds to the protein to prevent repression (ie. acts as an 
anti-repressor).
A-factor mutants of S.griseus were also found to show abnormally high levels of the 
NADP+ dependent enzymes, IDH, glucose 6-phosphate dehydrogenase (G6PDH) and 6- 
phosphogluconate dehydrogenase (6PGDH) (Grafe et al., 1980). Normally the amount 
of enzyme activity for these enzymes during antibiotic synthesis was barely detectable 
indicating that the inhibition of these enzymes and stimulation of antibiotic synthesis are 
in some way linked. The inhibition of IDH and G6PDH was shown to be due to the
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action of the potent inhibitor adenosine di-phosphoribose phosphate, which was shown 
to be produced from NADP+ by the action of the enzyme NADP+ glycohydrolase 
(NGH). The levels of NGH in wild-type S.griseus were found to increase during the 
onset of antibiotic synthesis but were very low in afsA  mutants. It therefore seems that 
IDH and the glycolytic enzymes are controlled by A-factor via the action of NGH; 
antibiotic genes are stimulated directly by A-factor. NGH has been shown not to play a 
role in the stimulation of antibiotic synthesis because afsA mutants that lack the A-factor 
binding protein lack NGH but still produce streptomycin. Grafe et al. (1980) also 
reported the results of some in vitro inhibition studies of IDH by adenosine di- 
phosphoribose phosphate, although the relevance is somewhat doubtful as they were 
performed solely on IDH purified from pig heart.
Other streptomycete species including S. coelicolor have also been found to produce 
A-factor type molecules. The mode of action of A-factor in S. coelicolor however seems 
to be different to the situation in S.griseus. In S. coelicolor, afsA mutants were found to 
sporulate and produce antibiotics as normal. They are also different in requiring the 
presence of a second gene, called afsB , for the expression of afsA  (reviewed by 
Horinouchi and Beppu, 1990).
S. coelicolor has also been found to require a third gene, called afsR , for the 
expression of A-factor, acting as a postive regulator (Hong et al., 1991). The action of 
this gene product was found to be stimulated when phosphorylated by a protein kinase. 
More recent work by Horinouchi's group (ISBA meeting, 1991) has shown that this 
protein kinase (encoded by afsK) is a membrane protein that is controlled by auto­
phosphorylation.
The actual role of A-factor in controlling secondary metabolism in S. coelicolor is 
unclear and there are no reports on the effects of A-factor on primary metabolism in this 
strain. It should therefore be borne in mind that A-factor has been shown to have an 
effect on primary metabolic genes in S.griseus and may play a similar role in S. 
coelicolor.
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L I  Role of TCA cvcle in  E . coli grown on glucose and acetate.
The function of the tricarboxylic acid (TCA) cycle is to produce energy and 
biosynthetic precursors and is therefore an example of an amphibolic pathway (figure 
1.3). Most fuel molecules such as fatty acids, amino acids and carbohydrates will 
eventually be converted to acetyl-CoA which then condenses with OAA to form citic acid 
in the first reaction of the cycle. Complete oxidation of an acetyl group to CO2 and H2O 
produces three molecules of NADPH and one molecule of FADH as well as one molecule 
of ATP. Reduced nucleotides are used to provide the cell with reducing equivalents for 
use in biosynthesis as well as for producing more ATP via the electron transport chain. 
However as well as losing carbon from the cycle as CO2 , carbon is also lost as the 
intermediates, oxaloacetate (OAA), 2-oxoglutarate (20G) and succinyl-CoA (Succ-CoA) 
are withdrawn from the cycle for the synthesis of other cell constituents (figure 1.3). If 
acetyl groups are not replaced at some point in the cycle the TCA cycle will stop due to 
the loss of intermediates.
During growth on glucose, oxaloacetate (OAA) is replaced by the anaplerotic enzyme 
phosphoenolpyruvate carboxylase (PEPc) which directly produces OAA by the 
carboxylation of PEP. Growth on acetate however requires a different pathway, called 
the glyoxylate bypass, as acetate is converted directly to acetyl-CoA for metabolism by 
the TCA cycle, by-passing the production of PEP and pyruvate completely (Komberg, 
1966).
As the name suggests the glyoxylate bypass by-passes those reactions of the TCA 
cycle that release CO2, by converting one molecule of acetyl-CoA plus one molecule of 
isocitrate to one molecule of of succinate and malate (see figure 1.3). This requires the 
presence of the two enzymes isocitrate lyase (ICL) and malate synthase (MS), which 
catalyse the first and second reactions of the pathway respectively (see figure 1.3).
1 .2 .1  Control of IDH activity bv IDH kinase/phosphatase in E. coli.
Under conditions in which both the glyoxylate bypass and TCA cycles are 
functioning, there is competition between ICL and IDH for available isocitrate. The flux 
between these pathways therefore needs to be coordinated to ensure the optimum ratio of 
flux through each pathway. There is no evidence for allosteric control of either of these 
enzymes though raising the question of how the two enzymes are controlled. Work 
performed by several groups indicated that the control was mediated via the regulation of 
IDH activity and is discussed below. The mechanism by which IDH activity can control 
flux is discussed in section 1.2 .2 .
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Figure 1.3 The TCA cycle and glyoxylate bypass.
The TCA cycle is represented as a cycle of reactions. The glyoxylate bypass 
(reactions 1 and 2) is drawn with arrows passing through the middle of the TCA cycle. 
Large arrows indicate flux to biosynthesis.
1) Isocitrate lyase (ICL). 2) Malate synthase (MS).
3) Isocitrate dehydrogenase (IDH).
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Holms and Bennett (1971) found that E. coli grown on limiting amounts of glucose 
exhibited diauxic growth. As cells metabolised glucose, acetate was excreted into the 
medium. The acetate was utilised by the cells once the preferred carbon source (in this 
case glucose) had been exhausted. Concomitant with the change from growth on glucose 
to acetate, the total level of IDH activity was found to decrease. Once all of the acetate 
was exhausted IDH activity increased again showing that the inactivation of IDH was 
fully reversible.
When E. coli was grown on acetate as a sole carbon source, specific activity of IDH 
was found to be only 30% of the value obtained during growth on glucose or pyruvate 
(Bennett and Holms, 1975). However, addition of pyruvate to such cultures increased 
IDH activity to levels similar to those found in glucose-grown cells. Once pyruvate was 
exhausted, the IDH activity returned to the original lower activity.
Dialysis of IDH and mixing experiments showed that this effect was not mediated by 
the action of low molecular weight effectors. Addition of chloramphenicol to cultures 
grown on acetate, just before the addition of pyruvate, did not prevent the increase in 
IDH activity either, showing that de novo protein synthesis was not responsible for this 
increase. It was therefore suggested that a reversible covalent modification of the enzyme 
might be responsible (Bennett and Holms, 1975).
Gamak and Reeves (1979a and b) showed that during the period in which IDH 
activity decreased, IDH became phosphorylated at a serine residue. LaPorte and 
Koshland (1982) demonstrated that both the phosphorylation an de-phosphorylation 
activities were catalysed by a bifunctional protein which was called the isocitrate 
dehydrogenase kinase/phosphatase (IKP). The phosphorylation catalysed by the IKP 
caused the complete inactivation of IDH. This is unusual as most other phosphorlation 
mechanisms alter the affinity of an enzyme for substrate (see section 1.2.3 and Barford,
1991). The IKP protein was found to be a homodimer meaning that the two activities 
must in fact be present on a single polypeptide. This was confirmed by the cloning of a 
single gene {ace K) that was able to produce IKP activity when expressed (LaPorte et 
al., 1985). However, it is still unclear if these activities are catalysed by the same or 
distinct active sites (Ikeda et a l, 1991).
Purification of the IKP allowed further studies of the properties of this enzyme in 
vitro (Nimmo et al, 1984). Both the kinase and phosphatase activities of the IKP were 
found to be active simultaneously but subject to allosteric regulation by a number of 
effectors. Such effectors will stimulate phosphatase activity and inactivate kinase activity 
when the cell requires high IDH activity.
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Purification and analysis of both the inactive and active forms of IDH from cells 
grown on acetate showed that the only difference between the two forms was the 
presence of a phosphorylated serine on the inactive IDH. Subsequent proteolysis of the 
phosphorylated, inactive, enzyme allowed Borthwick et al. (1984c) to identify a peptide 
which contained the phosphorylated serine. Comparison of this to the entire gene 
sequence, later published by Thorsness and Koshland (1987), showed that this serine 
corresponds to SER-113.
1 .2 ,2  How do changes in IDH activity control the flux between the TCA 
cvcle and glvoxvlate bvpass_l
It has been mentioned in section 1.2.1 that IDH activity in cells grown on acetate is 
lower than cells grown on glucose and that this control is mediated by the bifunctional 
kinase/phosphatase enzyme IKP. However the role of this activation/inactivation cycle 
has not yet been addressed. Holms and Bennett first proposed that the inactivation of 
IDH during growth of E. coli on acetate might allow ICL to compete more effectively 
against EDH for available isocitrate. This suggestion was supported by the following 
data.
Although different values have been reported for the Km of ICL for isocitrate, it is 
clear that the Km is higher than the Km of IDH for isocitrate (Nimmo et al., 1987). A 
consequence of this is that ICL cannot compete with IDH for isocitrate when intracellular 
concentrations of the substrate are low (Nimmo et al., 1984). This situation is found in 
cells grown on glucose, where the isocitrate concentration is below the levels of detection 
(ElMansi et a l, 1985). During growth on acetate, IDH is partially inactivated, reducing 
the flux of isocitrate through the TCA cycle and leading to a build up of isocitrate to an 
intracellular concentration of 570 pM (ElMansi et al., 1985 and Holms, 1987).
It was described in section 1.2.1 that IDH activity is controlled by a 
phosphorylation/dephosphorylation mechanism in which both activities are catalysed by 
IKP. The role of this system is essentially to maintain the isocitrate concentration at a 
value that will sustain the correct balance of flux between the glyoxylate bypass and TCA 
cycle. To control this system, the IKP is sensitive to various metabolites that can either 
stimulate phosphatase activity or inhibit kinase activity, depending on the requirement of 
the cells for precursors and energy. For instance, increasing levels of the TCA cycle 
intermediates, PEP, pyruvate, 3-phosphoglycerate, OAA and 2-oxoglutarate signal a 
reduced requirement for the glyoxylate bypass. To reduce the flux of isocitrate through 
the glyoxylate bypass, activity of IDH is increased, via stimulation of the phosphatase 
activity and inhibition of the kinase activity. Isocitrate has a similar affect on the kinase
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and phosphatase activity and could be the most important effector, as a low concentration 
of this metabolite directly prevents flux through the bypass.
AMP and ADP also stimulate phosphatase and inhibit kinase activity. These 
metabolites probably indicate reduced cellular energy levels, a situation where flux 
through the TCA cycle would be favoured (Nimmo et al., 1987).
1 .2 .3  Mechanism bv which IDH is inactivated.
Phosphorylation usually affects enzyme activity by altering the affinity for substrate 
or by modifying the response to effectors. Glycogen phosphorylase (GP) provides a 
good example of an enzyme controlled in this sort of way. In its de-phosphorylated form, 
GP is dependent on AMP for activity. Phosphorylation of a serine residue on the enzyme 
induces a large conformational change, which relieves the enzyme from AMP 
dependence. This contrasts with the situation found for the IDH from E. coli where 
phosphorylation (at SER-113) causes the almost complete inactivation of the enzyme. 
The differences between the roles of these two types of phosphorylation are discussed in 
a review by Barford (1991).
To investigate how the phosphorylation of SER-113 causes the inactivation of the E. 
coli IDH, mutants were created in which the SER-113 residue was changed by site- 
directed mutagenesis to amino acids with different properties. Substitution of SER-113 
by the negatively charged amino acid aspartate (S113D), which has the same charge as 
phosphorylated serine but not the same shape, caused virtually complete inactivation of 
the enzyme (Thorsness and Koshland, 1987). Substitution of the positively charged 
amino acid, lysine (S113K), or introduction of the bulky amino acid tyrosine (S113Y) 
only affected enzyme activity by a comparatively small amount (Dean et al., 1989). These 
experiments therefore suggested that it is the negative charge of the phosphorylated serine 
that is the main factor contributing to the inactivation of IDH, whereas steric interference 
contributes little to the inactivation.
Crystal structures were determined for both the phosphorylated and native IDH in 
order to determine if phosphorylation induces conformational changes in IDH that may 
contribute to inactivation of the enzyme (Hurley et al., 1990a). The only conformational 
changes observed were minimal and localised to around the site of phosphorylation. 
Comparison of the mutant enzymes that had aspartate or glutamate residues replacing 
SER-113 showed that this small change plays no part in inactivation as the inactive 
mutants had conformations that were more similar to the native IDH than to the 
phosphorylated form.
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It has therefore been shown that most of the inactivation was caused by the 
electrostatic effect of having a negative charge at position 113. No mention has yet been 
made of how this charge causes the inactivation. Before this crystal structure was 
available, Nimmo and colleagues suggested that this charge acted by preventing the 
binding of NADP+ to the phosphorylated enzyme. Fluorometric titration experiments 
indicated that NADPH would bind to active, native enzyme but not to the phosphorylated 
form, whilst phosphorylation of the active enzyme seemed to protect it from limited 
proteolysis in a similar way to the protection afforded by NADP+ bound to the enzyme 
(Garland and Nimmo, 1984). Inactive enzyme was also found to be incapable of binding 
to Procion Red columns, unlike the native form which would bind and could then be 
eluted with NADP+ (Borthwick et al., 1984 b). Yet further evidence was presented by 
McKee and Nimmo (1989) when they found that inactivation of the enzyme by 
phenylglyoxal could be prevented either by phosphorylation of the enzyme or by the 
addition of NADP+.
However, equilibrium dialysis experiments performed by Dean et al. (1989) 
indicated that it was isocitrate that could not bind to the phosphorylated enzyme and that 
NADP+ could bind equally well to both the phosphorylated and non-phosphorylated 
forms. Similar experiments were also performed with the mutant IDH in which the 
phosphorylatable serine had been changed to an aspartate residue causing virtually 
complete inactivation of the enzyme. Again, the enzyme was found to bind NADP+ but 
not isocitrate.
Once it had been established that enzyme activity was prevented by the exclusion of 
the substrate, experiments were performed to determine how phosphorylation of the 
enzyme caused such a dramatic reduction in enzyme activity (Dean and Koshland, 1990). 
The amino acid in IDH that is phosphorylated by the IKP (SER-113) was replaced with 
amino acids with different properties and the effect on IDH activity measured. The 
introduction of negatively charged amino acids {eg. S113D as mentioned above), showed 
that the negative charge caused a 10  ^fold increase in the Km for isocitrate, whereas steric 
interference (as shown by S113Y) caused a 104 fold increase. Loss of a hydrogen bond 
also caused a 2 fold decrease in the Kms (shown by S113A).
Measurements of Kms were also made for the native and mutant IDHs using the 
substrate analogue, 2R-malate. Although this analogue lacks the y-carboxyl group of 
isocitrate it does act as a poor substrate for the IDH. The Kms of the native IDH, the 
phosphorylated IDH and each of the mutant enzymes were found to be very similar. 
Since the analogue differs from isocitrate only in the fact that it does not possess a y- 
carboxyl group, it was concluded that the phosphorylation of IDH prevented isocitrate 
binding by repulsion of the isocitrate at this group. When the crystal structure of the IDH-
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isocitrate complex was determined it was shown that the SER-113 does indeed make 
contact with the carboxyl group of isocitrate (Hurley et al. 1990b).
1 .2 .4  IPH s from some other sources.
It was first noticed by Fukanaga et al. (1988) that most bacterial NADP+ dependent 
IDHs can be classified into one of two groups, based on their quaternary structure. Most 
of the enzymes studied so far belong to the class which is typified by the enzyme from E. 
coli and the IDH-I from Vibrio spp. ABE-1. They are homodimers with a subunit size 
of c.45 kDa. The second class of enzymes are all monomers of molecular weights around 
80,000 which are typified by the IDH from Azotobacter vinelandii and the IDH-II from 
Vibrio spp. These these two classes of IDHs have been called type I and type II 
respectively, after the two enzymes found in Vibrio spp. ABE-1.
Although most bacteria have been found to have either one or the other of these 
enzyme types (see figure 1.4 for summary), Vibrio spp. was found to contain one of 
each, whilst A.calcoaceticus was found to contain a type I enzyme and another, as yet 
unclassified IDH with a native molecular weight of 300 kDa (Self and Weitzman, 1972).
1.2.4.1 Type I IDHs.
Based on the subunit organisation alone (homodimers of c.45kDa subunits), most 
bacterial IDHs studied to date can be classified as type I IDHs. Fukanaga et al. (1988) 
showed that they could also be classified according to their cross-reaction with 
antibodies. Antibodies raised against the IDH-I from Vibrio spp. were found to cross- 
react with the E. coli and Salmonella typhimuriiun IDHs, both of which are dimeric 
enzymes. Moreover the antibody raised against the type II enzymes did not cross-react 
with these type I IDHs, showing that the monomeric IDHs are substantially different 
from the type-I enzymes.
Fukanaga et al. (1988) also showed that the N-terminal sequence of the Vibrio spp. 
IDH-I enzyme was similar to the N-terminal sequence from E. co li. It is now becoming 
clear that this is a general property of the type I IDHs since it was reported that the N- 
termini of the IDHs from Synechocystis spp. (Muro-Pastor and Florencio, 1992 and 
Thermus thermophilus (Eguchi et al., 1988) were also similar to the Vibrio spp. IDH-I 
and E. coli enzymes. It has since been found that that the entire protein sequence of the 
T. thermophilus enzyme is highly homologous to the E. coli sequence (Miyazaki et al.,
1992) as is the sequence from another dimeric IDH from Bacillus caldotenax (C.Wild, 
personal communication) indicating that the group-I IDHs are evolutionarily related.
1 9
IChapter It General Introduction.
IDH
Class
Organism
Native Mr 
(kda)
Reference.
I Vibrio spp. IDH-I
88(D) Ochiaief al., (1979)
I A.calcoaceticus IDH-I
100(D) Self and Weitzman (1972)
I T. thermophilus 115(D) ERuchi etal. (1988)
I P.variotii 99(D) Takao et al., (1986)
I R.spheorodes 105(D) Chung and Braginski 
(1972)
I B.stearothermophilus 92.5 (D) Howard and Becker (1970)
I E. coli 80(D) A.Borthwick (1984c)
I Synechocystis spp. 112(D) Muro-Pastor and 
Florencio (1992)
n Vibrio spp. IDH-II 81 (M)
Ochiai et al., (1979)
n A.vinelandii 78 (M) Barrera and Jurtshuck 
(1979)
n Rhodomicrobium vannielii 75-80 (M) Leyland and Kelly (1991)
ND A.niger 60 (M) Meixner-Monori et al. 
(1986)
ND A.calcoaceticus IDH-II 300 (M) Self and Weitzman (1972)
Figure 1.4 Summary of IDHs from some o ther organisms.
The table above classifies several EDHs by virtue of subunit size and quaternary 
structure.
The letters M and D in brackets indicate whether the enzyme is a monomer or a dimer 
respectively.
ND indicates that the enzyme belongs to a class of IDH that has not yet been 
determined and may therefore be unique.
i
f
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In common with the E. coli enzyme none of these enzymes seem to be allosterically 
controlled by any of the possible effectors such as AMP, ADP, ATP, NAD(P)+, 
NAD(P)H or intermediates of central metabolism. Also like the E. coli enzyme they are 
inhibited by the concerted effect of glyoxylate and oxaloacetate, although the 
physiological significance of this is doubtful (Nimmo, 1986). It was reported that the 
enzyme from Synechocystis spp. was inhibited by ADP and 2-oxoglutarate but the high 
concentrations required again make this effect seem insignificant in relation to control of 
the enzyme in vivo.
1.2.4.2 Tvoe II IDHs.
At the time that Fukanaga et al. (1988) had proposed the grouping together of the 
dimeric enzymes, there were only two examples of the 80 kDa monomeric IDHs. One 
was the IDH-II from Vibrio spp. and the other was from A.vinelandii, for which there is 
little further information available. The recent publication of a study of another 
monomeric form, from Rhodomicrobium vannielii (Leyland and Kelly, 1991), allows a 
more meaningful comparison of the monomeric IDHs to be made. It was reported that the 
N-terminal amino acid sequence of the R.vannielii enzyme was very similar to the N- 
terminal sequence of the IDH-II from Vibrio spp., but dissimilar to theVibrio spp. IDH-I, 
or any of the eukaryotic IDHs for which N-terminal data was available. Leyland and 
Kelly (1991) also reported that antisera raised against the R.vannielii IDH did not cross
j react with the IDHs from T. thermophilus or E. coli either, further
emphasising the differences between the type I and type II IDHs.
Unlike the IDHs from Vibrio spp. and other organisms, the R.vannielii enzyme has 
been reported to have both NAD+ and NADP-linked IDH activity (Leyland and Kelly, 
1991). The NAD-linked activity was reported to be inhibited by ATP. However the 
specificity (defined as k^/K m ) of the enzyme for NAD+ is 400 times lower than for 
NADP+, indicating that this activity and therefore the metabolic effect of ATP may be 
insignificant. It was also reported that the NADP+ dependent IDH activity was inhibited 
by OAA plus glyoxylate in the concerted manner reported for all IDHs so far studied 
(Nimmo, 1986). However, the NADP+ linked activity was also inhibited by OAA alone, 
a situation only previously reported for P.variotti which is a dimeric enzyme.
The classification of IDHs into type I and II does not take account of the properties of 
the IDH-II from A .calcoaceticus, which does not seem to belong to either class. The 
A.calcoaceticus enzyme not only has a native molecular weight (300 kDa) much larger 
than either of these groups, but it was also found to be stimulated by the addition of only 
20 pM pyruvate or glyoxylate. It was also stimulated 5-fold by the addition of 500 pM
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ATP, perhaps suggesting that each of these effectors regulates the IDH allosterically (Self 
and Weitzman, 1972; Self et al., 1973; Kleber and Aurich, 1975).
1.2.4.3 Possible role of IDH isoenzymes.
The existence of more than one form of IDH in | Vibrio spp. raises questions as to 
the function and control of each enzyme in cell metabolism. During growth on succinate it 
was found that the ratio of IDH-I activity to IDH-II was 1:5.6 (Ishii et al., 1987). 
However, during growth on acetate the level of IDH-I activity increased to 3 times its 
level on glucose, whilst the IDH-II activity remained virtually constant, altering the ratio 
of activities to 1:1.5. This change in activity was found to be due to increased levels of 
synthesis of IDH-I, as addition of chloramphenicol to the culture prevented this increase. 
This was further confirmed by monitoring the relative amounts of each enzyme, using 
antisera that had been raised against each.
It was assumed that this may somehow play a role in controlling the metabolism of 
isocitrate during growth on acetate. To elucidate the different roles that the enzymes may 
play, Fukanaga et al. (1988) isolated a mutant of Vibrio spp. (YG-83) that was 
completely devoid of any IDH-I activity yet had levels of IDH-II similar to the wild type 
strain (ABE-1). This strain grew at rates similar to the wild type on both acetate and 
succinate. The authors therefore concluded that IDH-I was not essential for growth on 
either substrate. However it is possible that this result is an artefact of the experiment 
since strain YG-83 was selected after two rounds of mutagenesis. The original 
mutagenesis produced an IDH-I mutant called YG-30 that was unable to grow on acetate 
without a cysteine supplement in the media. Its growth rate on glucose was also 10 fold 
lower than the growth rate of the wild-type strain. This cysteine auxotrophy was assumed 
to have occured by the coincidental introduction of a second mutation during 
mutagenesis. A second round of mutagenesis was therefore performed on the mutant 
YG-30 to select for a revertant to cysteine prototrophy which still lacked IDH-I activity. It 
was this strain (YG-83) that was used in the subsequent growth experiments. It is 
therefore possible that the successive rounds of mutagenesis could have modified the 
strain in some unexpected way that has caused the apparent loss of the requirement for 
IDH-I.
The situation found in A.calcoaceticus was found to be quite different to that in 
Vibrio spp. Although growth on acetate caused an increase in IDH-I activity by 1.5 fold 
compared to growth on succinate, IDH-II activity also increased, altering the ratio of 
IDH-I to IDH-II from 1:1.1, to 1:1.8 (Reeves et al., 1986). Experiments were not 
performed that would determine if this alteration was due to altered levels of protein 
synthesis, or by alteration of the enzyme activities. Once again, it was hypothesized that
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this has an effect on the control of the TCA cycle and glyoxylate bypass during growth 
on acetate. It was pointed out in section 1.2.4.2 that the A.calcoaceticus IDH-II enzyme 
is probably subject to allosteric control. It could therefore be that the activity of the 
allosterically controlled IDH is increased during growth on acetate to allow control of flux 
between the glyoxylate bypass and TCA cycle.
The role^isoenzymes and how essential they are for growth on different substrates in 
these two organisms is therefore still far from clear. Isolation of mutants for each of these 
organisms deficient in each of the enzymes would help to clarify the situation.
1.2.4.4 IDH isoenzymes from pig heart and Saccharomvces cerevisiae.
Many eukaryotes contain several forms of IDH, some of which are specific to certain 
organelles. The situation in S.cerevisiae provides a good example. This organism 
contains two mitochondrial IDHs, one of which is NADP-dependent and one of which is 
NAD-dependent, as well as another cytosolic NAD-linked IDH. The function of each 
enzyme is not really known, although it is assumed that the NAD-linked enzymes 
produce NADH for the production of energy via the electron transport chain. The 
NADP+ form probably produces NADPH and intermediates for cellular biosynthesis.
There is also a difference in the way that the enzymes are controlled. The 
mitochondrial NAD-linked IDH is controlled allosterically by effectors such as NAD+, 
AMP and citrate, whereas the NADP-linked enzyme activity is not affected by metabolites 
(Keys and McAlister-Henn, 1990). The NAD-EDH is different to the NADP-IDH in 
quarternary structure too. NAD-IDH was reported to be an octameric enzyme made from 
equal proportions of two subunits (EDH1 and IDH2) that are immunologically distinct 
and have different N-terminal amino acid sequences. The NADP+ isoenzyme is a dimer 
made from identical 45 kDa subunits (called IDP1) and is therefore similar to the NADP- 
IDH from E. co li.
The NAD-IDH from pig-heart has a subunit arrangement different from any of the 
IDHs mentioned so far. It was first reported that this was an oligomeric enzyme made 
from three different subunits in the ratio 4a:2p:2y (Ramachandran and Colman, 1980). 
However, Huang and Colman (1990) have since reported that the enzyme is actually a 
tetramer made up of three different subunits in the arrangement ap+ay.
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L 2 .5  Some sequence and structural similarities between the IDH from F. 
coli and other proteins.
The first IDH encoding gene was cloned from E. coli by LaPorte et al. (1985) which 
led to its sequencing by Thorsness and Koshland (1987). The inferred amino acid 
sequence was found to have no recognisable NADP+ binding site of the type originally 
proposed by Rossmann et al. (1974). What is more, it showed no sequence similarity to 
any other known dehydrogenase except for the NAD+ dependent enzyme, 
isopropylmalate dehydrogenase (IMDH) from Thermus aquaticus, which was also found 
to lack the Rossmann, type nucleotide binding sequence (see section 1.3.1).
The relevance of this similarity was not fully recognised however until the crystal 
structure of the E. coli IDH was elucidated by Hurley et al. (1989). It was then reported 
that sequence alignments could be made between the E. coli IDH and the six IMDHs for 
which sequence information was available, with between 25% and 29% identity. Since 
the IMDHs catalyse a very similar reaction to the IDHs and with a very similar substrate, 
it is perhaps not surprising to find that there is such a significant overall sequence 
conservation (Hurley et al., 1991).
A cluster of positively charged residues were found to be absolutely conserved in 
most of the sequences analysed, corresponding to ARG-119, ARG-129, ARG-153, 
TYR-160 and LYS-230 of the E. coli sequence. All of these residues were found to be 
contained within a pocket that perhaps allows them to interact with the negatively charged 
isocitrate (Hurley et ah, 1989). The residues that correspond to SER-113 of the IDH 
sequence are not conserved in the IMDHs, though. One would expect this, because SER- 
113 in IDH interacts with the y-COOH group of isocitrate, a functional group which is 
not present in isopropylmalate.
Elucidation of the three-dimensional structure of the isocitrate-IDH complex provided 
proof that the amino acids mentioned above, and SER-113, do in fact interact directly 
with the isocitrate (Hurley et ah, 1990b). It was expected from the amount of sequence 
conservation observed between the E. coli IDH and the IMDHs that the topology of the 
enzymes would be very similar. This was found to be the case when the crystal structure 
of the IMDH from Thermus thermophilus (a close relative of T.aquaticus ) was solved 
(Imada et ah, 1991). The arrangement of secondary structure in both enzymes is identical 
except for the absence in the IMDH of two |3-sheets and two a-helices that are present in 
the IDH.
2 4
Chapter 1. General Introduction.
It is therefore apparent from similarities in both the primary and tertiary structures, 
that both types of enzymes have diverged from a common ancestral protein to perform 
these two types of reaction which are similar. This evolution has led not only to the 
difference in substrate specificity but also to the difference in cofactor requirement.
As the work described in this thesis was nearing completion, three more IDH 
sequences were published. The IDH from T. thermophilus could be classified as a class 
I, E. coli -type IDH, by virtue of its subunit organisation and molecular weight (see 
section 1.2.4.1). It was therefore perhaps of little surprise that the recently published 
amino acid sequence for the T. thermophilus enzyme suggested that it was related 
evolutionarily to the IMDH/IDH group of enzymes (Miyazaki et al., 1992).
The T. thermophilus IDH was found to be 33% identical to the IMDH from the same 
organism and 37% identical to the E. coli IDH over most of its length. However the T. 
thermophilus IDH possesses an extra 140 amino acids at its C-terminus. Also, in 
common with the IMDHS, it lacks two of the p-sheets and two of the a-helices that are 
found in the E. coli IDH (see above). All the residues expected to bind substrate are 
conserved with respect to the E . coli sequence, including the amino acid corresponding 
to SER-113.
The other two IDH sequences published are both from S.cerevisiae mitochondria. 
One of the sequences is of IDH2; one of the two subunits of the NAD+ dependent 
enzyme (see section 1.2.4.4 and Cupp and McAlister-Henn, 1991). The other sequence 
is of the subunit that makes up the homodimeric, NADP-dependent IDH, IDP1 (see 
section 1.2.4.4 and Haselbeck and McAlister-Henn, 1991). Cupp and McAlister-Henn 
(1991) reported that the NAD-IDH showed 33% identity to the IDH from E. coli, despite 
the difference in cofactor specificity and quarternary structure. The same group also 
reported that there was no "significant homology" between the yeast and E. coli NADP- 
dependent IDHs, even though the yeast IDH could be classified as a type I IDH, like the 
enzyme from E. coli (Haselbeck and McAlister-Henn, 1991).
As well as the entire sequence for those proteins mentioned so far, peptide sequence 
is also available from each of the subunits that make up the NAD-IDH from pig-heart 
(Huang and Colman, 1990). It is described in section 1.2.4.4 that this enzyme has a 
different quarternary structure to both the NADP+ and NAD+ dependent enzymes 
mentioned so far being made up of three different subunits in the arrangement ap+ay. 
Three of the 5 peptides sequenced from the a  subunit were aligned with the sequence of 
the IDH2 subunit from yeast, as were four out of five peptides from the (3 subunit and all 
five of the peptides from the y subunit (Cupp and McAlister-Henn, 1991).This suggests
2 5
Chapter 1. General Introduction.
that all of the pig heart NAD-IDH subunits are related to each other and also to the NAD+ 
enzyme from yeast.
Lu2 N A P P + binding sites,
From the information discussed in the previous sections it would now seem that there 
are several IDHs and IMDHs that show relationships to each other (see section 1.2.5) 
based on sequence similarities. However none of these proteins were found to show any 
sequence or structural similarity to any other dehydrogenase and did not have a classical 
LDH-type NAD(P)+ binding site (section 1.3.1). In fact it was not until the crystal 
structure of the E. coli IDH-NADP complex was determined, that residues involved in 
nucleotide binding were identified.
It is now becoming clear that there are a number of different types of nucleotide 
binding sequences and structures, some of which are discussed here.
1 .3 .1  "Rossmann fold" (LDH) type nucleotide binding structures.
It had been noticed that the NAD+ and FAD+ binding domains of many proteins 
share a common structural motif that was called the "LDH fold", after the first enzyme in 
which this was identified. This structure consisted of two p ap ap  motifs which form a 
p-sheet that is responsible for the binding of the ADP moiety of the nucleotide, giving it 
the alternative name of the "PaP-ADP binding motif' (Wierenga et al., 1986). The first 
motif of the pair is involved in the binding of the adenine moiety whilst the second seems 
to be involved in the binding of the nicotinamide moiety (Rossmann et al., 1974).
Analysis of other nucleotide binding proteins by Wierenga et al., (1986) allowed the 
identification of eleven key amino acids that were conserved within this fold which, in 
turn, allowed the definition of a fingerprint that could be used to test other sequences for 
possible nucleotide binding sites. Some of these positions in the fingerprint required 
absolute conservation, whilst others described the type of side chain that an amino acid 
must possess. Most noticeable was the conservation of the sequence GXGXXG, which 
forms the loop between the first P-strand (called PA in the nomenclature of Rossmann et 
al., 1974) and the first a-helix (called aB; see figure 1.5). The first glycine (GLY-27 for 
spiny dogfish LDH; see figure 1.5) allows for the tight turn required of the loop whilst 
the second glycine (GLY-29, in figure 1.5) allows for the close approach of the 5'- 
pyrophosphate from NAD+ to the N-terminus of the a-helix. The third glycine (GLY-32, 
in figure 1.5) allows for the intercalation of the second p-strand, pB, and the helix aB at 
the point at which they are closest. All of the amino acids in the pB strand that come close 
to the helix aB were found to be hydrophobic residues that enable the two structures to
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come close to each other with the minimum of unfavourable interactions (see amino acids 
labeled in boxes ( D ) figure 1.5). An acidic amino acid was also always found at the end 
of the second P-strand which allowed the formation of a hydrogen bond between the side 
chain and the 2'-hydroxyl of the NAD+ (ASP-52 for the spiny dogfish LDH).
Wierenga et al. (1986) noted that the consensus sequence proposed by them excluded 
many of the NADP+ binding enzymes including those, such as GR, that are known to 
contain pap-type nucleotide binding folds. This was due to two differences. Firstly, they 
noticed that the core consensus sequence of nucleotide binding residues found in 
NADP+-linked enzymes is GXGXXA and not GXGXXG. Secondly, they realised that 
the acid amino acid found in NAD-linked enzymes, that is required to interact with the 2'- 
hydroxyl of the NAD+, would actually hinder the binding of NADP+ because of the 
negatively charged 2' pyrophosphate group. NADP-dependent enzymes were therefore 
frequently found to contain hydrophobic residues at the equivilent position. It was 
therefore proposed that these two main differences between NAD and NADP-linked 
enzymes could account for the different coenzyme specificities.
This simple explanation seemed to be supported by the results of a series of elegant 
experiments by Scrutton et al. (1990), which are discussed in section 1.3.2. However, 
recent work by Lilley et al. (1991) on the glutamate dehydrogenase (GDH) from 
Clostridium symbiosum has shown that this model cannot be said to be applicable to 
every NAD(P)-dependent enzyme.
■L3,2  Mutagenesis of glutathione reductase converts the enzyme fron 
being NADP+ dependent to NAD+ dependent.
Glutathione reductases (GRs) are known to contain LDH type PaP-folds because the 
crystal structure had been elucidated for the enzyme from human erythrocytes (Karplus et 
al., 1987). This enzyme belongs to a family of proteins called the "flavoprotein 
disulphide oxidoreductases", most of which are NADP(H)-dependent. One exception to 
this is the dihydrolipoamide dehydrogenase (DLDH) class of enzymes which are NAD- 
dependent, yet show significant sequence similarity to other members of the GR family. 
Scrutton et al. (1990) therefore compared the amino acid sequences from seven of the 
NADP-dependent enzymes (including GRs) with the sequences from seven of the NAD+ 
dependent enzymes (which included DLDHs) in an attempt to identify residues that might 
be involved in imposing coenzyme specificity.
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Figure 1.5 Schematic diagram  of the W ierenga P ap  fold of LDH.
An NAD+ molecule is shown in the position in which it is bound to the spiny dogfish 
M-lactate dehydrogenase (LDH). From Wierenga et a l, 1986.
0 = basic or hydrophobic amino acids.
A= small and hydrophobic amino acids.
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Residues were identified that were conserved in the NADP+ dependent enzyme but not in 
the NAD-dependent enzymes, and vice versa. Site-directed mutagenesis was used to alter 
amino acids in the GR from E. coli to those used by the DLDH from the same organism, 
in an attempt to alter the coenzyme specificity of GR. These changes are discussed below 
and summarised in figure 1.6 .
One of the most striking differences between the two types of enzymes was the 
complete conservation of arginine residues in two positions in all of the NADP+ 
dependent enzymes (shown as positions 4 and 7 of the sequence shown in figure 1.6) 
whereas there was no significant conservation in the DLDHs. Conversion of either of 
these arginines in the E. coli GR to the corresponding residues found in the E. coli 
DLDH sequence caused the Km for NADP+ to increase by 25 fold, whilst the kcat 
decreased by 3 fold. Conversion of both residues at once still gave a 25 fold increase in 
the Km for NADP+ but decreased the final kcat further, to only 5% of the wild type level. 
Although the conversion of these residues obviously led to a decreased affinity and 
reactivity for the NADP+ dependent activity of the mutant GR, it was found to only have 
a small effect on the ability of the enzyme to use NAD+ (there was a 3 fold drop in the 
Km for NAD+). This is consistent with the use of these residues to bind to the 2'- 
phosphate of NADP+, which is lacking in the NAD+ molecule.
The other striking difference is the presence of alanines found in all of the NADP+ 
dependent enzymes, (positions 1 and 2 figure 1.6 ) instead of the glycines found in most 
of the NAD+ dependent enzymes. The alanine at position 1 corresponds to the third 
glycine in the Wierenga consensus sequence, GXGXXG, which was reported to be 
necessary for the close approach of helix aB to the (3-sheet, |3B (Wierenga et al., 1986). 
Conversion of the alanine at position 1 (figure 1.6) in the E. coli GR to the 
corresponding glycine found in the NAD+ dependent enzymes caused a 40 fold decrease 
in the Km of the enzyme for NAD+ although the Km for NADP+ and the k^t for both co­
enzymes changed little. Introduction of the mutation in position 2 of the sequence was 
only performed in the presence of the other three mutations already mentioned (A179G, 
R198M, R204L) but was found to have little effect on any of the parameters for either of 
the co-enzymes.
Wierenga et al. (1986) had already proposed that in LDH type enzymes, the acidic 
residue at the end of sheet pB was used in binding of the 2'-hydroxyl of NAD+ and that 
this type of residue would hinder the binding of NADP+ (see above). This residue 
corresponds to position 3 of figure 1.6, where all the DLDHs were found to contain a 
conserved glutamate (other NAD linked dehydrogenases eg. LDH usually have aspartate) 
whereas all of the NADP+ dependent enzymes had non-acidic residues that would not 
interfere with the negatively charged 2'-phosphate found on NADP+. Valine-197 was
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1 2 3 4 5 6 7
GR - 174 G-X-G-X-X-A-X-X-X-A-(6X)-G-(6X)-X-R-K-H-(3X)-R-(2X)-D 207 
DLDH - 180 G-X-G-X-X-G-X-X-X-G-(6X)-G-(6X)-E-X-M-D-(3X)-P-(2X)-D 213
Summary of changes made to GR.
1. A179G 3. V197E 5. K199F 7. R204L
2. A183G 4. R198M 6 . H200D
Figure 1.6 G lutathione reductase is converted from  NADP+ to NAD+ 
dependency by site directed mutagenesis
Summary of the changes made to the E. coli NADP+ dependant GR in order to alter 
its coenzyme specificity to NAD+. The amino acids changed are indicated below and with 
the exception of change number 7, were changed to the equivalent amino acid found in 
the NAD+ dependent DLDH from E . coli (Scrutton et ai> 1990). The changes were 
made on the basis of those amino acids that were conserved within the enzyme type (ie. 
NAD+ or NADP+) which are shown in the sequences above. The non-conserved amino 
acids are shown as Xs.
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therefore substituted for a glutamate in the mutant GR that had already been modified at 
the four positions previously mentioned (A179G, A183G, R198M, R204L). At the same 
time two other mutations were introduced (K199F, H200D) in order to eliminate any 
residual positive charges in the surrounding area (positions 3, 5 and 6  in figure 1.6). This 
change increased the k ^ t of the NAD+ dependent enzyme activity by 3 fold. The for 
NADR1- dependent activity was also decreased by 2 fold. The Kms for the two 
coenzymes were also altered inversely, decreasing by 1.3 fold for NAD+ and increasing 
by 3 fold for NADP+.
With all of these mutations together, the effect was therefore to increase the specificity 
(kcat /Km) of GR for NAD+ by 70 fold whist decreasing the specificity for NADP+ by 
250 fold. It is worth pointing out though that there are some combinations of mutations 
that produced unexpected and as yet unexplained results, perhaps indicating a more 
complex model for specificity than the one proposed. However the experiments did show 
that both the NAD+ and NADP+ nucleotide binding domains studied are in fact related 
and can be interconverted by appropriate mutations.
In summary then, it would appear that there are "three classes" of amino acids that 
impose coenzyme specificity in different ways. Amino acids in positions 4 and 7 allow 
for favourable interactions with the 2'-phosphate of NADP+, which contributes to the 
ability of the enzyme to use NADP+, but does not affect its ability to use NAD+. 
Conversely the presence of a glycine at position 1 seems to increase the affinity of the 
enzyme for NAD+ considerably, whilst not affecting the enzymes specificity for NADP+ 
by very much. The third set of amino acids that are involved in imposing this specificity 
are those involved in binding of the 2'-hydroxyl of NAD+. These amino acids not only 
contribute to the ability of the enzyme to bind NAD+ but also contribute in the rejection of 
NADP+ by creating unfavourable interactions with the 2'-phosphate of this molecule.
1 .3 .3  GPH from C.svm biosum  does not conform to the Scrutton model 
for NAD(P)+ binding.
The general aplicability of the simple model for coenzyme specificity to all proteins 
has recently been thrown into some doubt by studies of the glutamate dehydrogenases 
(GDHs) from Clostridium symbiosm (Lilley e ta i,  1991).
This enzyme is an NAD+ dependent enzyme and yet contains a nucleotide binding site 
(identified by the presence of an Pap-nucleotide binding fold in the crystal structure) 
with the sequence GXGXXAXXXA. This sequence conforms to the consensus normally 
associated with the binding of NADP+ in NADP+ dependent enzymes (Scrutton et al., 
1990). NAD+ dependent enzymes are expected to possess the sequence GXGXXG
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(Wierenga et al., 1986). The empirical correlation of nucleotide binding sites therefore 
needs to be reassessed since some other factor must determine the coenzyme specificity 
of the C.symbiosum enzyme.
1 .3 .4  Non-LDH type nucleotide binding domains.
1.3.4.1 Flavoprotein pyrimidine nucleotide cytochrome reductases.
Karplus et al. (1991) had shown that the enzymes ferredoxin-NADP+ reductase, 
cytochrome P450 reductase, nitrate reductase and sulphite reductase were very similar at 
the amino acid sequence level and that they should be grouped together as a family of 
enzymes called the "Flavoprotein pyrimidine nucleotide cytochrome reductases". This 
family therefore contains both NAD+ and NADP+ dependent enzymes. Determination of 
the structure of ferredoxin-NADP+ reductase (FNR) from spinach allowed the amino 
acids involved in binding of FAD+ and NADP+ to be elucidated (Karplus et al., 1991). 
Sequence alignments of the FAD+ and NADP+ binding sites of FNR to the NAD+ 
dependent enzymes, nitrate reductase and cytochrome bs reductase, and the NADP+ 
dependent enzymes, cytochrome P450 reductase and sulphite reductase, showed that 
residues were conserved amongst enzymes with both coenzyme specificities.
The domain that contains NADP+ binding residues looked topologically similar to the 
domain found in the LDH type nucleotide binding fold, consisting of a 5-stranded parallel 
(3-sheet surrounded by 6 a-helices. NADP+ was found to bind to the C-terminal edge of 
this sheet, like in the LDH-type folds. The negatively charged 5'-phosphate of the 
NADP+ approaches the N-terminus of an a-helix, where interactions with the protein are 
probably stabilised by the positively charged dipole. This is again similar to the LDH- 
type fold. It was also reported by Hyde et al. (1991) that those amino acids in NADP+ 
dependent members of the family that would bind the 2’-phosphate of NADP+, were 
different from the amino acids used by NAD+-dependent members of the family. This is 
again reminiscent of the structure in the LDH type folds. Two invariant glycines were 
also found within the conserved sequence, GXGXXP which in part coincides with the 
LDH type consensus sequence, GXGXXG/A.
There are however significant differences between the nucleotide binding fold of this 
family of enzymes and those found in the LDH family. For instance the loop containing 
the conserved GXGXXP sequence was found to be at the end of a (3-sheet that would 
correspond to the (3C-sheet of the LDH rather than the normal PB-sheet. It was also 
found to make a much tighter turn than the loop found in the LDH family of enzymes.
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The complete conservation of the proline in the FNR type sequences, instead of the 
glycine normally expected for an NAD+ binding fold, or the alanine expected in NADP+ 
binding folds, is also a difference between this family of enzymes and the LDH-type 
folds. It also indicates that this amino acid cannot play a major role in determining the 
coenzyme specificity of the enzymes, as it is conserved in both NAD+ and NADP+ linked 
forms.
The differences found between the LDH and FNR type enzymes may indicate that 
they have both evolved separately the ability to bind NAD(P), although a divergent 
relationship cannot be ruled out.
1.3.4.2 Aldose reductase.
One of the conserved features in all of the NAD(P)+ binding enzymes discussed so 
far is the binding of the cofactor at the C-terminal edge of a parallel p-sheet. Another is 
the use of the positive dipole found at the N-terminal end of an a-helix to stabilise protein 
interactions with the the negatively charged pyrophosphate moiety of NAD(P).
However neither of these features are used by aldose reductase from pig lens, which 
is found to be a single domain made from an eight stranded aP-barrel that could not 
contain a typical pap-ADP binding fold (Rondeau et al., 1992). This enzyme uses both 
the C and N-terminal ends of the p-sheets to bind NAD(P)+ and relies solely on the use 
of positively charged amino acids to stabilise the pyrophosphate moiety.
It remains to be seen if this structure is used by any other enzymes for the binding of 
nucleotides but indicates another way in which nature has evolved a mechanism for 
binding of NAD(P)+.
1.3.4.3 E. coli IDH nucleotide binding site.
It was mentioned in section 1.2.5 that the E. coli IDH shows little similarity to any 
other dehydrogenase, except for the IMDHs to which it is related. Analysis of the crystal 
structure of the E. coli IDH and of sequences from both types of enzyme revealed that 
there is no Pap-ADP binding fold either (Hurley et al., 1989). It was not until the 
structure of the NADP+ bound to the IDH was determined that one could examine the 
structural features and the amino acids involved in the binding of NADP+.
NADP+ was actually found to bind within the same cleft as isocitrate which is formed 
between the large and small domains of the subunit and is different to any of the binding 
structures discussed so far. The negatively charged pyrophosphate moiety is found to
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bind at a loop that is found at the N-terminus of an a-helix, taking advantage of the 
positive charge found there. This is therefore similar to both the LDH and FNR type 
folds (Wierenga et al., 1985). The close approach of a loop to the N-terminus of an a- 
helix therefore seems to be a feature used in many NADP+ binding sites.
In summary then it could be said that there are now several examples of NAD(P)+ 
binding structures which seem to have evolved independently of each other. Some 
similarities in the structures employed (and in some cases the amino acids) would seem to 
indicate that the number of structures that can be used in nucleotide binding is limited. 
However there is still significant variability even between related binding structures.
L A  Aims of the project.
As described in section 1.1.2, it is of interest to study IDH because of the control it is 
likely to have over the TCA cycle and glyoxylate bypass and the effect that it may have on 
antibiotic biosynthesis, especially of the polyketide, actinorhodin. Alteration of the levels 
of IDH activity in S. coelicolor will provide information as to what control (if any) IDH 
has over both primary and secondary metabolism and may provide an insight into how it 
could be altered to increase antibiotic production.
IDH activity could be increased by the introduction of multiple copies of the gene for 
IDH whilst mutations can be introduced into the chromosomal copy by insertional 
disruption studies. The ultimate aim of this project was therefore to clone the gene from 
S. coelicolor that encodes IDH so that these studies could be performed.
Perhaps the best way to clone this gene is by complementation of a mutant of S. 
coelicolor that has no IDH activity (and would therefore probably be auxotrophic for 
glutamate or proline). Randomly cloned DNA fragments could be introduced into the 
mutant and transformants selected for restoration of prototrophy. Unfortunatlely no S. 
coelicolor IDH mutants are available. Attempts to make them have proved difficult, 
probably due very poor growth rates or the lethality expected for such mutants 
(S .Fischer, personal communication).
Mutants of E. coli do exist which lack IDH activity which could be used in similar 
complementation studies. However this makes two important assumptions;
a) That the streptomycete IDH gene will be expressed in E. coli. From the comments in 
section 1.1.3. it is clear that this could not be relied upon.
b) That the streptomycete IDH enzyme will be able to replace the function of the E. coli 
IDH to an extent that will allow prototrophic growth.
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The method of choice was therefore to clone the gene using the technique of so-called 
"reverse genetics". This involves obtaining part of the amino acid sequence of the protein 
of interest from which one can predict the most likely DNA sequence encoding the region 
(based on the codon usage bias of other streptomycete genes). Oligonucleotides can then 
be constructed that should hybridise to the coding sequence, providing a specific probe 
for selection of DNA fragments that contain the gene of interest
As there was no protein sequence information available for the S. coelicolor IDH the 
first step was therefore to purify the protein to a level that would enable the determination 
of either N-terminal or internal peptide sequence (by Edman degradation). The aims of 
this project were therefore as follows.
1) To purify the IDH from S. coelicolor and study some of the relevant basic properties 
of the enzyme.
2) To obtain N-terminal and/or internal protein sequence.
3) To design and synthesise an oligonucleotide based on the protein sequence and use as 
a probe for screening libraries and/or digests of S. coelicolor genomic DNA.
4) To sequence the enzyme for comparison to other proteins, especially the E. coli IDH 
and to search for any interesting conserved features at either the DNA or amino acid level.
5) To initiate complementation studies in E. coli and overexpression and gene 
disruption experiments in streptomycetes.
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2 .1  Chemicals and biochemicals*
Ampicillin, benzamidine, blue dextran, bromophenol blue, Coomassie brilliant blue, 
ethidium bromide and spermidine were obtained from Sigma Chemical Co., Poole, UK.
Bactotryptone, casamino acids, yeast extract and Bactotryptone (agar) were obtained 
from Difco, Detroit, USA.
ATP, DTT, NAD+, N A D P+, NADPH, p h o sp h o en o lp y ru v a te , 
phenylmethanesulphonyl fluoride (PMSF), N,N,N',N'- tetramethylethylene diamine 
(TEMED), and Tris buffer were obtained from Boehringer Mannheim, Lewes, UK.
DMSO, phenylalanine, polyethylene glycol 8000, and tryptophan were obtained from 
BDH Chemicals, Poole, U
Agarose, isopropyl-p-thiogalactoside (IPTG), phenol (ultrapure), and 5-bromo-4- 
chloro-3-indoyl-B-galactoside (X-gal) were obtained from BRL, Gibco Ltd., Paisley, 
UK.
Acrylamide, bisacrylamide and SDS were obtained from FSA Laboratory Supplies, 
Loughborough, UK. Junlon PW110 was a gift from Honeywell and Stein Ltd., 
Wellington, UK.
Oligonucleotides were synthesised on an Applied Biosystems Model 280A DNA 
synthesiser, at the Institute of Genetics, University of Glasgow.
All other chemicals were of analytical reagent grade and were obtained from one of 
the following suppliers: BDH Ltd., Poole, UK ; Formachem Ltd., Strathaven, UK; FSA 
Laboratory supplies, Loughborough, UK; Koch-Light Ltd., Haverhill, UK.
2-l1  Enzvmes. p roteins and kits.
A kit for molecular weight determination and the following enzymes and proteins 
were obtained from Sigma Chemical Co., Poole,UK.
All restriction enzymes, T4 DNA ligase, and T4 Polynucleotide kinase were obtained 
from BRL, Gibco Ltd., Paisley, UK.
Sequencing kits used were, TaqTrack™ (Promega Corporation, Madison, USA), T7 
sequencing kit (Promega Corporation, Madison, USA), and Taqenase™ sequencing kit 
from USB Biochemicals (La Jolla, USA).
X DNA packaging kits "GIGAPACK™ GOLD" and the plasmid vectors pBlusescript 
II (KS+) and (SK+) were supplied by Stratagene (La Jolla, USA).
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1*2  Media used for growth of S.coelicn la t.
All growth media were sterilised by heating to 120°C for 15 mins in an autoclave. 
Supplements and buffer solutions were heated to 108°C and CaCl2 to 114°C for 10 mins. 
Heat-labile solutions, such as amino acids, were sterilized by filtration through Nalgene 
0 .2 2 jim pore membranes.
2.3.1 Minimal Media.
The minimal media below was used to allow growth on defined media with different 
carbon sources (developed by Hobbs et al., 1989).
a) Glucose NMM.
4 g glucose, 4.5 g NaNo3, 5 g NaCl, 5 g Na2SC>4 , 1 g MgS0 4 .6H2 0 , 0.5 g CaCl2 , 
O.Olg ZnSC>4 , 1.2 g Tris buffer, 1 g Junlon, 20 g KH2PO4 pH 7.2. Made to 1 litre with 
distilled water. The phosphate was autoclaved separately and added prior to inoculation.
Also added was 1 ml of a filter sterilized trace salts solution containing per litre ; 
2.04g ZnCl2, 1.015g MnCl2 .4H20 , 0.310g H3BO 3 , 0.425g CuC12 .2H20 , 0.242g 
Na2MoO4 .2H20 , 0.238g CaCl2.6H20 , 8.775g FeCl3 and 0.415g Nal.
b) Acetate NMM.
Same as above except;- Glucose was replaced by 1 g/1 of NaAcetate. NaCl was 
ommited. The pH of the mixture was adjusted to pH 7 with NaOH prior to autoclaving at 
5 psi for 50 minutes.
2.3.2 Complex media.
a) Sova Mannitol Agar (SM)
This was used as a general plating media for Streptomyces, particularly for production 
of spores. It consists of 20g mannitol, 20g soya bean flour, 16g agar, made up to 1 litre 
using tap water.
b) Yeast extract-Malt extract (TEME).
This media was used for most purposes. It consists of 3g Difco yeast extract, 5g 
Difco bacto peptone, 3g Oxoid malt extract, lOg glucose, 340g sucrose, made up to 1 
litre in distilled water.
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2lA  Buffers used in purification of IDH.
a.) Phosphate buffer.
Stock phosphate comprises of 0.5 M KH2PO4 adjusted to pH 7.0 with KOH. 
tO Buffer A.
50 mM phosphate buffer (pH 7.0), 1 mM EDTA and 0.4 M DTT. DTT was always 
added immediately prior to use from a freshly thawed frozen stock.
c) Buffer B.
As buffer A but 50GnM phosphate buffer. 
di Extraction buffer.
As buffer A but with 3.5 mM benzamidine (made in dH2 0  and kept as a frozen stock) 
and 1.2 mM PMSF (made up fresh in absolute alcohol) which were added to inhibit 
proteases. Benzamidine and PMSF were added to buffer A just before addition to cells.
ei Assay buffer
0.15 M Tris-HCl (pH 7.5) and 0.5 mM MgCl2 was stored at 4°C.
f) Sample buffer (2X1.
10 mM *"T> , pH 7.2, 20% (v/v) glycerol, 1% (w/v) SDS, 0.01%
(v/v) bromophenol blue, 1% (v/v) 2-mercaptoethanol.
2 .5  Chromatography media.
Pre-packed Mono Q HR5/5 (1 ml volume), HR10/10 (8 ml volume), phenyl- 
Superose, Superose 6  and Superose 12 columns were obtained from Pharmacia Fine 
Chemicals and used in conjunction with a Pharmacia f.p.l.c. system according to 
manufacturers recommendations. All buffers were filtered using Millipore-GS filters 
(pore size, 200 }im; Millipore S.A.Peterborough Road, Harrow U.K.) Samples were all 
filtered through a Millex™-GV filter unit before being loaded onto the column.
2 J& General biochemical methods.
a) pH measurement.
pH measurements were made with a Radiometer Model pH meter, using a 
combination electrode calibrated at room temperature.
b} Conductivity.
Conductivity measurements were made at 4°C with a Radiometer Model CDM2e 
conductivity meter.
c) Protein estimation.
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Protein was determined by the method of Bradford (1976), with bovine serum 
albumin as standard from which a calibration curve was determined.
d) Denaturing polyacrylamide eel electrophoresis of proteins.
Electrophoresis in the presence of 0.1% (w/v) SDS was performed by the method of 
Laemmli (1970), with a 3% stacking gel and usually a 10% running gel. The ratio of 
acrylamide : bis-acrylamide was 30 : 0.8 and polymerization was induced by addition of 
0.03% (v/v) TEMED and 0.05% (w/v) ammonium persulphate (freshly made). An equal 
volume of sample buffer (2X) was added to sample and boiled for 2 mins. The amount of 
sample loaded was usually based on the activity of the sample. 0.05 U of IDH activity 
was required to visualise a band of IDH protein by coomassie staining.
g) Protein staining.
Protein was localised on gels either by staining with Coomassie blue. Staining was 
with Coomassie reagent (0.1% Coomassie brilliant blue G250 in 10% (v/v) glacial acetic 
acid 50% (v/v) methanol) for 1 hour at 40°C. The gel was then destained in 10% acetic 
acid, 10% methanol at 40°C overnight. Gels were then dried down for storage or 
autoradiography.
f) Drying down destained polyacrylamide protein gels.
Slab gels were dried down for easy storage or autoradiography. Destained gels were 
placed on top of 2 pieces of Whatman no.3MM chromatography paper cut to size. Heat 
proof SaranWrap™ was placed over the top of this and the sandwhich dried down for 
30-60 mins on a Biorad Slab Gel Dryer model 1125.
g) Preparation of dialysis tubing.
New dialysis tubing was boiled in 1 mM EDTA for 10 mins and stored at 4°C until 
needed. Tubing was rinsed in distilled water before use.
h} Assay for ICL activity.
The formation of glyoxylate by ICL was coupled to the oxidation of NADH using 
lactate dehydrogenase (El-Mansi et al. 1987) and the corresponding decrease in 
absorbance at 340 nm followed at 37°C. Each Reactions were carried out in 50 mM 
Mops/NaOH ph 7.3, 5 mM MgCl 2, ImM EDTA, 5 mM DL-isocitrate, 0.2 mM NADH, 
0.1 mg/ml pig heart lactate dehydrogenase. The reaction was initiated by the addition of 
sample.
ii Concentration with Centricon -30 micro concentrators.
Centricon™ 30 micro concentrators were obtained from Amicon Corporation Cherry 
Hill Dr., M.A., U.S.A and used essentialy as described in the manufactureres
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instructions. Samples were loaded into a concentration device in a maximum volume of 2 
mis. The apparatus were then subjected to centrifugation at 3000.g for the appropriate 
length to reduce the sample to 200-300pls {e.g. 20 mins will reduce 2mls to 200p.ls at 
3000.g). If the original sample had a volume greater than 2mls the retentates were pooled 
and the volume reduced further by another round of concentraion.
2 _ lI  Production of S.coelicolor spores.
a) Preparation suspensions and storage.
Concentrated spore suspensions were required for inoculating liquid cultures of S. 
coelicolor. The protocol described by Hop wood et al. (1985a) was followed with minor 
modifications.
A boiling tube containing a slant of SM agar (produced by pouring ca. 15ml of molten 
agar into the tube and allowing it to solidify with the tube held a 5° from the horizontal) 
was inoculated with 150jil of a spore or mycelial fragment suspension and incubated at 
30°C. After 10 days the surface of the culture was covered in a dark grey mass of spores. 
The slant was then sealed using parafilm and frozen at -20°C. Spores could then be 
harvested immediately or stored at -20°C indefinitely. The spores were harvested by 
adding 5ml of (IH2O to the frozen slant and rubbing the surface of the slant with a 10ml 
glass pipette. When the surface had been scraped clean of spores, the spore suspension 
was decanted into a sterile universal. The slant was rinsed with an additional 5ml of 
dH 2 0 to remove any spores remaining from the first wash. The spore suspension 
(c.lOml) thus produced was dark grey in colour. Contaminating agar or mycelial 
fragments were removed by a single passage through a cotton wool filter, as described in 
Hopwood et al. (1985a). The filtered spore suspension was then either used fresh to 
inoculate YEME media or frozen at -20°C after the addition of glycerol to 20% (v/v).
b) Spore counts.
Colony forming units were determined by plating suitably diluted spore samples on 
SM plates. Counts of the number of colonies were made after incubation at 30°C for 5 
days.
2 .8  Growth of S.coelicolor  mvceiia in liquid media.
Cultures were grown in 2 litre conical flasks containing 400 ml of medium at 30°C on 
an orbital shaker at 200  rpm.
a) Minimal media (NMMi.
4 1
Chapter 2. Materials and methods.
For growth on NMM flasks were inoculated from a frozen spore suspension with 
2.5x105 spores/ml media. Cells grown on NMM were harvested after 72 hours or just as 
the mycelia started to produce undecylprodigiosin (red) antibiotic. Mycelia harvested from 
NMM cannot be stored frozen because the Jonlon forms a sicky glue like consistency 
once thawed.
b) Complex media fYEME).
Most growth experiments were grown on this complex media which produced 
reproducible and rapid growth. For growth on YEME spores from frozen suspensions 
could be used although it was found to be more convenient to use suspensions that were 
freshly prepared from a frozen slope. The spores obtained from the preparation of 
suspension from one slope, were used to inoculate 800 mis of media. Cells grown on 
YEME could be harvested after 48 hours and stored as cell pellet at -20°C indefinitely 
until required.
2 .9  H arvesting of mvcelia.
After growth mycelia were recovered from the growth media by centrifugation (20 
minutes 7,500 g) and resuspended in extraction buffer (100 mM-potassium phosphate pH 
7, 0.4 mM-DTT, 1.2 mM-PMSF, 3.5 mM-benzamidine) and the cells lysed using a 
French Press. Cells grown on YEME (section 2.8b) were resuspended and washed twice 
in 1/ 10 th culture volume distilled dH2 0  prior to resuspension in extraction buffer.
2 ,  IQ  P r e p a r a t io n . .Q L cr u d e _gxjtrag&
a) Cell breakage
Cell pellets were resuspended in ice-cold extraction buffer (1 ml buffer/4g wet weight 
of cells) and broken by three passages through an automatic French pressure cell at 98 
mpa (14 300 psi internal pressure). The cell was pre-cooled on ice before use (cat. no. 4- 
3398A, American Instruments Company, Maryland, U.S.A.).
b) Removal of cell debris.
The suspension obtained from above was subjected to centrifugation at 10,000.g for 
1 hour at 4°C.
2 .11  Methods for characterisation of IDH.
2 .1 1 .1  Assay for IDH activity.
The assay used was essentially the same as that of Reevesef al. (1972) but was 
performed at the growth temperature of S.coelicolor (30°C) instead of 37°C.
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al Standard spectrophotmetric assays,
These were performed with assay buffer. To this was added 0.4 mM NADP, 2.5 
mM DL-isocitrate which were kept as frozen stocks (-20°C) and added to assays just 
before use. Enzyme was normally added last at an appropriate dilution to 1ml of assay 
buffer in a quartz cell with a 1 cm path length. The production of NADPH was monitored 
at 340 nm using a Phillips PU 8720 UV/VIS spectrophotometer.
Unless otherwise stated, one unit of enzyme activity is defined as the amount of 
enzyme required to catalyse the disapearance of 1 |imol of substrate (or the production of 
ljimol of product) per minute. Specific activity is defined as the number of units of 
activity per milligram of protein.
b} Spectrofluorometric assays.
When the Kms for isocitrate and NADP were determined for LDH, the accurate 
concentration of the respective substrates was needed. To determine the concentration of 
isocitrate, excess NADP (0.4 mM) was added to the assay mixture with an appropriate 
amount of active IDH enzyme. The spectrophotometeric reading was made to zero against 
this blank. Dilutions of the isocitrate stock (containing an estimated concentration of less 
than 0.3mM with respect to the D-form) were then added to the cuvette and the reaction 
allowed to proceed to completion. The final absorbance reading at 340 nm was then used 
to calculate the amount of NADPH produced and therefore the amount of isocitrate 
consumed) in the reaction, using the extinction co-efficient for NADP (E340nm=6.23xl03 
M/cm). The concentration of NADP was calculated in a similar way using excess 
isocitrate (2.5 mM) and limiting amounts of NADP (less than 0.4 mM). Reactions were 
again started by the addition of isoctrate.
When determining Kms for isocitrate and NADP for IDH, and when screening 
substances for activation/inhibition effects on IDH activity, the production of NADPH 
was followed on a spectrofluorometer. This method was more sensitive being able to 
detect lower concentrations of NADPH. A Perkin-Elmer LS-5 luminescence specrtometer 
was used with an excitation wavelength of 340 nm and a detection wavelength of 460 nm 
(slit width lOnm for both).
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2 .1 1 .2  Subunit Mr.
SDS PAGE was used to estimate the subunit Mr of the purified protein. A molecular 
weight marker kit, purchased from Sigma Chemical Co., was used to provide the protein 
standards for calculation of the subunit Mr. The proteins used to produce standard curves 
of Rf against log Mr are listed below. Rf is defined as the distance travelled by the protein 
divided by the distance travelled by the dye front.
Protein
rabbit muscle myosin 
E.coli p-galactosidase 
rabbit muscle phosphorylase b 
bovine albumin 
egg albumin
bovine erythrocyte carbonic anhydrase
2 .1 1 .3  Native Mr.
Gel permeation chromatography on a Superose 12 column was used to estimate the 
native Mr of the purified protein. This was carried out at room temperature using a 
Pharmacia f.p.l.c. apparatus. The column was eluted with buffer A (flow rate = 0.3 
ml/min, fraction size 0.3 ml). The eluate was monitored at 280 nm and the column 
calibrated with the proteins listed below.
P rote in Nati.ye._M]
horse apoferritin 4 4 3 ,0 0 0
rabbit muscle pyruvate kinase 232,000
rabbit muscle aldolase 158,000
pig muscle lactate dehydrogenase 140,000
hexokinase 100,000
ovalbumin 45,000
2 .1 1 .4  N-terminal sequence analysis by gas-phase sequencing.
N-terminal amino acid sequencing of intact S.coelicolor IDH was earned out using 
an Applied Biosystems model 470 protein sequencer by with on-line detection of amino 
acid thiohydantoins. All glassware for protein chemistry was heated for 1 hour in 6N 
HC1 or 6N HNO3 then left steeping overnight. It was then rinsed exhaustively with 
distilled water and dried in a hot oven.
Subunit Mr
205.000
116.000 
97,400 
66,000
45.000
29.000
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2 .1 1 .5  Phosphorylation of IDH with E.coli IDH kinase/phosphatase.
IDH kinase/phosphatase was partially purified by Fiona Douglas (Department of 
Biochemistry, Glasgow University) essentially using the method of Nimmo et al. 
(1984). The reaction mixture was;
25 mM Mops-NaOH (pH 7.3), 0.5 mM EDTA, 0.5 mM DTT, 100 mM MgCl2, 0.5 mM 
ATP and IDH kinase/phosphotase (c. 6  pU of activity). Approximately 700 mU of IDH 
activity was added to the assays. ATP was added last to start the reaction which was left 
for 1 hour at 37°C. IDH enzyme activity was measured over a time period.
2 .1 1 .6  W estern blotting procedures.
2 .1 1 .6 .1  B u ffe rs .
a) Transfer Buffer.
20 mM Tris.Cl pH7.2, 150 mM NaCl, 0.5% Tween 20.
b) Substrate buffer.
50 mis 10 mM Tris.Cl (pH 7.4), 150 pi 4% H2O 2 , 30 mg of chloronapthol 
dissolved in 10 mis methanol. (H2O2 was added immediately prior to use.
c) Blotting buffer (xlO stock).
20 mM Tris.Cl pH 7.2,150 mM NaCl.
2 .1 1 .6 .2  T ransfer of protein to nitrocellulose.
Proteins in samples were seperated by SDS PAGE as described in section 2.6d, 
except that 5 pis of pyroniny was added to allow eventual visualisation of protein on the 
nitrocellulose. Proteins were then transferred to 0.45p nitrocellulose papers (Adderman 
and Co., Kingston-upon-Thames, Surrey KT2 6 NH) using a Bio-Rad trans-blot cell 
containing Buffer A with 16.6% methanol. The transfer was run at 0.65 mA/cm2 of filter 
for 4 hours.
2.11.6.3 Probing nitrocellulose filters with antibodies.
The nitocellulose paper was placed in blotting buffer containing 5% normal donkey 
serum at 4°C for at least 16 hours. The nitrocellulose paper was then rinsed twice in 
blotting buffer. The paper was then soaked in transfer buffer containing 5% (v/v) normal 
donkey serum and 0.5% (v/v) rabbit anti-E.coli IDH antisera (gift from H.G.Nimmo, 
Gsagow University) at 25°C for 90 mins, after which the nitrocellulose paper was 
washed in transfer buffer 4 times for 12 mins each, followed by washing in blotting 
buffer for 12 mins. The nitrocellulose paper was then soaked in blotting buffer 5% 
containing 5% (v/v) normal donkey serum and 0.05% peroxidase conjugate donkey anti­
rabbit IgG at 23°C for 90 mins. It was then washed five times (12 mins each time) in 
blotting buffer and developed by soaking in substrate buffer for 5 mins at 23°C. The final
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product was then washed in CIH2O and left to dry. Stain fades with time so important 
filters should be photographed immediately.
Normal donkey serum and peroxidase donkey anti rabbit IgG were obtained from the 
Scottish Antibody Production Unit.
U lI  E.coli strains.
The E.coli strains used in this study are shown below.
STR A IN GENOTYPE REFERENCE/SOURCE
DS941 rec F143, pro A7, str 31, thr 1, leu 6 , tsx 33, 
mtrX 2, his 4, arg E3, lac Y+, lac ZAM15, lac 
N, gal K2, ara 14, sup E44, xyl 5.
Gift from Dave Sherratt 
(Institute Genetics, Glasgow 
University.)
EB106 icd 11, dad R l, trp A62, trp E61, tna 5, X' Apolostolakos et al., 1982 
(Genetic Stock centre, Yale 
University,.U.S.A)
TGI sup E, hsd A5, thi, Hlac-pro AB), F\tra  
D36, pro AB+, lac IQ, lac ZAM15].
Gibson (1984)
NM621 F~jup E44, thy +, rec D, thi 1, leu B6 , lac 
Y l,
ton A21, mcr A, mcr B, hsd R, rec D1009, 
pho R::TnlO
Whittaker et al., 1988
2, 1 3  P l a s m i d  a n d  p h a g e  v e c t o r s .
The plasmid pUC18 was obtained from Pharmacia. Plasmid pB luescrip t™  II  
(KS+ and SK+) was obtained from Stratagene (La Jolla, CA, USA).
The Streptomyces coelicolor genomic library was constructed using the XGEM-11 
replacement vector supplied as "Bam HI arms" by Promega Corporation, Madison, 
USA.
pCK505 is a pBR322 derived plasmid containing the wild type icd gene from E. 
coli. (LaPorte et al., 1985) and was a gift from Prof. D.E.Koshland Jr., University of 
California, Berkerly, U.S.A.).
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2 .1 4  Media for propagation of E.coli.
Chemicals of good quality were used in the preparation of the growth media and 
solutions; AnalaR grade when available. The sources of many of the chemicals varied 
during the course of this work. The most common suppliers were BDH Chemicals Ltd, 
Poole, Dorset; Difco Laboratories, Detriot, Michigan, USA and Sigma Chemical Co. Ltd, 
Poole, Dorset, 
al L-broth
lOg tryptone, 5g yeast extract, 5g NaCl, lg  glucose, 20mg thymine, made up to 1 
litre in distilled water and adjusted to pH 7.0 with NaOH.
b) L-agar
As L-broth without glucose and the addition of 15 g/1 bacto-agar. 
cl Top agar.
As L-agar but with only 10 g/1 bactoagar.
d) Top agarose.
As L-Agar but with 6.5 g/1 agarose.
e) Minimal agar
Agar was made to 17.5 g/1 with water. To every lOOmls of this 25mls of DM salts 
were added and glucose and thiamine were added to give concentrations of 2  mg/ml and 
20 (ig/ml, respectively. Other supplements were added if neccasary.
£1 Davis and Mingoli (DM) Salts (x4)
28g K2HPO4 , 8g KH2PO4 , 16g KH2P 0 4 lg  trisodium citrate, MgS0 4 .7H20 , made 
up to 1 litre with distilled water, 
g l Minimal top agar
6.5 g/1 bacto-agar in (IH2O.
T u l l  Growth of E.coli strains.
al DS941 and NM621.
Normally propagated on L-agar and L-broth, depending on the application, 
bl TGI
It is neccasary to maintain the strain on minimal media in order to maintain a selection 
for the F' episome which allows the production of pilli neccassary for M l3 bacteriophage 
infection. Growth in liquid medua is always performed on YT for the same reasons, 
cl EB106
For growth on liquid media L-broth was always used. The strain is mutated in the icd 
gene (encoding IDH in E. co li) that for unknown reasons makes the strain resistant to 
naladixic acid (NalR) as well as making the strain auxorophic for glutamate or proline. It 
is therefore important to always grow this strain with Naladixic acid (10 Jig/ml) in order 
to prevent reversion of the gene to wild type. For growth on solid media, minimal media
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was usually used which is supplemented with 40mM proline to allow growth of the icd • 
mutant
2 .1 6  Preservation of E.coli strains.
E.coli strains were stored in glycerol. An 800 p.1 aliquot of an overnight culture was 
mixed with an equal volume of 40% (v/v) glycerol, 2% peptone (w/v) and frozen at - 
70°C. The strains were revived by scraping the surface of the frozen suspension with a 
toothpick and either inoculating liquid broth or streaking onto agar to a isolate single 
colony.
2., 1 7, G e n e r a l  D N A  m e t h o d s .
2 .1 7 .1  Commonly used buffers.
a) TE buffer (lOx).
100 mM Tris.Cl pH 8 ,1 mM EDTA. Sterilised using an autoclave and stored at room 
temperature. Use as a lx solution for most applications.
b) Phage buffer (lx).
20 mM Tris.Cl pH7.4, 100 mM NaCl, 10 mM MgS04. 
cj TBE buffer f 10x1 pH8.3.
109g Tris, 55g boric acid, 9.3g Na2EDTA.2H2 0  made up to 1 litre in distilled water, 
pH should be c.8.3.
d) TAE Buffer (10x1 pH 8.2.
48.4g Tris, 16.4g Na acetate, 3.6g Na2EDTA.2H2 0 , made up to 1 litre in distilled 
water, pH adjusted to 8.2 with glacial acetic acid, 
el Agarose gel loading buffer (10x1 pH 7.4.
0.5% (w/v) bromophenol blue, 0.05% (w/v) xylene cyanol, 50% (w/v) ficoll, 1% 
(w/v) SDS, 100 mM EDTA.
£1 X-Hind III DNA markers.
X c857s7 DNA was obtained from BRL, Gibco Ltd., Paisley, UK. This DNA was 
cleaved with the restriction enzyme Hind HI and resulting DNA fragments made to a final 
concentration of 27 jig/jil in TE (final concentration lx) with loading buffer added to lx 
concentration. 10 jils was used on agarose gels as markers for comparing the size and 
concentration of bands in samples.
Sizes of fragments are 23,130 bp, 9,416 bp, 6,557 bp, 4,361 bp, 2,322 bp and 2,027 
bp. a*cK
2 .1 7 .2  Organic solvent extraction.
Protein was removed from DNA solutions by phenol/chloroform extraction. An equal 
volume of TE-saturated phenol was added to samples which were then mixed by
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vortexing and centrifuged in a microfuge for 1-5 minutes. The upper aqueous phase was 
removed to a fresh microfuge tube and the process repeated this time using 
phenol/chloroform (1:1 v/v). Finally, traces of phenol were removed by extraction with 
an equal volume of chloroform in an identical manner. Precipitation with ethanol or 
isopropanol removed any remaining solvent.
2 .1 7 .3  Precipitation of DNA using ethanol or isopropanol.
DNA solutions were precipitated by the addition of 1/50 volume of 5M NaCl 
and 2 volumes of cold ethanol or an equal volume of isopropanol. After mixing, the 
DNA was pelleted by centrifugation (27000g, 30 min, 4°C for volumes of 7.5-20ml or 
12000g, 15 min, 4°C for small volumes in microfuge tubes). The pellet was washed in 
70% (v/v) ethanol and dried briefly in a vacuum desiccator or in an open tube on the 
bench.
2 .1 7 .4  Spectrophotometric measurement of nucleic acid.
Nucleic acid concentrations were determined spectrophotometrically at 260 nm. In a 1 
cm path length an absorbance value of 1.0 corresponds to 50 pg/ml for double stranded 
DNA , 33|ig/ml for single stranded DNA and 20 pg/ml for oligonucleotides.
2 .1 7 .5  Digestion of DNA with restriction enzymes.
Restriction digests were carried out using the BRL React buffers which were 
provided with each batch of enzyme. There are ten different React buffers with a range of 
salt concentrations, each one suitable for a range of enzymes. Analytical digests were 
carried out in a volume of 10 or 20 jil at 37°C. Preparative digests were carried out in 
larger volumes. When DNA was digested with two restriction enzymes, the endonuclease 
requiring the lower salt buffer was used first. After the recommended duration of 
digestion the salt concentration was adjusted and the second enzyme added.
2 .1 7 .6  Ligation of DNA fragments.
The ligation of DNA fragments was carried out usually at a DNA concentration 
of 6mg/ml. The molar ratio of insert fragment to vector was 2:1, when the vector could 
not ligate to itself e.g. when using vector that has been dephosphorylated or has been cut 
with two enzymes). A molar ratio of 10:1 was used when the ends of the vector could 
ligate to each other. Ligations were performed usually in 20pl of lx  ligation 
bufferprovided by BRL, containing 1U of T4 ligase per pg of DNA. The reactions were 
incubated for 4 hours at room temperature or overnight at 16°C.
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2 .1 7 .7  Agarose gel electrophoresis.
DNA was visualized on horizontal neutral agarose gels. Although 0.8% (w/v) gels 
were most commonly used, 1-2 % (w/v) gels were occasionally used to separate 
fragments of <1.5kb. Gels were routinely prepared and run in TBE buffer, however, 
TAE buffer was used when DNA fragments were to be isolated from the gels (see 
section 2.17.9). ^-markers were used on all gels as size markers and for quantification of 
the amount of DNA by comparing the intensity of bands to those of the samples (section 
2.17.If).
a} Mini gels.
BRL model H6 gel kits were used for the rapid analysis of DNA after digestion with 
restriction enzymes or precipitation steps. 0.16g agarose was added to 20ml of IX TBE 
(TAE), boiled then cooled to 60°C. EtBr was added to 200ng/ml and the molten agarose 
poured into a 7.6cm x 5.1cm gel caster with an 8 well slot former (4.1 x 0.8mm wells). 
After the gel had set, the slot former was removed and the gel placed in the tank with 
500ml of 1 x TBE (TAE). Depending on the time available and the level of resolution 
required the DNA was separated by electrophoresis for 30-45min with an applied voltage 
of 2-10V.cm’ *. The separated DNA molecules were visualised on a 302nm UV 
transilluminator.
b) Large gels.
200ml gels were also used to ensure good separation of DNA fragments for accurate 
sizing and/or Southern analysis. They were made by pouring 200ml of molten agar 
containing 200pg EtBr, into a 16.5 x 23cm gel former with a 20 space slot former. The 
gels were run overnight at 20V in 1 x TAE or TBE buffer in gel tanks with a capacity of 3 
litres. DNA samples were mixed with 1/5 volume of 5 x AGL buffer, heated to 70°C for 
2min and cooled on ice before loading onto the gel.
2 .1 7 .8  Photography of agarose gels.
Gels stained with ethidium bromide were viewed on a 302nm UV transilluminator 
and photographed using Polaroid type 67 land film or using a Pentax 35mm SLR loaded 
with Ilford HP5 film. Both cameras were fitted with Kodak Wratten filters (No. 23A).
2 .1 7 .9  Recovery of DNA from agarose gels by electroelution.
The DNA band of interest was visualised by examination of under a hand-held long- 
wavelength ultraviolet lamp. A slice of DNA containing the desired DNA band was 
excised, placed in a piece of dialysis tubing clipped at one endm and lxTAE buffer 
added. All air bubbles were removed before sealing the bag with another clip. The bag 
was placed in a shallow layer of lxTAE in an electrophoresis tank. A voltage of 50 V 
was apllied across the bag for 2 to 3 hours causing DNA to migrate from the gel onto the
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inner wall of the bag. The current was reversed for 1 minute to release DNA from the 
wall of the bag into the buffer. Buffer was then transferred from the dialysis bag to sterile 
Eppendorf tubes and DNA purified by phenol/extraction.
2 .1 7 .1 0  Autoradiography.
Autoradiography was performed in metal cassettes (medical chest X-ray type) using 
Kodak X-OMATS film. Enhancement in the intensity of the autoradiographic images was 
obtained when the film was exposed at low temperature (-70°C) in close contact with a 
du Pont Cronex Lightening Plus intensifying screen. The X-ray films were developed 
using a Kodak X-OMAT automatic processor, Model ME-I.
2 .1 8  Introduction of plasmid DNA into E.coli.
2 .1 8 .1  Preparation of competent cells.
a) Hanahan method.
For high transformation efficiency cells, the following steps were carried out 
(Hanahan, 1983). Cells were prepared and harvested as above but were then resuspended 
in 2.5 ml of ice cold TFB (10 mM-MES/KOH pH 6.3, 100 mM-RbCl, 45 mM-MnCl2, 
10 mM-CoCl2, 3 mM-hexaminecobaltic chloride) and incubated on ice for 15 minutes. 
Then, 100 pi of DMSO was added and the cells were incubated on ice for 5 minutes. 
Next 100 pi of 2.25 M-DTT, 40 mM-potassium acetate pH 6.0 was added and the cells 
further incubated on ice for 10 minutes. Finally, 100 pi of DMSO was added, then the 
cells were kept on ice and used on the day of preparation.
b) CaCh method.
An overnight culture of the recipient strain was diluted 1 in 100 into 30ml L-broth and 
incubated for 90-120 min to a density of approximately 108.m H  cells (OD^qq 0.45- 
0.55). The cells were harvested using a centrifuge (12000g, 5 min, 4°C) and 
resuspended in 10ml of ice-cold 50mM CaCl2. The cells were pelleted again, 
resuspended in 1ml of ice-cold 50mM CaCl2 and kept on ice for at least 15 min before 
use.
2 .1 8 .2  Transformation procedure.
Transformations were carried out in sterile 1.5 ml microfuge tubes. Ligation mix 
refers to any DNA being used in the transforming process and usually was a ligation 
mixture. An aliquot of ligation mix (or plasmid) containing up to 25 ng plasmid DNA 
was added to 100 pi aliquots of competent cells and the mixture was incubated on ice for 
at least 30 minutes. The DNA/cell mix was then heat shocked at 42°C for 2 minutes. 1 ml
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of L-broth was added to the tubes and they were incubated without shaking at 37°C for 
30 mins. The cells were then plated onto LB plates containing the appropriate 
antibiotic/chromogenic substances and incubated overnight at 37°C.
2 .1 8 .3  Selection of pUC derived recombinant clones.
al Ampicillin
Stock solutions (20mg/ml made up in water) were added to molten agar (cooled to 
55°C) to a final concentration of 50|ig/ml. This maintained selection for the plasmid 
which makes cells carrying the vector resistant to ampicillin. 
bl X-gal (5-bromo-4-chloro-3-indolvl-B-galactosidase).
Was used in conjunction with IPTG to identify E. coli strains DS941 and TGI 
containing pUC or M13mp vectors with inserts in their multiple cloning sites. 
Recombinants containing inserts are generally white while those lacking inserts are blue, 
x-gal was stored at a concentration of 20mg/ml in dimethylformamide (DMF) at -20°C 
while IPTG was stored at a concentration of 24mg/ml in dH20  at -20°C. X-gal and 
IPTG were added to L-agar plates to a final concentration of 20jig/ml and 50p.g/ml, 
respectively.
2 .1 9  Preparation of plasmid DNA.
2 .1 9 .1  Reagents for isolation of plasmid DNA from cells.
Protocols based on the alkaline lysis method (Bimboim and Doly, 1979) were used 
for the isolation of plasmid from small (5ml) or large (50-200ml) culture volumes of E. 
coli.
al Bimboim Dolv I fBDD
50mM glucose, 25mM Tris-HCl (pH 8.0), lOmM EDTA. Lysozyme was added 
immediately before use to a final concentration of l-4mg/ml. 
b} Bimboim Dolv II fBDII)
0.2M NaOH, 1% (w/v) SDS which was stored in a plastic container, 
cl Bimboim Dolv III (BDIID
5M KOAc (pH 4.8); prepared by mixing equal volumes of 3M CH3COOK and 2M 
CH3COOH.
dl DNAase-free RNAase.
Pancreatic RNAase (RNAase A) was dissolved at a concentration of lOmg/ml in 
CIH2O, heated to 100°C for 15min and allowed to cool slowly to room temperature. The 
RNAase was then aliquoted and stored at -20°C.
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2 .1 9 .2  Growth of E .co li .
Liquid cultures of E. coli strains from which plasmids were to be isolated were 
grown in L broth with the appropriate antibiotic selection (usually ampicillin at 50|ig/ml). 
The volume of broth inoculated depended on the quantity of plasmid required. Routinely, 
5 ml and 200 ml cultures were used for small and large scale plasmid preparations, 
respectively (see sections 2.19.3 and 2.19.4). For the preparation of competent cells, 
liquid cultures of E. coli DS941 were grown in L broth while E. coli TGI was grown in 
2YT. To maximise aeration of the culture, the volume of the Ehrlenmeyer flask was at 
least five times that of the broth. All cultures were incubated at 37°C in an orbital shaker 
at ca. 250 rpm.
2 .1 9 .3  Large scale plasmid preparations
2 0 0ml cultures of stationary phase cells were harvested using a centrifuge (12000g, 
5min at 4°C). The pellet was resuspended in 4ml of Bimboim-Doly I solution and 
incubated on ice for 5min. Then 8ml of Birnboim-Doly II solution were added and the 
solution left on ice for 5-10 min before 6ml of cold Bimboim-Doly III solution were 
added. The suspension was mixed gently and left on ice for 15-30 min. The cell debris 
and most of the chromosomal DNA was removed by centrifugation (32000g, 5 min at 
4°C). The remaining nucleic acid was precipitated by the addition of an equal volume of 
isopropanol and then harvested by centrifugation ( 39200g, 15 min). The nucleic acid 
pellet was washed with 70% (v/v) ethanol. The plasmid DNA was further purified by 
equilibrium density centrifugation on a caesium chloride.ethidium bromide (CsCl/EtBr) 
gradient. The nucleic acid pellet was redissolved in 1 ml of dF^O and 4.5g of CsCl 
dissolved in 3.5ml of dF^O. The DNA and CsCl solutions were combined with 250jil of 
EtBr (10 mg/ml), creating a solution with a density of 1.58 g/ml. The nucleic acid-CsCl 
solution was spun in a BecKman Ti70 angled rotor at 289,000g for 16 hours at 20°C. 
Two bands were visible in the gradients after centrifugation, a lower supercoiled plasmid 
band and an upper chromosomal and relaxed plasmid DNA band. The lower band was 
removed using a 1ml syringe and the EtBr removed by repeated extractions with water- 
saturated butanol. After dilution with 3 volumes of cfflyi), 9 volumes of absolute ethanol 
were added. The precipitate was pelleted by centrifugation (27000g, 4°C for 30min). The 
resulting plasmid pellet was washed twice with 70% (v/v) ethanol and dried in vacuo 
before being redissolved in 1ml dH20 . This procedure yielded very large amounts of 
pure plasmid DNA (up to lmg from E. coli cultures) suitable for all in vitro 
manipulations.
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2 .1 9 .4  Small scale plasmid preparations
Routinely, plasmids were isolated from 1.5ml of E. coli cultures. The cells were 
pelleted by centrifugation in a 1.5ml microfuge tube (12000g for 30secs) and 
resuspended in 100 jxl of BDI, containing lysozyme at a concentration of 1 mg/ml, using 
a vortex mixer. This was followed by the addition of 200pl of BDII and repeated 
inversion of the microfuge tube to mix thoroughly the suspension. Immediately 
afterwards, 150 |il of prechilled BDIII was added to the viscous bacterial lysate, mixed 
gently on the vortex mixer and placed on ice for 5-10 min. The cell debris and most of the 
chromosomal material was harvested by centrifugation (12000g, 4°C for lOmin) in a 
microfuge. The supernatant was transferred to a fresh tube and extracted with half 
volumes of phenol/chloroform and chloroform. The nucleic acid was then precipitated by 
the addition of 2 volumes of ethanol and allowed to stand at room temperature for 3 - 
5min. The precipitate was harvested by centrifugation in a microfuge (12000g, 4°C for at 
least 15min). The resulting pellet was rinsed twice with 70% (v/v) ethanol before it was 
allowed to dry by leaving the tube open on the bench. The nucleic acid was then 
resuspended in 50jil d l^O  containing DNAase-free RNAase (20pg/ml). The typical yield 
of high-copy-number plasmids such as pUC from E. coli was 2-5p.g. Plasmid prepared 
in this way could be used for most in vitro manipulations.
2 .2 0  Preparation of S.coelicolor  genomic DNA.
Total DNA from S.coelicolor was prepared by Mrs. M. Stone and Ms. A. Wylie 
(Department of Genetics, University of Glasgow) essentially as described by Hopwood 
et al., (1985a).
2 .2 1  Techniques with E.coli bacteriophageA
2 . 2 1 . 1  Preparation of plating bacteria for infection with bacteriophage X,
50 ml of L-broth with 0.2% (w/v) maltose, 20 mM-MgS04 was inoculated with a 
single colony of the appropriate E.coli strain (e.g. NM621), and grown overnight on an 
orbital shaker. The cells were pelleted by centrifugation (12,000.g, 5 minutes, 4°C ) and 
resuspended in 0.5 volumes of sterile, ice cold 10 mM MgSC>4 . The cell suspension was 
diluted if the ODgoo was greater than 2 (i.e. 1.6 x 109 cells/ml). The cells were stored at 
4°C and remained viable for at least 3 weeks.
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2 .2 1 .2  Infection of bacteriophage X, plating and titre.
Serial 10-fold dilutions of X phage stock (or packaged X DNA) were prepared in 
phage buffer (10 mM-Tris HC1 pH 7.5,10 mM-MgS0 4 ). Bacteriophage X infection was 
achieved by adding 100 pi aliquots of each dilution to 100 pi (1.5 x 108 cells) of plating 
bacteria suspension. The samples were incubated at 37°C for 20 minutes. 3 ml of top 
agarose at a temperature of 45°C was added and the mixture was poured onto plates 
containing bottom agar. The plates were left to stand for 5 minutes at room temperature 
to allow the top agarose to harden and then incubated at 37°C overnight. The plaques 
were counted and the titre determined for each dilution assayed.
2 .2 1 .3  Isolation of phage particles from a plaque.
The plaque of interest was stabbed out of the plate using the narrow end of a sterile 
glass Pasteur pipette to form a plug of agar. The plug was left in 1 ml of phage buffer 
with 70 pi of DMSO (to kill any cells) for two hours at room remperature (or overnight at 
4°C) to allow bacteriophage particles to diffuse out of the agar. An average plaque yields 
106-107 infectious bacteriophage particles, which can be stored indefinitely at -70°C in 
phage buffer/DMSO without loss of viability.
2 .2 1 .4  Preparation of X DNA.
a) Growth of X and preparation of phage lysates.
Approximately 1.6 x 108 cells, of prepared bacterial suspension were infected with 
105 plaque forming units (pfu) and plated out as described in 2.21.2. Plates were 
incubated overnight or until the plaques touched one another. 10 ml of phage buffer was 
added to the resulting lysates and plates agitated gently at room temperature for 2 hours. 
The phage buffer was transferred to microfuge tubes, centrifuged to remove bacterial 
debris and the supernatant retained. To the supernatants, 10 jil of 1 mg/ml DNasel and 10 
pi of 10 mg/ml RNase A was added and this was incubated at 37°C for 1 hour. 70 pi of 
DMSO per 1 ml phage buffer was added to the X phage lysates and they were stored at 
40C.
b} DNA Preparation from X phage lysates.
An equal volume of 20% (w/v) PEG 8000, 2M-NaCl in phage buffer was added to 
one volume of X phage lysate (see 2 .2 1 .2 ) and incubated for 1 hour at 0°C. The 
precipitated phage particles were recovered by centrifugation in a microfuge (10 minutes, 
4°C) and the supernatant discarded. The pellet was resuspended in 5 }il of 10% (w/v) 
SDS and incubated for 5 minutes at 68°C. 10 pi of 5M-NaCl was added to the mixture 
which was then extracted once with an equal volume of phenol/chloroform (see 2.17.2)
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then extracted once with chloroform alone. An equal volume of isopropanol was added to 
the retained aquaeous phase and following incubation at -70°C for 15 minutes the X phage 
DNA was recovered by centrifugation in a microfuge (15 minutes, 4°C). The DNA pellet 
was then washed with 70% (v/v) ethanol, allowed to air dry and dissolved in 50 pi of 
lxTE buffer. This DNA was suitable for restriction analysis, Southern blotting, and sub­
cloning.
2 . 2 2  Construction of a X genomic library.
2 .2 2 .1  Partial digestion of genomic DNA with Sau 3A.
a] Small scale digestions.
These were performed eesentially as described in the Promega "Protocols and 
Applications Guide". Ten serial dilutions of Sau 3A enzyme were made in ice cold Sau 
3 A reaction buffer (lx) to span the concentration range 0.7 mU/|il to 200mU/pl. To 45 pi 
of a solution containing 1 pg of S.coelicolor genomic DNA (in lx  Sau 3A reaction 
buffer), 5 pis of the diluted enzyme was added. Digestion was then allowed to proceed 
for excactly 30 mins before being stopped by the addition of 1 pi of EDTA (0.5 M). 
DNA was analysed by electrophoresis on a 0.4% (w/v) agarose gel to determine which 
concentration(s) of Sau 3A produced the greatest flourescence in the 15-23 kb range. 
Electrophoresis was carried out slowly (eg. 50V for 2.5 hours in a minigel) at 4°C to 
prevent melting of the low percentage gel.
b} Large scale digestions.
A full scale digestion was performed with 200 pg of DNA using HALF the optimal 
Sau 3A concentration determined in the small scale digests (Sambrook et a i, 1989). All 
reactions were scaled up to keep the DNA, buffer and enzyme concentrations the same as 
in the small scale reactions.
2 .2 2 .2  Size selection of digested DNA.
Partially digeted DNA was precipited using ethanol and the pellet resuspended in 100 
pis of TE (lx). Loading buffer was added and the sample loaded in to a well 5 cm long in 
a large 0.4% agarose gel (no ethidium bromide). DNA fragments were separated by 
electrophoresis overnight at 4°C. DNA was visualised using a long wave UV monitor, to 
reduce damage done to the DNA, and a gel slice excised that contains DNA in the 15-23 
kb range. DNA was electroeluted from the gel purified and purified by phenol/chloroform 
extraction followed by ethanol extraction (section 2.17.9).
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2 .2 2 .3  Ligation of DNA
The replacement vector (A.-GEM-11) used was supplied by Promega as Bam HI 
arms. The linker fragments had been removed and the arms de-phosphorylated with 
alkaline phosphatase by the supplier to prevent re-ligation of the arms to each other.
To 500 ng of vector was added 500 ng of the size selected DNA. The DNA mixture 
was then ethanol precipitated and the pellet resuspended in 5 |il of ligase buffer 
containing 1 p.1 of DNA ligase. The reaction was allowed to proceed for 4 hours at room 
temperature. A control was also performed using 100 ng of vector alone.
2 .2 2 .4  In vitro packaging of ligated X DNA.
Stratagene GIGAPACK GOLD II was used to package the ligation mixture 
essentially as described in the manufacturers protocol guide supplied with the kit. 
However each reaction set was split into three in order to allow three packaging reactions 
from each set (instead of the reccommended one reaction per set). This had no apparent 
effect on the packaging effeciency. Packaging reactions were also performed on the 
control ligation performed with no insert to determine the number of background plaques 
produced (section 2.22.3). The phage particles produced by this in vitro packaging was 
used to infect a culture of NM621 ready for titration as described in section 2.21.2.
2 .2 2 .5  Amplification and storage of library.
Phage particles produced by in vitro packaging start to rapidly lose viability after 4 
weeks storage at 4°C (Kaiser and Murray, 1985). An appropriate aliquot of DNA of the 
primary library was therefore used to infect a culture of NM621 (section 2.21.2) which 
was then plated at low density to give c.3000 plaques per 150 cm2 plate and allowed to 
grow for 8-10 hours at 37°C. Plates were overlayed with 10 mis of phage buffer and and 
left overnight at 4°C to allow phage to diffuse into the buffer. Buffer was then decanted 
and the agar surface rinsed with another 2 mis which was added to the original 10 mis in 
a 50 ml F a l c o n ™  tube.
Chloroform was added and the mixture left for 15 mins at room temperaure to kill any 
bacteria. Cell debris was removed by centrifugation at 2000g for 5 mins. DMSO was 
added to a final concentration of 1% and the supernatant divided into 1.2 ml aliquots for 
storage indefinitely at -70°C.
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2 .2 3  Techniques for handling E.coli bacteriophage M13.
2 .2 3 .1  Transfection and plating of M13.
Cloning in M l3 vectors is essentially the same as cloning in plasmids. M l3 produces 
a double stranded, replicative form (RF) which is isolated and treated just like an ordinary 
plasmid such as pUC18/19. After introduction of foriegn DNA into such vectors by 
ligation, they can be introduced into a suitable M l3 host such as TGI (ie. one that 
produces pilli).
E.coli TGI was made competent by one of the method above and the transformation 
protocol followed up to and including the heat-shock stage. After this step, 200 jil of a 
fresh exponential TGI culture were added to the transfected cells, followed by 10|a.l of 
IPTG (24 mg/ml) and 50 jil -gal (20 mg/ml). The cells were then mixed and added to 
2.5ml of molten water-agar (0.6% w/v, pre-cooled to 45°C), which were poured onto 
thoroughly dried L-agar plates. Plaques containing recombinant phage appeared white on 
the agar as.
2 .2 3 .2  Isolation of plaques.
An agar plug was pulled from the agar that contained the plaque of interest and phage 
soaked out into phage buffer similar to described in section 2.21.3. However Ml 3 are 
sensitive to chloroform and DMSO and so these additives were ommited.
2 .2 3 .3  Preparation of M13 single stranded DNA.
The single-stranded M13 templates were prepared as described in the "M13 
Cloning/Dideoxy sequencing Instruction Manual" published by Bethesda Research 
Laboratories.
a) Minipreparations
A single M13 plaque was used to infect 1.5ml of 2X YT broth containing 15|il of an 
overnight culture of E. coli TGI. This was grown at 37°C for 5-6 hours with vigorous 
shaking, then transferred to a microfuge tube and harvested by centrifugation at room 
temperature for 5min. The supernatant, containing the phage particles, was recovered and 
respun. The supernatant (1ml) that remained was mixed with 200jil of a solution of 20% 
(w/v) PEG (6000)/2.5M NaCl and left to stand at room temperature for 15min to 
precipitate the phage particles. These were recovered by centrifugation at room 
temperature in a microfuge for 15min. The supernatant was discarded, the pellet respun 
and all traces of supernatant removed. The pellet was then resuspended in 100pl d ^ O  
and extracted twice with phenol/chloroform and twice with chloroform. The DNA was 
then ethanol precipitated from the aqueous phase and recovered by centrifugation in a
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microfuge. The ssDNA was then washed with 70% (v/v) ethanol, dried in vacuo and 
redissolved in 2 0pl (IH2O.
!>} Maxipreparations.
The same overall procedure was followed as for the "minipreparations", except that 
all the volumes were scaled up 20 fold. The cells from a 30ml culture were spun out 
(14000g for 2min), the supernatant recovered and respun as before. The supernatant 
(20ml) that remained was then precipitated with 5ml of 20% (w/v) PEG/2.5M NaCl for 
10 min at room temperature and the phage harvested by centrifugation (14000g at 20°C 
for 15min). The phage pellet was resuspended in 1ml of (IH2O, then reprecipitated and 
processed as for the minipreparations with the volumes scaled up accordingly.
2 .2 4  Labelling of DNA with 3 2 P.
a) Labelling the 5* terminus of oligonucleotides with bacteriophage T4 polynucleotide 
kinase.
Bacteriophage T4 polynucleotide kinase can catalyze the transfer to a free hydroxyl 
group of the y-phosphate group from ATP on the 5' terminus of DNA. In a total reaction 
volume of 10 jil the mixture contained : 8 pmoles of purified oligonucleotide, kinase 
buffer (50 mM-Tris/HCl pH 8 , 10 mM-MgCl2 , 5 mM-DTT, 1 mM-spermidine), 8 
pmoles (y-32p) ATP and 10 units of T4 polynucleotide kinase. The reaction was carried 
out at 37°C for 30 minutes by which time it had gone to completion. Unincorporated 
label was removed using gel filtration (section 2.24b).
b) Removal of unincorporated radionucleotide.
Unincorporated label from end-labelling reactions was removed by gel filtration 
chromatography on a 20x1 cm Sephadex G-50 column. Sephadex G-50 was hydrated in 
lxTE and poured columns equilibrated in lxTE. The reaction mixture was mixed with an 
equal volume of Blue Dextran dye in lxTE and loaded directly on top of the column. The 
radioactivity was monitored as it passed down the column and as it approached the 
bottom, fractions were collected manually. Labelled oligonucleotide was co-eluted first 
with the Blue Dextran dye, followed by a trough then a second peak of radioactivity 
corresponding to unincorporated label. The fractions containing the largest number of 
counts were pooled.
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2 .2 5  Southern blotting.
After electrophoresis and photography, the resolved DNA fragments were transferred 
under alkali conditions to Hybond-N™ and described in "Blotting and
hybridization protocols for Hybond-N™  membranes" published by Amersham 
International pic).
2 .2 5 .1  Reagents.
a) Denaturing solution.
1.5M NaCl, 0.5M NaOH.
b) Alkali transfer buffer.
0.25M NaOH, 1.5M NaCl.
_c} 20X SSC.
3M NaCl, 0.3M tri-sodium citrate.
2 .2 5 .2  Procedure.
The gel was rinsed in distilled water, placed in enough denaturing solution to immerse 
it completely and left for 30min. The gel was removed, excess liquid removed by blotting 
and equilibriated for 10-15min in alkaline transfer buffer. The DNA was then transferred 
to the nylon membrane in alkali buffer, by capillary action (disposable nappies proved a 
particularly useful absorbent material for driving the transfer process). After blotting for a 
least 4 hours(but usually overnight), the membrane was washed briefly in 2X SSC to 
remove any adhering agarose.
2 .26  Hybridisation of oligonucleotides to filter bound nucleic acid.
Southern analysis was carried out by a method adapted from Southern (1975), and
m w
described in "Blotting and hybridization protocols for Hybond-N membranes" 
published by Amersham International pic.
2 .2 6 .1  Prehybridisation.
Hybond-N filters were not pre-wetted, but were placed directly into a polythene bag 
containing prehybridisation solution (6xSSC, 0.05% (w/v) sodium pyrophosphate, 200 
pg/ml heparin, 0.05% (w/v) SDS); the volume of prehybridisation fluid was determined 
by filter surface area multiplied by 0.2. The bag was placed in an agitating waterbath and 
the filter prehybridised for at least 4 hours at 60°C.
2 .2 6 .2  Hybridisation and washing.
After prehybridisation the bag was opened and hybridisation solution added. The 
hybridization solution was the same as the prehybridization solution, except that it 
contained 0.5% (w/v) SDS and the salt cocentration was varied according to the
6 0
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conditions required (see results of individual hybridisations). 50 |ils of the solution was 
used per cm2 of filter surface area. 8.33 pmols (approximately 50 ng) of labelled 
oligonucleotide (section 2.24) was added to the bag before it was sealed. Hybridisation 
conditions were as described for each individual hybridisation.
Hybridised filters were washed then three times in large volumes of buffer at ionic 
strengths appropriate to the experimental conditions. The temperature of this buffer also 
varied experimentally. After washing, the filters were left damp, wrapped in Saran wrap 
and exposed to Fuji RX film using intensifying screens at -70°C (section 2.17.10). Films 
were developed by a Kodak X-OMAT processor.
2 .2 7  Screening of plasmid clones bv colony hybridisation
Recombinant pUC clones were screened using a modification of the method 
described by in the protocol described in the Hybond-N protocol manual. Nylon filters 
(Hybond-N, Amersham) were placed on duplicate agar plates containing the selective 
antibiotic. Bacterial colonies were crossed onto a master plate (containing antibiotic) then 
onto the filter containing plates. The plates were inverted and grown overnight at 37°C. 
Alignment marks were made on the filters. The filters were removed and placed colony 
side up on pad of absorbent filter paper soaked in denaturation solution (1.5 M-NaCl, 0.5 
M-NaOH) and left for 7 minutes. The filters were then transferred, colony side up, to a 
pad of filter paper soaked in neutralising solution (1.5 M-NaCl, 0.5 M-Tris/HCl pH 7.2, 
1 mM-EDTA). They were left for 3 minutes then this step was repeated with a fresh pad 
soaked in the same solution. The filters were then washed in 2 x SSC, transferred to dry 
filter paper and allowed to air dry, colony side up. Finally, the filters were baked at 80°C 
for 2 hours. The filter was then hybridised with a nucleic acid probe (section 2.26).
2 .2 8  Screening a phage X library
a) First round screening
Cells from a prepared bacterial suspension were infected (section 2.21.2) with phage 
from the bacteriophage X library at a ratio of 104 pfu/108 cells. 2 x 10  ^pfu were plated 
onto 10 x 10 cm petri dishes using 8 ml of 0.65% (w/v) top agarose in LB. The plates 
were incubated overnight at 37°C. Up to six impressions could be taken from one plate 
onto nylon membranes, provided time was allowed for fresh phage to diffuse to the top 
agarose surface (Sambrook et al., 1989). Alignment marks were made on the plate and 
marks on the filter made using a syring needle. Filters was removed and treated as 
described for colony filters (section 2.27).
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jj} Secondary screening
Desired plaque regions or single plaques were isolated as described in section 2.23.2. 
A lawn of bacteria (108 cells) were plated onto a 9 mm circular petri dish and a loopful of 
phage particles was streaked onto the plate. The plates were then grown up overnight at 
37°C. A dozen individual plaques from this plate were picked and crossed onto a 10 x 10 
cm square plate overlaid with bacteria then grown up overnight at 37°C. An impression 
was taken of the plate onto duplicate nylon filters which were prepared as before (section 
2.28a).
When identified by hybridisation and subsequent autoradiography a plug of positive 
phage was stabbed from the secondary plate and stored (section 2.23.2).
2 .2 9  DNA Sequencing techniques.
2 .2 9 .1  Sequencing reactions.
Dideoxy sequencing (Sanger etal., 1977) was carried out on single-stranded M13 
templates using either a TAQuenase™ kit (supplied by United States Biochemical 
Corporation ), or a TaqTrack kit (supplied by Promega), or a T7 sequencing kit (supplied 
by Promega).
a} Sequencing with Tag polymerase.
Reactions were mainly performed according to manufacturaers insructions. However 
the extension and labelling reactions as well as termination reactions were carried out at 
65°C to help further reduce artefacts caused by secondaty structure. 35SATP was used 
for labeling.
b) Sequencing with T7 polymerase.
Extension and labeling reactions were performed as suggested by the manufacturers. 
Termination was however carried out at 42°C instead of the normal 37°C. 35S-ATP was 
used for labeling.
c) Autoradiography.
Autoradiography was performed in metal cassettes (medical chest X-ray type) using 
Kodak X-OMATS film. All autoradiography of sequencing gels was performed at room 
temperature. Autoradiography at -70°C produces bands that are diffuse and therefore 
more difficult to read. The X-ray films were developed using a Kodak X-OMAT 
automatic processor, Model ME-I.
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2 .3 0  Denaturing PAGE for DNA^sequencing,
A BRL sequencing unit (Model S2) was used for high voltage polyacrylamide gel 
electrophoresis.
2 .3 0 .1  Preparation of polyacrylamide gels.
6 % (w/v) denaturing polyacrylamide gels were used for sequencing and single- 
stranded probe isolation. The gels were prepared from the following stock solutions:
40% (w/v) acrylamide stock 15ml
urea 55g 
10XTBE 10ml 
dH20  35ml
The urea was dissolved by heating the mix to 37°C and then cooled to room 
temperature The sequencing gel solution could be stored at 4°C for several weeks without 
loss of resolution. Before pouring the gel, 300jil of freshly prepared 10% (w/v) 
Ammonium persulphate and 50|il of TEMED were added to 50ml of the stock solution.
2 .3 0 .2  Preparation of glass plates and pouring the gel.
The plates (40cm X 33cm) were cleaned thoroughly with alcohol and water and 
assembled using three spacers (0.4mm thick) along the vertical sides and the bottom of 
the gel. The entire assembly was held in place by clamps. The gel solution was poured 
from a beaker down one edge of the plates while tilting the plates at an angle of about 
30°. The plates were then laid at an angle of 5° and the sharks tooth combs inserted. The 
gel polymerized usually within 30min at room temperature.
2 .3 0 .3  Electrophoresis of sequencing gels
The gel was pre-electrophoresed for 30min at a constant power of 60W. Prior to 
loading, the samples containing sequencing loading buffer were heated to 95°C for 5 
mins, placed on ice and loaded on to the gel. 6 % (w/v) gels were run for 1.75-2hrs to 
read the first 100 nucleotides and for 4.5-5hrs to read up to 400 nucleotides.
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3.1 Introduction.
One of the aims of this project was to clone the gene encoding IDH in S.coelicolor. 
To this end it was decided to purify the protein in order to obtain N-terminal amino acid 
sequence; an oligonucleotide probe could then be constructed for use in identifying the 
gene by hybridisation. This approach had an added advantage over other cloning 
methods, allowing the determination of some of the physical and kinetic properties of the 
enzyme.
In this chapter I describe the successful procedures used for the purification of IDH 
from S.coelicolor and the characterisation of some of the enzyme's properties. A 
comparison of some of these properties to those of other IDHs characterised is also 
discussed.
H  Results.
1 . 2 . 1 Activities of ICL and IDH alter on different carbon sources .
An initial experiment was performed in conjunction with Dr H.Bramwell 
(Departments of Genetics and Biochemistry, Glasgow University) in which S.coelicolor 
was grown in NMM supplemented with either glucose or acetate. The results in figure
3.1 show that there is very little ICL activity in crude extracts prepared from mycelia 
grown with glucose as the sole carbon source. However significant ICL activity is 
present in crude extracts prepared from mycelia grown with acetate as the sole carbon 
source. There is also a reduction in the specific activity of IDH in acetate grown mycelia 
compared to glucose grown mycelia. This is similar to the situation found in E.coli 
where a reduction in IDH specific activity is required for the operation of the glyoxylate 
bypass (section 1.2 .2 ).
3*2.2 Purification of IDH from S.coelicolor.
S.coelicolor was grown in the complex liquid medium, YEME, which produces 
approximately five times the biomass obtained from S.coelicolor grown on NMM (see 
section 2.8). The typical yield of biomass derived from 1.6 L of medium was 4-5 g (wet 
weight) from which crude extracts were obtained that contain around 500 mg of protein. 
The total IDH activity in crude extracts is usually 100-150 U.
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Acetate Glucose
Total protein (mg) 120 106
Total IDH (U) 11.35 34.20
Specific activity IDH (mU/mg) 94.59 322.63
Total ICL (U) 1.88 0.176
Specific activity ICL (mU/mg) 15.67 1.66
Figure 3.1 IDH and ICL activity from S.coelicolor grown in glucose 
and acetate minimal media.
S.coelicolor was grown for 60 hours in NMM with either glucose or acetate as the 
sole carbon source (section 2.8). Crude extracts were prepared as described in section
2.9 and 2.10 and the protein concentration (section 2.6c) and ICL and IDH activities 
(sections 2.6h and 2.11.1a respectively).
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Harvesting of mycelia and all stages of the purification were carried out at 4°C, 
unless otherwise stated, accept for the running of FPLC columns which was performed 
at room temperature. Buffers and media are described in sections 2.3-2.5.
Step 1; Production of a crude extract.
Harvested mycelia (5-6 g) was resuspended in 15-20 mis of extraction buffer to 
obtain a smooth paste. Cells were disrupted by three passages of this paste through a 
french pressure cell as described in section 2.10. Cell debris was then removed by 
centrifugation at 10,000 g for 1 hour. The clear yellow supernatant was decanted and 
subjected to further purification.
Step 2: Ammonium sulphate fractionation.
Powdered ammonium sulphate was gradually added to crude extract, with stirring, 
to bring the solution to 45% saturation by adding 278 mg of ammonium sulphate to every 
millilitre of crude extract. After stirring for a further 30 mins the precipitated protein was 
removed by centrifugation at 12,000 g. The supernatant was then brought to 80% 
saturation in a similar way by the addition of a further 245 mg/ml of ammonium sulphate 
and the protein again iecovered by centrifugation.
The pellet obtained was then resuspended in 1-3 mis of buffer A (section 2.4) for the 
next stage of the purification.
Step 3: FPLC using anion exchange Mono-O columns.
The resuspended pellet was dialysed overnight against 1 L of buffer A with at least 
two changes. To check that dialysis had gone to completion the conductivity of the 
solution was compared to that of buffer A alone.
For samples with a total protein content of up to 400 mg a large scale Mono-Q 
column (HR10/10) was used (section 2.5) with a flow rate of 4 ml/min. If the total 
protein content of the sample was less than 50 mg, then a small scale Mono-Q column 
(HR 5/5) was used in preference with a flow rate of 1 ml/min, since resolution and 
reproducibility seemed to be superior. Columns were equilibrated by washing with buffer 
A before use.
Samples were loaded onto a Mono-Q column and the column washed with buffer A 
until no further protein emerged. A linear gradient of 100% buffer A to 100% buffer B 
(creating a phosphate gradient of 50-500 mM at pH 7) was then applied to the column 
with a constant flow rate.
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Most of the IDH activity was eluted between 185 mM and 240 mM phosphate (for an 
example see figure 3.2).
When fractions containing more than 10% of the total activity were pooled, 80-90% 
of the original enzyme activity was routinely obtained. An increase in the specific activity 
of IDH (purification factor) of approximately 10 fold was obtained.
Step 4: FPLC using a Superose 12 gel filtration column.
A Superose 12 column was equilibrated in Buffer A and 300 jil of the pooled 
fractions from step 3 loaded onto the column. Buffer A was passed through the column at 
a flow rate of 0.3 ml/min whilst collecting 0.3 ml fractions (see figure 3.3).
When scaling up the purification procedure the volume of the pooled fractions from 
the Mono Q was often 2-4 mis. This volume was therefore reduced by the use of 
Centricon-30 micro-concentrators (following the manufacturers recommended protocols), 
into a volume more appropriate for loading onto the Superose 12 column. It was found 
that up to 500 jil could be loaded without affecting the purity of the final samples, 
provided that less than 10 mgs of protein was loaded at a concentration of less than 30 
mg/ml.
Fractions containing IDH activity from either side of the main peak were analysed by 
SDS-PAGE and stained with coomassie blue and those fractions containing only a single 
major band were pooled for further use. Although small amounts of contaminating 
proteins can be seen (see figure 3.4), it is estimated that greater than 95% of the total 
protein in the pooled fractions is IDH. Samples from the Mono-Q and Superose 12 
purification stages were analysed by PAGE (figure 3.4). A purification table (figure 3.5) 
summarises the results obtained from a typical purification.
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Figure 3.4. SDS-PAGE of samples from the Mono-Q and Superose-12 
co lum ns.
Fractions (c. 1.5 mis) eluting from a Mono-Q HR 10/10 column were assayed for 
activity. The three fractions with the highest activity were pooled. The pooled fractions 
(track 4) and some of the other fractions containing IDH activity, were analysed by SDS- 
PAGE (section 2.6d). Fractions from the Superose-12 column were also analysed. 
Approximately 8pg of protein was loaded into lanes 1-7 and 4pg into lanes 8-15.
Track Fraction. Elution volume. IDH Activity Track Fraction. Elution volume. IDH Ac
fU/mg} (U/mg)
1. Mono Q 25.5 0.26 8. Superose 12 12.8 0.01
2. Mono Q 22.5 0.26 9. Superose 12 12.5 0.04
3. Mono Q 21 0.29 10. Superose 12 12.2 0.04
4. Mono Q 16.5+18+19.5 0.60 11. Superose 12 11.9 0.14
5. Mono Q 13.5 0.43 12. Superose 12 11.6 0.24
6. Mono Q 12 0.13 13. Superose 12 11.3 0.12
7. Mono Q 9 0.00 14. Superose 12 11.0 0.05
15. Superose 12 10.7 0.01
7 1
Chanter 3. Purification and characterisation o f IDH from S.coelicolor.
Sample. Total 
Activity (U)
Total Protein 
(mg)
Specific activity 
(U/mg)
Yield
(%)
Purification
Factor
Crude extract 367 1602 0.23 100 1
Resuspended 45-80% 
Ammonium 
Sulphate pellet
308 269.8 1.14 84 5
Dialysed ammonium 
sulphate pellet 229 62
Pooled Mono-Q 
(HR 10/10) fractions.
110 5.4 20.4 30 89
Concentrated Mono- 
Q fractions 84 23
-
Pooled Superose 12 
fractions
31 1.13 27.33 8 119
Table.3.5 Purification table showing main steps of purification.
Cells were grown for 60 hours on the complex media YEME and the purification 
described in section 3.2.2 carried out. The purification factor shows the increase in 
specific activity compared to the specific activity of the crude extract.
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Mr is molecular weight in Daltons.
| Rf is the mobilty of the markers defined as distance travelled by protein relative to dye
| front.
Numbers indicate the Mr of the standard molecular weight markers (section 2.11.3).!
i
i
i
Figure 3.6 SDS PAGE calibration curve.
The gel in figure 3.4 was used to calculate the Rf values for the standard molecular 
weight markers (section 2.11.3) which had been seperated by SDS PAGE. The results 
were plotted against the logarithm of their molecular weight to produce the calibration 
curve above. The Rf of the S.coelicolor IDH was also calculated (shown as ’O' in the 
above graph) allowing calculation of its molecular weight (81 kDa). The curve was fitted 
by eye. Other experiments produced similar results (+/- 5kDa).
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Figure 3.7 Standard curve for Superose 12 calibration.
Standard molecular weight markers (section 2.11.3) were loaded onto a Superose 12 
column and the elution volume for each was determined. The average data from three 
runs are represented in the graph above. The elution volume of the S.coelicolor IDH 
protein was also determined in triplicate and the average value shown by the point ’O'. 
The average native molecular weight of IDH was calculated to be 89 kDa (+/- 5 kDa).
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3 .2 .3  Native and subunit molecular weieht determination.
The subunit molecular weight of the S.coelicolor IDH was estimated by comparing 
the mobility of the protein on SDS PAGE to the mobility of markers with known 
molecular weights (figure 3.6). The results of several such experiments showed that the 
S.coelicolor IDH has a subunit molecular weight of approximately 80,000 (+/- 5 kDa).
A Superose 12 column was used in order to determine the native molecular weight of 
the active form of IDH. Comparison of the elution volume of IDH to that of the markers 
(figure 3.7) shows that the S.coelicolor IDH has a native molecular weight of 
approximately 90,000 (+/- 5 kDa). This is similar to the value determined for the subunit
molecular weight, indicating that the S.coelicolor IDH is a monomer. This is different to 
the situation in E.coli, where the enzyme is a dimer.
2 *2,4  Western blotting.
Because the S .coelicolor and E.coli IDHs have such different subunit molecular 
weights it was of interest to determine if their was any similarity between them. Western 
blots of the S.coelicolor enzyme were probed with the E.coli anti-IDH antiserum 
(section 2.11.6). Samples from various stages of the purification were tested, as well as a 
sample of partially purified IDH from Bacillus caldotenax (a gift from C.Wild), whose 
subunit molecular weight is known to be similar to E.coli. The E.coli enzyme was also 
applied to the gel as a positive control. Figure 3.8 shows that the protein corresponding 
to the S .coelicolor IDH does not cross react with the antibody raised against the E.coli 
enzyme. However an S.coelicolor protein with a similar mobility to that of the E.coli 
and B.caldotenax IDHs does cross react. The intensity of the band bears no relation to 
the amount of IDH activity loaded This indicates that S.coelicolor contains a protein with 
some similarities to the B.caldotenax and E.coli IDHs, but it is not the IDH that has 
been the subject of purification in this work.
2* 2,5 Attempt to phosphorvlate the S.coelicolor IDH with the E.coli 
IDH kinase/phosphatase.
As already described in section 1.2.1, E.coli IDH activity is controlled by a 
reversible phosphorylation mechanism which is catalysed by the IDH kinase/phosphatase 
(IKP). We were interested to discover how the S.coelicolor enzyme may be controlled 
and whether it may be regulated by a similar mechanism to that occurring in E.coli. 
Attempts were therefore made to see if the E.coli IKP could inactivate the S.coelicolor
7 5
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IDH in vitro . Conditions were used that were similar to those used for the inactivation of 
the E.coli enzyme in vitro (see section 2.11.5).
Figure 3.9 shows that the activity of the S.coelicolor enzyme was not affected by the 
kinase/phosphatase under the conditions used, whereas the control with the E.coli 
enzyme shows 82% inactivation after 12 mins. Neither enzyme showed any decrease in 
activity when incubated under identical conditions without the kinase/phosphatase.
This must indicate that there are significant differences between the IDHs from 
S.coelicolor and E.coli that prevents the IKP from recognising the S.coelicolor enzyme 
as a substrate. It is therefore unlikely that the S.coelicolor IDH is controlled by an IKP 
similar to that from E.coli. This does not however preclude the possibility that the 
S.coelicolor IDH may be controlled by a different phosphorylation mechanism or indeed 
some other mechanism of covalent modification.
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Figure 3.8 W estern blot of IDH enzymes probed with an ti-E.coli ID H  
an tiserum .
Samples from various stages of the purification of the S.coelico lor  IDH were 
analysed by SDS PAGE on a 10% gel. The E.coli enzyme was also loaded as a control 
as w'ell as a partially pure extract from Bacillus caldotenax (gift from C.W ild). Protein 
was transferred onto nitrocellulose and probed with rabbit anti-E.coli IDH antiserum 
(section 2.11.6).
Lane 1 Partially purified IDH from E .co li,
Lane 2 Crude extract from S.coelicolor
Lane 3 Ammonium Sulphate (45-80%)
Lane 4-6 Fractions from across the Mono Q peak of activity.
Lane 7-11 Fractions from across the Superose 12 peak of activity.
Lane 12 High molecular weight markers.
Lane 13 Partially purified fraction from B.caldotenax.
0.50 U.
0.07 U.
0.07 U.
0.07 u.
0.07 u.
p 
1
H-» o u
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mins after kinase added.
Figure 3.9 Effect on S.coelicolor IDH activity of Incubation with the 
E.coli  IKP.
Active S.coelicolor IDH eluted from the final stage of purification was incubated for 
60 mins with the E.coli IKP (IDH kinase/phosphatase) as described in section 2.11.5. 
The activity of the enzyme was measured at various time points. An identical experiment 
was performed with the E.coli IDH as a control. Approximately 700 mU of IDH was 
added to the reaction mixture in each case
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3 .2 .6  K ms of IDH for NADP+. isocitrate and M n ^ .
Initial attempts to measure Kms of IDH were made using a spectrophotometer 
(section 2.11.1a). The values for both isocitrate and NADP+ were in the range 1-2 jiM. 
At these low Km values it was neccessary to repeat experiments using a 
spectrofluorometer (section 2.11.1b) which has greater sensitivity for detecting NADPH. 
The Km for Mn2+ was large enough to measure using the spectrophotometric 
measurements (see below). All reactions were initiated by the addition of isocitrate and 
the initial reactions measured at least in triplicate.
The Km was then calculated by the method of Lineweaver and Burk (1934) (see 
figures 3.10-3.12). Mean Km values for isocitrate, NADP+ and Mn2+ of 1.30 jiM , 2.06 
JJ.M and c. 13 pM respectively.
The specific activity of the purified IDH assayed with saturating concentrations of 
M n2+, isocitrate and NADP+ gave a maximum rate of reaction (Vmax) of 36 U per 
milligram of protein. The turnover number for the enzyme has therefore been calculated 
to be 2880 m in'l.
I t 2 , l  Screening for inhibitors and activators of IDH activity.
IDH from E.coli is not allosterically controlled and seems to be entirely controlled by 
the effects of the kinase/phosphatase (see Chapter 1). It was of interest to find out if the 
S.coelicolor enzyme is controlled by a mechanism similar to that employed by E.coli or 
if it is controlled by the effects of metabolites on enzyme activity. Its response to various 
metabolites also provides further data for comparison to EDHs from other organisms.
Any of the metabolic intermediates from glycolysis and the TCA cycle could be 
potential inhibitors of IDH enzyme activity. Other candidates include those molecules that 
are known to act as signals of the energy state of the cell such as ADP, ATP, AMP and 
cAMP and those indicating the reducing capacity of the cell, namely NAD+, NADP+, 
NADH and NADPH.
Assays were performed in the presence of 1 mM of the metabolites to be tested under 
conditions similar to those used for the determination of the Kms of the enzyme. 
Isocitrate and NADP+ were present at Km concentrations to ensure that the enzyme 
activity was less than Vmax allowing changes in activity to be observed.
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It can be seen from figure 3.13 that all of the metabolites tested had some sort of 
inhibitory effect on the enzyme activity, although it is doubtful that many of them would 
be significant at the concentrations to be found in the cell (see section 3.3.4).
3 . 2 , 8  N - t e r m i n a l  s e q u e n c e  d e t e r m i n a t i o n .
The purified enzyme was exhaustively dialysed against 0.5% ammonium bicarbonate 
before being freeze dried under vacuum. Material was then sent to Mr Brian Dunbar at 
Aberdeen University for sequencing by automated Edman degradation on an Applied 
Biosystems gas phase sequencer. Twenty three amino acids were determined although 
the first three were ambiguous. This was probably caused by interference by the 
ammonium bicarbonate. Protein was therefore purified again from a different experiment 
and this time dialysed against distilled water for sequencing at ICI Pharmaceuticals 
(Alderly Edge) by Ms J.Young.
This attempt produced 24 amino acids confirming the original sequence and giving 
the first three amino acids unambiguously. Figure 3.14 summarises the yields obtained 
for each cycle. Comparison of this sequence to that of the IDH-II from Vibrio spp. ABE- 
1 showed that the two sequences are 69% identical whereas there was no significant 
similarity to the E.coli sequence (see section 3.3.2 and figure 3.15).
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Figure 3.10. Determination of the Km of IDH for isocitrate.
a) Shows a direct plot of IDH activity (where V is an arbitrary activity unit measured on 
the spectrofluorometer; section 2.11.1b) against concentration of D-isocitrate. Km was 
defined as being the concentration of D-isocitrate required to give an enzyme activity of 
half Vmax.
b) The results shown in 3.10a were displayed as a double reciprocal plot (Lineweaver- 
Burk plot). The line intercepts the horizontal axis at -1/Km. All curves and lines were 
drawn by eye. 's' is the substrate concentration in jiM.
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F igure 3.11. Determination of the Km of IDH for NADP+
a) Shows a direct plot of IDH activity (where V is an arbitrary unit of activity measured 
on the spectrofluorometer; section 2.11.1b) against concentration of NADP+. Km was 
defined as being the concentration of NADP+ required to give an enzyme activity of half 
Vmax*
b) The results shown in 3.11a were displayed as a double reciprocal plot (Lineweaver- 
Burk plot). The line intercepts the horizontal axis at -1/Km. All curves and lines were 
drawn by eye. 's' is the substrate concentration in jiM.
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Figure 3.12. Determination of the K™ of IDH for M n2+
a) Shows a direct plot of IDH activity (where V is an arbitrary unit of activity measured 
on the spectrophotometer ; section 2.11.1a) against concentration of Mn2+. Km was 
defined as being the concentration of Mn2+ required to give an enzyme activity of half 
Vmax*
b) The results shown in 3.12a were displayed as a double reciprocal plot (Lineweaver- 
Burk plot). The line intercepts the horizontal axis at -1/Km. All curves and lines were 
drawn by eye. ’s' is the substrate concentration in |iM.
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Figure 3.13 Effect of TCA cvcie and glycolytic intermediates on IDH 
act iv ity .
M etabolites were tested for their ability to increase or decrease S.coelicolor IDH 
activity compared to controls performed without metabolite. Assays were carried out in 
150 mM TrisCl (pH 7.6) at 30°C, in the presence of 1 mM M nCh, 1.5 pM  isocitrate and 
2 p.M NADP+. M etabolites were used at a concentration of ImM. All assays were 
performed on a spectrofluorometer (section 2.11.1b). The assay with ATP in the reaction 
mixture shows a reduction in IDH activity of 74%. However ATP is known to chelate 
M nC l2, perhaps explaining this reduction in activity. Another assay was therefore 
perform ed in the presence of ATP with another Im M  M nCl2, bringing the final 
concentration to 2 mM (labeled ATP+Mn).
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Cycle 1 2 3 4 5 6 7 8 9 10 11 12
Amino acid T D S T I I Y T H T D E
pmols 134 180 188 88 170 154 124 95 50 34 94 23
Cycle 13 14 15 16 17 18 19 20 21 22 23 24
Amino acid A P A L A T Y S F L P V
pmols 83 47 45 40 22 18 27 10 19 20 7 15
Figure 3.14 N-terminal amino acid sequence of the S.coelicolor IDH.
Approximately 1 nmol of purified IDH was applied directly to an "Applied 
Biosystems" gas phase sequencer (section 3.2.8). The identity of the amino acid 
derivative produced by each cycle is shown using the single letter code for amino acids. 
The yield of each amino acid derivative is also shown.
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J-YPe I IP H S i
a ) — T N L I I I P T T G D K I T F I B G K L S V P N G P I I P Y I Z G D G I G V D
b ) M Z S L V V V P A Q G L L I T L Q N G K L S V P G N P I I P Y I z G D G I G V D
c ) MQ G E K I T V Q N G V L N V P N N P I I P F I E G D G T G P D
d) ----------------------- P L I T T E T G KKM H V L E D G R K L I T V I P G D G I GP E
e ) M Y E K L Q P P S V G S K I T F V A G K
Type II IPH s.
f ) - N E A P T I V W T R T D E S P A L A S Y S L L P I V Q A F T E T A G V S V V Q
g )  - T D - S T I  I Y T H T D E A P A L A T Y S F L P V V R A Y A S Q A G V A V E T
h)  S T D N S L I I Y T I T D
X ypg-IJD H §t Type II IDHs.
a ) Vibrio spp. IDH-I f ) Rhodomicrobium vannielii IDH
Fukanaga et al., 1988. Leyland and Kelly, 1991.
b )E.coli IDH g) S.coelicolor EDH
Thorsness and Koshland, 1987. This work.
c )  B.caldotenax IDH h ) Vibrio spp IDH-II
C.Wild, personal communication. Fukanaga et al., 1988.
e) T.thermophilus IDH.
Miyazaki et al., 1992.
d ) Synechocystis spp .IDH 
Muro-Pastor and Florencio, 1992.
Figure 3.15 Comparison of the N-terminal sequences from type I and II 
IDH s.
Unless otherwise stated amino acid sequences were obtained via direct sequencing of 
the proteins (see references). However residues 24-38 of the S.coelicolor sequence were 
predicted from the DNA sequence of the gene encoding IDH inS.coelicolor (see figure 
5.2). Similarly residues 15-34 of the B.caldotenax IDH were predicted from the DNA 
sequence (C.Wild personal communication). The IDH from T.thermophilus was 
obtained entirely from the DNA sequencing of the gene.
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 D iscu ss im
3 . 3 . 1  Purification and physical characteristics.
IDH activity was purified from cell free extracts by a three step procedure that 
incorporated the use of ammonium sulphate fractionation, Mono Q ion exchange 
chromatography and gel filtration on a Superose 12 column. Use of the FPLC facilitated 
a rapid and convenient purification that could be performed within 48 hrs and produced 
increases in specific activity of up to 130 fold with up to a 30% yield.
Many of the IDHs that have been purified to date have employed reactive dye 
columns. Attempts were made to use one of these columns, Procion Red sepharose, with 
which activity could be eluted using 0.5 mM NADP+ but not 0.5 M KC1. This may be a 
useful step, if optimised, for further purification of the enzyme should it be required. 
Another potentially useful step that has not been optimised was the use of hydrophobic 
column chromatography using either phenyl sepharose or the FPLC equivalent, Phenyl 
superose. Protein bound to these columns if the sample was made to 1.7 M with respect 
to ammonium sulphate, and applied to a column equilibrated in the same buffer. Protein 
with IDH activity was eluted using a gradient of decreasing concentration of ammonium 
sulphate.
SDS-PAGE analysis of the purified IDH protein showed that its subunit molecular 
weight is 80,000. The similarity to the value obtained for the native molecular weight 
(90,000) indicates that the S.coelicolor enzyme is a monomer similar to the IDH-II from 
Vibrio spp. (Ochiai et al., 1984) and the IDH from Rhodomicrobium vannielii (Leyland 
and Kelly, 1991).
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3 . 3 . 2  Classification of IDHs into distinct groups.
3 . 3 . 2 . 1  Type I IDHs.
It has been suggested by Fukanaga et al. (1988), that IDHs from E.coli, Salmonella 
typhimurium  and Vibrio spp. can be grouped together by virtue of their subunit 
organisation and cross reactivity with antibodies. Antibodies raised against the Vibrio 
spp. IDH-I enzyme cross react with IDH from E.coli and the close relative of E.coli, 
S.typhimurium (Fukanaga et al., 1988). It has now been shown that another dimeric 
IDH, this time from Bacillus caldotenax , can also cross react with the anti-E.coli IDH 
antibody (figure 3.8).
Comparison of the N-termini of the IDHs from B.caldotenax, E.coli, Synechocystis 
spp. and T.thermophilus and the IDH-I from Vibrio spp., provides further evidence for 
the classification of these enzymes into a group of related enzymes (figure 3.15). I have 
therefore called this family the class I enzymes, after the IDH-I from Vibrio spp.
Phosphorylation of IDH has been demonstrated in vivo in E.coli (see section 1.2.1) 
and S.typhimurium  (Wang and Koshland, 1982). The B.caldotenax  IDH can be 
inactivated in vitro by phosphorylation using the E.coli IKP (Catherine Wild, 
Department of Biochemistry, Glasgow University, personal communication). This may 
suggest that many of the dimeric, type I, IDHs may be controlled by a phosphorylation 
mechanism.
3 . 3 . 2 . 2  Classification of the S.coelicolor IDH as a "type II IDH".
Polyclonal antiserum raised against the monomeric form of EDH from Vibrio spp. 
(IDH-II), showed no cross-reaction with the type I IDHs from E.coli, S.typhimurium or 
the IDH-I from Vibrio spp. (Fukanaga et al., 1988). Based on this information and the 
monomeric structure of IDH-II, it seems that this enzyme belongs to a separate class of 
bacterial IDHs. Analysis of the N-terminal sequence of the S.coelicolor enzyme shows 
marked similarity to that of the Vibrio spp. IDH-II enzyme (see figure 3.15). It also has a 
similar quaternary structure to IDH-II and has been shown to not cross react with the 
anti-E.coli IDH antibody. It is clear that these two enzymes could be grouped into a 
second class of IDHs, that I will call the type II class, after the IDH-II from Vibrio spp.
Recent characterisation of the Rhodomicrobium vannielii (Leyland and Kelly, 1991) 
IDH supports this classification. This enzyme can also be classified as a type II IDH: it is 
a large monomeric protein (75-80 kDa) and possesses an N-terminal sequence very 
similar to both the S.coelicolor IDH and Vibrio spp IDH-II. Antiserum raised against
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the Rhodomicrobium vannielii IDH was found not to cross-react with the E.coli IDH, 
further suggesting that the E.coli type I enzymes are dissimilar to the type II IDHs. Initial 
attempts to phosphorylate the S.coelicolor IDH using the E.coli IKP were unsuccesful 
indicating that the S.coelicolor EDH is not controlled by an E.coli -like phosphorylation 
mechanism. It will remain to be seen if this is another general property of type II 
enzymes.
In the absence of any western blotting data and N-terminal sequence information, it is 
difficult to say if the two A.calcoaceticus IDHs can also be classified in this way. It 
seems likely that the dimeric form may belong to the class I type of IDHs, having a 
similar subunit molecular weight. The second enzyme is reported to have an unusually 
large molecular weight of 300,000 and is unique in its stimulation by AMP and ADP. 
These properties make the enzyme more similar to the NAD+ dependent enzyme found in 
higher organisms (Barnes et al. 1971) perhaps representing yet another class of IDH.
3 . 3 . 3  KmS for NADP+. isocitrate and Mn2+
To see if enzymes could be classified further, based on their kinetic properties, we 
measured the Kms of the S.coelicolor IDH for NADP+, isocitrate and Mn2+ and 
compared them to the kinetic parameters of some other IDHs (compiled in figure 3.16). It 
would seem that there is little correlation between the class of IDH to which an enzyme 
belongs and the kinetic characteristics they possess. Direct comparisons are difficult 
though because of the wide range of assay conditions used. The Km for NADP+ for the 
type II IDH from Rhodomicrobium vannielii was however determined under very similar 
conditions and gave a similar value to that for the S.coelicolor IDH.
3 . 3 t4 Inhibitors.
It was of interest to find out how the S.coelicolor IDH may be controlled. From 
preliminary experiments it seems unlikely that the S.coelicolor enzyme will be controlled 
by an E.coli like kinase/phosphatase. Not only is the enzyme different in its monomeric 
size and immunological properties but initial attempts to phosphorylate the enzyme using 
the E.coli kinase/phosphatase have proved unsuccessful. This does not however exclude 
the possibility of control by some sort of covalent modification catalysed by an enzyme 
with a different specificity.
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It may be possible that the S.coelicolor IDH is allosterically controlled in a manner 
similar to that proposed for the A.calcoaceticus EDH-II (Self and Weitzman 1972 and 
Self et al., 1973) and P.variotti (Takao et al. 1986). To investigate this possibility 
several metabolites were screened for any stimulatory or inhibitory effects. Most of the 
metabolites tested had some inhibitory affect on enzyme activity, although it is doubtful 
for most of them whether this is significant at the high concentrations used. However 
ATP, NADH, OAA and glyoxylate plus OAA did have a large effect on IDH activity.
Inhibition of enzyme activity by ATP has been found for IDHs from several 
organisms including Azotobacter vinelandii (Barrera and Jurtshuk, 1970), 
A.calcoaceticus, (Kleber and Aurich 1975) and Aspergillus niger (Meixner-Monori et al. 
1986). Meixner-Monori et al. (1986) suggested that such effects are probably an artefact 
caused by the chelation of Mn2+ by ATP. For measurements with the S.coelicolor EDH, 
1 mM ATP was found to inhibit enzyme activity by 61% when ImM of Mn2+ was 
present. Addition of a further 1 mM of Mn2+ still produced an inhibition of 44%. One 
may expect that the use of 2 mM Mn2+ would negate any chelation effects of ATP (which 
is only at half the molarity), perhaps indicating that this effect is in fact real. Leyland and 
Kelly (1991) have reported similar effects. NAD and NADP-linked activities are inhibited 
by ATP with Kis of 1.3 mM and 4.4 mM respectively. Further studies are needed to be 
confirm the physiological significance of these effects.
OAA was found to inhibit the S.coelicolor enzyme activity by 60% at the 1 mM 
concentration used. This effect had only previously been reported for the IDH from 
P.variotti. (Takao et al., 1986) whose activity was reduced by 70% using 1 mM OAA. 
Recently an inhibition of 44% has also been reported for the Rhodomicrobium vannielii 
IDH using 1 mM OAA (Leyland and Kelly, 1991).
S.coelicolor was also found to be completely inhibited by 1 mM glyoxylate plus 1 
mM OAA. Such a potent concerted inhibition is not unusual and has been reported for 
NADP+ dependent IDHs from mammalian sources (cited in Nimmo, 1986) and A.niger 
(Meixner-Monori et al., 1986) as well as from all bacterial sources tested. The 
physiological significance of inhibition by either OAA alone or OAA plus glyoxylate is 
however doubtful when one considers the small inhibition likely to be caused by the low 
intracellular concentrations of these metabolites (Nimmo, 1986).
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Inhibition by 1 mM NADH is a property of the S.coelicolor enzyme that has not been 
reported for any of the other NADP+ dependant IDHs. NADH is required to provide 
reducing power for the generation of ATP via the electron transport chain. 
Transhydrogenases have been found in many of the organisms mentioned, including 
S.coelicolor, enabling them to reduce NAD+ at the expense of NADPH (Ragland et al, 
1966). It is thought that this activity enables organisms to use, indirectly, the NADPH 
produced by IDH for the production of ATP. Inhibition by NADH could therefore serve 
as a signal of excess reducing power which reduces the total flux through the TCA cycle. 
It is possible that the NADH acts as an analogue of NADP+ which could bind to the co­
factor binding site and thus prevent enzyme activity. This effect could once again be an 
artefact of the assay though. Further studies would need to be performed to determine if 
NAD+ would still have an effect at a physiological concentration.
Some of these observations could have been investigated further although any data 
obtained would probably not provide any definitive information as to how IDH is 
controlled in vivo. It was therefore decided to progress onto the cloning of the gene as no 
gene has yet been studied that encodes a type II IDH.
Cloning of the gene will allow protein sequence information to be obtained from the 
genetic sequence. The cloned gene will also be a valuable tool for later analysis of gene 
function. This may provide valuable information as to how this type of enzyme and its 
gene is regulated and may thus help to prove the existence or absence of isoenzymes.
Ii
I|
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4.1 Introduction.
One of the aims of this project was to clone the gene encoding IDH in S.coelicolor. 
Cloning of this gene will enable us to use it as a tool for the study of expression levels 
and regulation at different times of the life cycle and will provide the means to 
overexpress the enzyme in S.coelicolor. Insertional inactivation experiments can also be 
performed using the cloned gene to create mutants with reduced or complete lack of IDH 
activity.
The most immediate benefit of cloning this gene would however be the ability to 
obtain the amino acid sequence of the protein for comparison to other proteins, via 
sequencing of the gene. When it was discovered that the major IDH activity in 
S.coelicolor was due to an enzyme that belongs to the type II class of IDHs, this aim 
became a high priority as no other gene of this type has been cloned. This gene will from 
now on be called icd B, in order to distinguish between this gene and those genes that 
code for type I enzymes (from now on referred to as icd, as named in E.coli).
As discussed in section 1.4 the best way to clone this gene in the absence of 
S.coelicolor icd B mutants, is by the so-called technique of reverse genetics which 
requires the construction of an oligonucleotide designed against the N-terminal amino 
acid sequence of the IDH protein. The oligonucleotide can then be used to screen for 
DNA containing the N-terminal region of the icd B gene. Two methods were used to 
select for such fragments of DNA.
One method involved the construction of a library in the lambda bacteriophage 
vector, kGEM-11, that fully represents the entire S.coelico lor  genome. The 
oligonucleotide was then used to screen plaques to select for clones containing the N- 
terminal region of the gene.
The second method involved the screening of a partial library constructed with the 
plasmid vector pUC18. The library is called partial because it was constructed from only 
a small proportion of the fragments produced by restriction digestion of genomic DNA 
(gDNA). DNA was selected by screening digests of gDNA with the N-terminal 
oligonucleotide. DNA that hybrisises to the oligonucleotide was isolated by size selection 
and used to construct the partial plasmid library. This library was then screened using the 
same oligonucleotide to select for transformants that contained at least part of the 
S.coelicolor icd B gene.
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In this chapter the methods used to clone the gene are described, along with the 
construction of some of the subclones derived from this study. Attempts were also made 
complement a strain of E.coli that is devoid of any IDH activity.
4.2 Results.
4.2L, 1 Design of an oligonucleotide.
Amino acid sequence information obtained from the N-terminus of the purified IDH 
(see section 3.2.8) was used to design an oligonucleotide for use as a probe in 
subsequent screening procedures. The high G+C content of streptomycete DNA imposes 
a bias on the choice of codons used by the organism, with a strong preference being 
given to those that contain Gs or Cs in the third position of a codon. An oligonucleotide 
was therefore designed taking advantage of this bias using the streptomycete codon 
preference table compiled by Seno and Baltz (1989).
In designing an oligonucleotide regions that contain amino acids such as serines, 
leucines or arginines should be avoided, as these amino acids can be coded by any of six 
synonymous codons. Conversely, regions containing methionines and tryptophans were 
highly favoured as these amino acids are encoded by only one codon. Amino acids such 
as asparagine, lysine, isoleucine and aspartate are also favoured because they show 
greater than 90% preference for one codon. Where amino acids are encoded for by two 
codons with an almost equal frequency, mixtures of oligonucleotides can be synthesised 
that cover both possibilities. Taking these factors into account the oligonucleotide Oligo- 
N was synthesised with the sequence as shown in figure 4.1.
4 .2 .2  Screening of digested genomic DNA.
To determine which restriction enzymes would be useful for the construction of a 
partial plasmid library, genomic DNA was digested to completion using a variety of 
restriction enzymes and the fragments produced separated by agarose gel electrophoresis 
(see figure 4.2a).
DNA was transferred to Hybond-N nylon membrane by Southern blotting and the 
membrane then baked and prehybridised as described in section 2.26.1. After 
prehybridisation the radiolabeled oligonucleotide (oligo-N) was added to the bag 
containing the membrane and hybridisation allowed to proceed for 2 hours before the 
being washed three times (see section 2.26.2). Different hybridisation and washing 
conditions were tried, by gradually altering the salt concentration and temperature, until
9 5
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conditions were found in which only a single hybridising fragment was found for each 
restriction digest (see figure 4.2b and c).
The conditions which allowed visualisation of a unique hybridising DNA fragment 
were; hybridisation at 55°C, in 5xSSC and washing at 65°C in 2xSSC.
4 . 2 . 3  Cloning of Sal I gDNA fragments into pUC18.
As the S.coelicolor IDH-II is 80-90 kDa, the maximum size of the icd B gene will 
be 2.7kb, assuming an average molecular weight for an amino acid of 100 Da. Most of 
the restriction digests produced a hybridising fragment that was either too small to contain 
the entire gene or were too large to conveniently clone into plasmids (see figure 4.2 b and
c). However Sal I and Pst I produced 5 kb hybridising restriction fragments, which are 
large enough to potentially contain the whole icd B gene and yet is a convenient size for 
introduction into a plasmid vector.
In a scaled up reaction Sal I was used to digest 50 jig of gDNA to completion. 
Fragments were then separated by agarose gel electrophoresis using 0.8% (w/v) TAE 
gels. A slice of gel that contained DNA fragments in the size range of 4.5 kb to 5.5 kb 
was then excised and the DNA extracted by electroelution and purified as described in 
section 2.17.9.
A ligation was then set up containing c.40 ng of the size selected DNA and lOOng of 
linearised pUC18 vector This vector was supplied by Pharmacia, already linearised by 
Sal I and treated with calf intestinal alkaline phosphatase. This treatment removes the 
phosphate group from the 5' ends of the linearised molecule, preventing both the 
intramolecular and intermolecular ligation of vector molecules. The efficiency of removal 
of the phosphate from the 5' ends of the vector meant that 99% of colonies obtained after 
transformation were expected to be recombinants.
Varying proportions of the ligation mix were used to transform a culture of E.coli 
DS941 that had been made competent by the method of Hanahan (see section 2.18.1a). 
Colonies that contained recombinant plasmids (detected by the white colour of colonies 
plated on media containing X-gal; section 2.18.3) were then picked for subsequent 
screening by hybridisation to oligo-N.
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Figure 4.2 Restriction digests and southern blotting of genomic DNA.
a) Genomic DNA (6 |ig) was digested for 2 hours at 37°C (except for Sma I which was 
digested at the recommended temperature of 25°C) using 20 units of each of the 
restriction enzymes shown below. Fragments were separated by electrophoresis through 
a 0.8% (w/v) agarose gel overnight (2 volts per cm length of gel) and photographed with 
UV illumination (section 2.17.7).
b) DNA was transferred to Hybond-N for hybridisation with oligo-N (section 4.2.2). 
Hybridisation was at 55°C (with 5xSSC buffer) for 2 hours. Washing was at 60°C 
(5xSSC). Several bands can be seen in each lane, showing that conditions are not 
stringent enough to allow specific hybridisation to the icd B gene alone.
c) The same filter (shown in b) was subjected to further washing at 65°C in 2xSSC. 
Only one DNA fragment is seen to hybridise to oligo-N in each lane showing that specific 
hybridisation conditions have been reached. Autoradiography was for 12 hours at -70°C 
(section 2.17.10). The size of each band is shown below. The size of each DNA 
fragment was calculated by comparison to the mobility of the X Hind III DNA markers 
(section 2.17. If) using a calibration graph (see section 2.17.7).
1. X Hind HI Markers (see section 2.17. If) 7. S a il  (5 kb)
2. Undigested (>23 kb) 8. Hind III (>23 kb)
3 .X b a I  (>23 kb) 9. Kpn I (9.42-14 kb)
4. Sma I (2.9 kb) 10. Eco RI (>23 kb)
5. Sst I (11-23 kb) 11. Pst I (4.5 kb)
6. S p h l  (9.42-14 kb) 12. Bam HI (1.6 kb)
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± l2 A  Screening of partial plasmid library.
Three hundred of the transformants were picked and plated onto L-agar containing 
ampicillin as a 10x10 array on three plates (100 colonies per plate). Duplicate arrays were 
also made on Hybond-N and the colonies grown overnight before being treated ready for 
hybridisation (see section 2.27). Radiolabeled oligo-N was used as the probe and 
hybridisation and washing conditions were similar to those determined in section 4.2.2., 
although washing was initially performed at only 60°C
Autoradiography of the filters revealed two colonies that hybridised strongly to 
oligo-N, whilst two colonies were found to hybridise comparatively weakly (Figure 4.3
a). Each of these clones were then streaked to single colonies on L-amp plates and 10 
purified colonies of each type plated as triplicate arrays for re-screening. Washing was 
this time performed at 65°C. This time only the recombinants DS941/pRT60 and 
DS941/pRT84 showed significant hybridisation to oligo-N (see figure 4.4b).
Plasmids isolated from these two recombinants were mapped with restriction 
enzymes and found to contain identical inserts in the same orientation relative to the 
vector. All further experiments were performed using the isolate DS941/pRT60.
■4.2,5 Restriction mapping of pRT60.
pRT60 was digested with several restriction enzymes that were known to cut in the 
pUC18 polylinker. Fragments were separated by agarose gel electrophoresis and the 
sizes of the fragments noted. DNA fragments were then transferred to Hybond-N 
membrane by Southern blotting and oligo-N used in hybridisations to determine which 
fragments contained the oligo-N binding site. In this way a restriction map of the plasmid 
was deduced and the region containing the 5' end of the gene was determined (see figure 
4.4a).
The oligonucleotide binding site was within the 0.8 kb Bam HI/Sal I fragment, on 
the extreme right of the insert (with respect to figure 4.4). As the oligonucleotide binds to 
the end of the gene that encodes the N-terminus of IDH there were two possibilities. If 
the rest of the icd B ORF lay to the left of this 0.8 kb fragment then the entire icd B gene 
would be contained within this 5 kb Sal I fragment. However, if the rest of the gene lay 
to the right of this oligonucleotide binding region only a part of the N-terminal region of 
icd B would have been cloned.
9 9
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Figure 4.3. Colony hybridisation.
a) 300 E.coli colonies were grown on three seperate plates. DNA from the colonies was then 
transferred onto Hybond N in duplicate and the filter probed using o ligo-N  (section 4 .2 .4). 
Hybridisation was performed at 55°C  in 5xSSC. Washing was at 60°C  in 2xSSC. Autoradiography 
was for 2 hours at -7(PC. The duplicate filters from each of the three plates (i to iii) is shown.
i) The colony showing the most hybridisation to oligo N was called pRT 60. l he only other colony
showing hybridisation in duplicate was allied pRT 52.
ii) The colony hybridising to oligo N was called pRT 84.
iii) The colony hybridising to oligo N was called pRT 65.
b) The positive clones obtained in the primary screening were re-screened (section 4 .2 .4). Only 
pRTB 60 and pRT 84 still showed hybridisation when filters were washed at 65°C  in 2xSSC. pRT 60  
was used for further study.
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4 ,2 ,6  O rientation of the icd B ORF.
To determine whether the whole gene had been cloned it was essential to find out in 
which direction the ORF was pointing. The 0.8 kb Bam YUJSal I fragment was therefore 
introduced into both M13mpl8 and 19 to produce the clones M13rtl8 and 19 (see Figure 
4.4 b). Single stranded DNA prepared from one of these clones will contain the anti­
sense strand of the gene, whilst the other will contain the sense strand.
Sequencing reactions were performed on single stranded DNA (ssDNA) prepared 
from each of these clones using oligo-N as the primer. As this anti-sense oligonucleotide 
would bind only to the template that contained the complementary sense strand, only one 
of the reactions would produce a sequencing ladder. A DNA sequence was obtained 
when M13rtl9 was used as a template (showing that it contained the sense strand), whilst 
M13rtl8 failed to produce sequence showing it contained the anti-sense strand.
Comparison of the orientation of those fragments in M13 to the restriction map of 
pRT60 allowed the deduction that the icd B ORF read from left to right (as shown in 
figure 4.4). This meant that only part of the 5' region of the gene had been cloned.
4.».2,Z Construction of a genomic library in the vector ^-Oem 1 1 .
As a contingency that the entire gene might not be cloned from the partial plasmid 
library, a lambda (X) library was made that represents the entire S.coelicolor genome. 
This library will be a useful resource for the cloning of other genes.
To make a representative library, genomic DNA needs to be cleaved in a more or 
less random manner and introduced into a suitable vector ready for its replication in a 
host. Lambda replacement vectors are the vectors most commonly used for this purpose 
since relatively large (10-20kb) fragments of foreign DNA can be introduced and the 
libraries can be easily stored for long periods of time (Kaiser and Murray, 1985).
Limiting amounts of Sau 3A were used to partially digest genomic DNA (section
2.22.1). Sau 3A recognises a 4 bp sequence which occurs frequently in DNA sequences 
and produces a staggered end that is compatible with Bam HI staggered ends. Small scale 
digests were performed to determine the concentration of Sau 3A that produces the 
greatest amount of DNA in the size range suitable (9—20kb) for cloning into the lambda 
vector ^-GEM 11 (Promega ’’protocols and applications guide").
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Figure 4.4. Restriction maps of clones and subclones used in this study.
a) A clone containing the plasmid pRT60 was isolated (section 4.2.4). The 4.8 kb 
Sal I fragment had been introduced into the Sal I site of the plasmid pUC18. The Hind in 
site of the plasmid's polylinker lies to the right of this fragment (when orientated as 
shown) with the Eco RI site to the left.
b) The 0.8 kb Bam Hl/Sal I fragment from pRT60 was cloned into M13mpl8 and 
19 to give M13rtl8 and 19 respectively (section 4.2.6).
c) A X clone was isolated that hybridised to oligo-N (4.2.9). The orientation of 
insert in X-GEM-11 was not determined.
d) The 5 kb Pst I fragment from Xl was subcloned into pBluescript II (KS+) which 
had been digested with the same enzyme (section 4.2.10). Orientation of the insert in the 
vector is indicated by the position of the T7 and T3 promoters which flank the insert.
e) The 2.9 kb Eco RWPCma I fragment from pRTBl was cloned into pBluescript II 
(KS+) which had been digested with the same enzymes (section 4.2.11) Orientation of 
the insert in the vector is indicated by the position of the T7 and T3 promoters which 
flank the insert.
f) The same 2.9 kb Eco RVIXma I fragment from pRTBl was also cloned into 
pBluescript II (SK+) (section 4.2.11). Orientation of the insert in the vector is indicated 
by the position of the T7 and T3 promoters which flank the insert.
L
i l l l i i  - Shows the region that was sequenced (chapter 5). Restriction site positions 
are therefore known accurately. Other restriction sites are present but are not shown 
because they cut too frequently.
- The restriction sites shown in this region are known to exist from restriction 
mapping analysis. However it is also known that there are several other Sma I sites 
present whose positions were not determined and are therefore not shown.
1 1 -. A restriction map for this region was not determined.
— ► - Shows the direction in which the icd B open reading frame runs. The start 
codon is 56 base pairs from the Eco RV shown and the stop codon indicated by the label 
END.
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All conditions were scaled up suitably for digestion of 200 pg of gDNA. Fragments 
were separated by electrophoresis on a 0.5% (w/v) agarose gel and fragments in the 11- 
18 kb size range purified from the gel by electroelution. 500 ng of X-GEM 11 arms were 
then ligated to 500 ng of the prepared insert at a total concentration of 200 ng/p.1. The 
ligation mixture was then packaged using Gigapack GOLD in vitro packaging extracts 
(Stratagene, see section 2.22.4) and the titre of recombinant phage determined (section
2.21.2). 2.3xl05 pfu were obtained with a background of wild-type phage (determined 
by ligation of arms without insert) of 2%.
4 .2 .8  Amplification of the library .
Libraries made by in vitro packaging of DNA start to lose Mobility significantly 
after four weeks in storage at 4°C. X phage that have been packaged in vivo are however 
found to be far more stable. 12,000 pfu from the primary library were therefore used to 
infect a culture of E.coli NM621, which was then allowed to grow on plates. Phage 
harvested from these plates were used as the amplified library (see section 2.22.5) and 
could be stored for long periods. The equation below (Clarke and Carbon, 1976) can be 
used to calculate the probability of having every possible sequence from the S.coelicolor 
genome represented in a library made from a known number of plaque formnig units 
(pfu).
pfu = ________ lnfl-pi_________ .
ln[l-(insert size/genome size)]
Assuming a genome size of 8 x 106 bp for S.coelicolor (Hopwood and Keiser 
1990) and a minimum insert size in the X vector of 11 kb, 12,000 pfu (of which 11,760 
are recombinant) will give a probability (p) of 0.999999906 (ie/ virtually 1.0). This meant 
that a library made from 12,000 pfu almost certainly contained every possible sequence 
from the S.coelicolor genome and was therefore considered representative.
4 .2 .9  Screening of the amplified X library.
If each DNA sequence was equally represented in this library then the number of 
plaques required to be screened would be the same as for screening a primary library. In 
other words 3,347 plaques would have to be screened in order to have a 99% chance of 
picking up any one sequence (using the equation above). Approximately 9,000 plaques
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were therefore grown on a lawn of E.coli and the DNA transferred to Hybond-N nylon 
membrane as described in section 2.28. This is almost three the number required to have 
a 99% chance of picking up a particular sequence.
Plaque lifts were treated as described in section 2.27.and hybridisation experiments 
carried out using oligo-N as the probe. After hybridisation at 55°C in 6xSSC and 
eventual washing at 65°C in 2xSSC, 11 plaques were identified that bound to the 
radiolabeled probe (see figure 4.5 a-d).
Nine of these plaques were then isolated and phage streaked out on a lawn of E.coli 
to produce distinct single plaques. Twelve purified plaques from each of the isolates were 
then plated in a triplicate array. Two of the plates were used to take lifts of plaques onto 
Hybond-N and the third kept as a master plate. The duplicate membranes were then 
probed using oligo-N. Only two plaques were found to hybridise in duplicate to the 
probe. Both were derived from ^-1 (see figure 4.5 e).
Restriction of DNA prepared from each of these plaques with several enzymes 
showed that both recombinant phage contained the same insert. This was to be expected 
as they were derived from the same original isolate. A Southern blot of the gel used in 
restriction analysis was screened using oligo-N to determine the fragment which 
contained the 5' region of the icd B gene. Digestion of X-\ DNA with Bam HI, Pst I and 
Sma I produced fragments of 1.8 kb, 5 kb and 3.6 kb that hybridised to oligo-N. These 
are the same sizes as those obtained by hybridisation experiments with genomic digests 
(section 4.2.4). Digestion with Sal I however produced a hybridising fragment of only
2.8 kb, compared with the 5 kb fragment produced by Sal I digestion of gDNA. This 
means that one of theSau 3A endpoints lies within the 5 kb Sal I fragment produced 
from genomic digests. The precise position of this endpoint relative to the insert found in 
pRT60 is shown in figure 4.4a and shows that the entire icd B gene must be contained 
within A.-1.
Southern blotting of genomic DNA digests had shown that oligo-N bound to a 5 kb 
Pst I fragment. Restriction analysis of pRT60 had shown that the start of the gene was 
within a c.1.5 kb Pst I/Sal I fragment (figure 4.4a). It was therefore deduced that a 
second Pst I site must lie 3.5 kb to the right of this Sal I site. Since the length of the 
gene can be no longer than 2.8 kb, then the end of the gene cannot lie further than 2.8 kb 
to the right of this same Pst VSal I fragment. Consequently we can conclude that the end 
of the gene must lie to the left of the second Pst I site and that the entire icd B gene must 
therefore lie within the 5 kb Pst I fragment.
1 0 4
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4 . 2 . 1 0  Cloning of the 5kb Pst  I fragment into pBluescript II (KS+1.
The recombinant, A.-1, contained an 11 kb fragment which was too large to easily 
restriction map. X -l DNA was therefore digested to completion with Pst I and the 5 kb 
fragment (known to contain the entire icd B gene) was isolated by agarose gel 
electrophoresis followed by electroelution. This fragment was then ligated to pBluescript 
II (KS+) which had been restricted previously with Pst I. The resultant plasmids were 
introduced into E.coli DS941 which had been made competent by the CaCl2 method. 
Three of the transformants containing plasmids with inserts were isolated and the 
plasmids mapped by restriction digestion. All three isolates contained plasmids with 
identical restriction maps indicating that all three contained identical inserts in the same 
orientation. The restriction map produced is shown in figure 4.4c.
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Figure 4.5 Plaque hybridisation with oligo-N.
Three filters (with approximately 3000 plaques on each) were screened by 
hybridisation to oligo-N. Duplicate filters were prepared by taking plaque lifts as 
described in section 2.28. All 6 filters were subjected to hybridisation at 55°C in 5xSSC 
and washed at the temperatures shown below. Only one of the duplicate filters is shown. 
Those plaques seen to hybridise on duplicate filters are circled.
a). All filters were originally washed at 60°C in 5xSSC. One of the filters screened at 
this temperature is shown here.
b). The same filter as in a) is shown after being washed at 65°C 2xSSC. It shows the 
decrease in the number of plaques hybridising to the oligonucleotide.
c) and d). Shows the other two filters that were treated in the same way as the filter 
shown in a) and b).
e). Nine of the plaques (from filters b), c) and d)) that were found to hybridise in 
duplicate were purified to single plaques. Twelve purified plaques from each isolate were 
plated (horizontally adjacent to each other in figure 4.5e) ready for re-screening (section 
4.2.9). Only two plaques were found to still hybridise which were both derived from the 
same original isolate. These were called XI and X2 and were later found to be identical 
(section 4.2.9).
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4 . 2 . 1 1  Cloning of the 2.9kb Eco RV/Sma I fragment from pRTBl.
Sequencing of M13rtl8 and 19 identified the translation start codon of the icd B 
gene, which is just 47 nt downstream of the Eco RV restriction site. This meant that the 
end of the gene could be calculated to be somewhere to the left of the unique Sma I site 
found in pRTBl, since a 90kDa protein would require a gene 2.7 kb long (see section 
4.2.3).
The Eco KM/Sma I fragment was therefore used to clone the entire ORF of icd B* 
which may also contain some of the required upstream and downstream regulatory 
sequences. Both Eco RV and Sma I produce blunt ends which does not allow for the 
directional cloning of this fragment into a vector. However the isoschizomer of Sma I, 
Xma I, recognises the same site but produces staggered ends with a 5' overhang rather 
than blunt ends (see below).
Xma I was therefore used instead of Sma I to enable directional cloning of the insert 
into both pBluescript II (KS+) and pBluescript II (SK+). Due to the expense of the 
enzyme it is provided at only low concentrations. However its thermostability allows 
digestion to be carried out overnight at 37°C.
Complete digestion of both of the vectors and pRTBl by Xma I was followed by 
complete digestion with Eco RV. The appropriate fragment was then separated and 
purified by agarose gel electrophoresis followed by electroelution. The purified fragment 
was then ligated to each of the linearised pBluescript plasmids (SK+ and KS+) to create 
the recombinant plasmids pRTB2 and 3 respectively (see figure 4.4 e).
± J u l l  Attempts to complement the E.coli icd -_mutant, EB106.
It was of interest to see if the S.coelicolor icd B gene could complement the E.coli 
icd ‘ mutant, EB106, since this could provide an insight into the similarities between the 
IDHs from the different organisms and could provide final proof that a functional gene 
from S.coelicolor, that encodes an IDH, had been cloned.
It is worth pointing out at this stage that for reasons that are as yet unclear, E.coli 
ic d ' mutants, simultaneously confer resistance to naladixic acid (Helling and Kukora,
5 'C C C VGGG 3 ’ 
3'GGGaCCC 5 '  
Sma I
5 1CVCCGGG 3 '  
3'GGGCCaC 5 '  
Xma I
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1971). This provides a useful way of maintaining selection for mutants which would 
otherwise rapidly revert back to wild type. EB106 was therefore made competent for 
transformation by the CaCl2 method (naladixic acid was added to all media until the cells 
were harvested, see section 2.15c) and the plasmids pRTBl, 2, and 3, pBluescript II 
(KS+) and pCK505 introduced into the this strain. pCK505 is a pBR322 derived plasmid 
that was used as a positive control since it contains the whole of the wild type E.coli icd 
gene and is known to be able to complement this mutant (LaPorte et al., 1985).
Several hundred transformants were obtained from each of these transformations. A 
single colony from each transformation was plated on to several selective media to test for 
complementation. It can be seen from figure 4.6 that none of the plasmids (other than the 
control plasmid pCK505) enabled EB106 to grow on minimal media without an amino 
acid supplement, showing that complementation had not occurred.
a)
BLANK
EB106
pCK505
pRTBl pRTB2
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Figure 4.6 Complementation of the icd  m utation in the E.coli s tra in  
EB 106.
Plasmids pRTBl, pRTB2 and pRTB3 (see figure 4.4) were introduced into the E.coli 
mutant EB106 which is devoid of IDH activity (due to a point mutation in icd ). Each of 
these plasmids contain the entire ORF for the icd B gene from S.coelicolor (section
4.2.11 and figure 4.4). As a positive control for complementation a plasmid (pCK505) 
that contains the wild type icd gene from E.coli was also introduced into the strain. As a 
negative control the vector pBluescript II (KS+)was also introduced into EB106. 
Transformants were streaked onto the selective media below. None of the media 
contained naladixic acid (nal) in case any complementation caused reversion to nal 
sensitivity.
a) L-agar: All strains should grow on this complex media including EB106 (with no 
plasmid). This plate therefore confirms cell viability.
b) MM+pro+amp: Ampicillin was added to minimal media (section 2.15c) to select for 
cells that contained plasmids (pBluescript II confers ampicillin resistance to strains 
containing the plasmid). Proline was added as a supplement that will allow icd ~ strains to 
grow, provided that the strain possesses a plasmid.
c) M M-pro+amp: Ampicillin was also added to the minimal media. Proline was not 
added to the media. Only those strains that contain a plasmid capable of complementing 
the icd ‘ mutation will be able to grow.
The results show that only plasmid pCK505 can complement the icd ~ mutation of 
E.coli. It was therefore concluded that the icd B gene from S.coelicolor cannot 
complement this mutation when introduced into EB106 on either of the plasmids used 
(section 4.2.12).
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4.3 Discussion.
The cloning of the icd B gene that codes for the type II IDH from S.coelicolor 
would prove an invaluable tool for the study of the genes regulation and expression and 
the role of the enzyme in cellular function. It could be used to study the effect of over and 
under expression of the gene on cell growth and antibiotic biosynthesis on different 
growth media, especially by comparing the difference between cell growth on acetate and 
glucose. Complete inactivation of the wild type genomic copy could also be performed, 
using a disrupted copy of the cloned gene in insertional inactivation experiments.
The most immediate benefit derived from cloning of the gene would however be the 
ability to obtain the DNA and hence amino acid sequence, for comparison to other genes. 
Using the N-terminal amino acid sequence obtained from the type II IDH from
S .coelico lor , an oligonucleotide was designed (using the codon bias found in 
streptomycete DNA) which was used as a probe for screening for the icd B gene. Initially 
digests of S.coelicolor genomic DNA were used to find empirically the hybridisation and 
washing conditions required to produce hybridisation to the icd B gene alone.
The most stringent conditions employed in these screening experiments were 
hybridisation at 55°C (with 6xSSC) and washing at 65°C (with 2xSSC). Raising of the 
temperature by another 5°C led to complete loss of signal. Binnie (1990) reported that 
final washing conditions are normally performed at 5°C below the Tm of a probe 
showing that the Tm for oligo-N is between 65 and 70°C. Knowing the Tm for the probe 
allows us to calculate the percentage similarity of oligo-N to the target sequence using the 
equation below (Albertson, 1988).
Tm = 81.5+16.6(logM)+0.41(G+C)-(820/l)-1.2(100-h)
Where
Tm= temperature at which half of the DNA hybrids melt G+C=Percent G+C content
h=percent homology between probe and target sequence l=length of probe
M=molarity of monovalent cation in the hybridisation buffer.
Using the values, M=0.33 (2xSSC), Tm=70°C, and G+C=65.7, this equation 
indicates that oligo-N is 91.4% identical to the target sequence, suggesting 2-3 
mismatches. Later sequencing of this region shows that oligo-N does indeed have 3 
mismatches when compared to the target sequence (see figure 5.3) indicating that the 
most stringent conditions possible were used in hybridisation experiments. If the final 
washing conditions were carried out at a temperature only 5°C lower, then other DNA
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fragments were found to also hybridise to the oligonucleotide. This shows that maximum 
stringency is required in order to produce a unique single band.
It is worth pointing out that when determining hybridisation/washing conditions it is 
important to consider the combination of conditions used at each stage. In this case, 
hybridisation at lower stringencies produced signals that could not be washed off, even 
after exhaustive washing using the conditions of high stringency finally employed ie. 
65°C (6xSSC). Conversely, hybridisation at 65°C (6xSSC) produced no signals at all, 
even though the subsequent washing conditions were no more stringent than those 
eventually used during washing. The combination of hybridisation at one stringency and 
washing at a higher stringency were the only set of conditions that would produce unique 
hybridisation signals using this probe. This highlights the difficulty often experienced 
when trying to find specific hybridisation conditions using oligonucleotide probes with an 
unknown number of mismatches.
Another major problem encountered during these screening procedures, was the 
occurrence of significant amounts of non-specific hybridisation to the membrane that 
could often obscure any specific signals. The use of analytical grade NaCl for making the 
SSC buffer was found to reduce this problem considerably, with general purpose NaCl 
giving variable results depending on the batch used (Dr H.Bramwell, Departments of 
Biochemistry and Genetics, University of Glasgow, personal communication). To 
increase the signal to noise ratio the amount of target DNA was increased by loading 5- 
10|ig of digested genomic DNA onto gels, instead of the ljig initially used. Around 6000 
plaques from the S.coelicolor X library were screened for hybridisation to oligo-N. This 
number of plaques contains a total of 6.6x107 bp of insert DNA (assuming a minimum 
insert size of 11 kb) which is the equivalent of 8.25 genome lengths. Assuming equal 
representation of each sequence in the library we would therefore expect to obtain 8-9 
positive signals.
When the X library was screened 11 plaques were found to hybridise to oligo-N in 
the initial screening. However only one of these was found to hybridise during a re­
screening procedure, less than the 8 plaques expected by calculation. Chance may have 
played a role in reducing the number of positives obtained but it must also be remembered 
that the library that was screened had undergone an amplification step. The presence of 
some inserts in a X phage can lead to a reduced growth rate compared to other 
recombinant phage and can lead to their under-representation in the amplified library. 
Although this can be a problem for libraries amplified in liquid culture, it is generally 
considered that there is less of a problem when amplification is performed on solid media 
(Kaiser and Murray, 1987). Nevertheless it is possible that clones containing the icd B
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gene (or a proximal sequence) could produce smaller plaques on plates and thereby be 
less represented than expected.
Another explanation is the possibility that the some of the wrong plaques had been 
picked from the original plates screened, since the line up of the autoradiograph to the 
original plate is not very accurate, especially on plates on which plaques are plated to high 
density.
Restriction digests of the clones that were isolated from this library was compared to 
the map of pRT60 and the information obtained from genomic digests. This showed that 
this clone contained the entire icd B ORF (c.2.7 kb) within a 5kb Pst I fragment which 
was cloned into pBlusescript to obtain the clone pRTBl. Further restriction mapping and 
subcloning allowed the introduction, in both orientations, of a 2.9kb fragment 
(containing the entire icd B gene) into pBluescript
The availability of a strain of E.coli that is deficient in an active form of IDH {icd" 
mutant, EB106), prompted an attempt to complement the mutation using the S.coelicolor 
icd B gene. Introduction into EB106 of all of the plasmids available, that contained the 
whole of the S.coelicolor icd B ORF (pRTBl, 2 and 3), produced no complementation. 
It is possible that the constructs pRTB 2 and 3 do not contain the upstream (or 
downstream) regulatory sequences required for gene expression, since they have only 
short stretches of DNA up and down stream of the ORF. However it is almost certain that 
pRTB 1 will contain those sequences required for expression in its native host at least.
It is well known though that only a fraction of streptomycete genes are capable of 
being expressed in E.coli, due to the lack of E.coli like promoter sequences (Jaurin and 
Cohen, 1985). The most likely explanation for lack of expression of this gene in E.coli is 
therefore a low level, or complete absence, of transcription from the gene. Indeed later 
sequence analysis would seem to confirm that the appropriate sequences normally 
required for expression of genes in E.coli are absent (see section 5.3.4). This gene will 
therefore require modification of its non-translated regions (ie. RBS and promoters) in 
order to allow its expression in E.coli.
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5.1 Introduction.
A fragment of DNA had been cloned which was expected to contain the whole gene 
encoding IDH, (section 4.2.9). As this is the first gene for a type II IDH to be cloned, it 
was of great interest to deduce its peptide sequence for comparison with other proteins, in 
the hope of gaining some insight into its function and mechanism of action.
It was also described in section 1.1.3 how RNA polymerase and promoter 
heterogeneity play a key role in the differential control of gene expression (reviewed by 
Strohl, 1992). The relationship between promoter structure and gene function and the 
level and time of expression is however still unclear. Such relationships will only be 
solved by the analysis of more promoters. It was therefore of interest to examine the 
upstream sequences of the icd B gene as a first step in the study of its promoter and to see 
if there were any similarities to other known promoters. A search for other regulatory 
sequences, such as ribosome binding sites and terminators, was also made.
At the time of writing the most up-to-date study of such regulatory sequences had 
been performed by Seno and Baltz (1989) which has also served as an excellent review 
of the knowlege accumulated so far about streptomycete sequences. The information 
about streptomycete regulatory sequences that is presented in this chapter has therefore 
been obtained from this publication unless otherwise stated.
In this chapter I describe the strategy used to obtain the DNA sequence of icd B and 
the surrounding region and the analysis of this sequence. Analysis of the amino acid 
sequence deduced from the DNA sequence of icd B is discussed in chapter 6.
5.2 Results.
5 . 2 . 1  Choice of sequencing strategy.
Probably the most reliable, easiest and most used method of sequencing DNA is by 
the di-deoxy method of Sanger et al., 1977. Quality controlled kits can be purchased 
from various suppliers that contain all of the reagents required for performing these 
reactions, making this method both reliable and convenient. In this method the strand 
complementary to the one being sequenced is synthesised in vitro by extension from a 
DNA primer using a DNA polymerase (DNApol).
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Four separate reactions are performed each containing all four dNTPs required for 
chain elongation. Each separate reaction also contains one of the four dideoxy nucleotide 
analogues (ie. ddATP, ddCTP, ddGTP or ddTTP). These analogues are used at a 
concentration that allows their incorporation at a random position in the growing chain.
For instance the presence of a cytosine in the template will allow the incorporation of 
a dGTP or a ddGTP molecule into the newly synthesised strand. If the nucleotide 
analogue is incorporated into the chain, further elongation is prevented. A family of DNA 
molecules is therefore generated each terminating at the position corresponding to where a 
cytosine was on the template. Similar reactions performed with the other analogues 
generate fragments that terminate at positions corresponding to the other three 
nucleotides.
The molecules in each reaction mixture can be separated on the basis of their length 
by denaturing polyacrylamide gel electrophoresis (see section 2.30). Running each 
reaction next to each other on a gel allows determination of the order in which each of the 
nucleotides occur in the growing chain. The use of a radioactive nucleotide during the 
reaction allows the newly synthesised strands to be visualised by autoradiography.
The most widely used DNApol has been derived from the T7 bacteriophage and has 
been modified to remove its 5’ to 3' exonuclease activity. However streptomycete DNA 
has a propensity to form secondary structures, due to its high G+C content, which often 
causes the enzyme to pause for significant periods of time at these points. This manifests 
itself as bands in all four lanes of a sequencing autoradiograph with the same mobility 
(known as "four track stops") making determination of the true bases around this region 
very difficult. This problem can be circumvented to a large extent by using higher 
incubation temperatures for sequencing reactions, which helps to melt the intramolecular 
secondary structures. Most sequencing using the T7 polymerase therefore used a 
temperature of 42°C for the termination reactions, rather than the recommended 
temperature of 37°C (see section 2.29.1b).
Regions in which secondary structure was still a problem were sequenced using Taq 
polymerase. This thermostable DNApol, isolated from the extreme thermophile, Thermus 
aquaticus allowed reactions to be performed at temperatures of up to 70°C. However 
bands on autoradiographs were found to be thicker and less well defined when Taq pol 
was used in reactions compared to when T7 pol was used. As one reads DNA sequence 
from an autoradiograph bands get closer together near the top of the gel (where the larger 
DNA molecules are found), eventually getting so close that individual bands cannot be 
resolved. Consequently less sequence can be read from reactions produced by Taq pol as
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the thicker bands produced merge sooner. Taq polymerase was therefore not routinely 
used.
Another problem incurred by the high G+C content of streptomycete DNA is the 
greater frequency with which compressions occur. Whereas "four track stops" are caused 
by the formation of secondary structures during the sequencing reaction, compressions 
are due to the formation of secondary structures as the DNA is being separated by 
electrophoresis. Compressions are identified as regions on an autoradiograph where 
bands become unevenly spaced over a localised region. A band from one of the reaction 
mixtures will have a slower mobility than normal whilst a band from one of the other 
nucleotide reaction mixtures will have a faster moblity than normal. If this aberrant 
behaviour is extreme, then two bands from different lanes can appear to have similar 
mobilities. This obviously makes determination of the sequence at this point difficult. 
Deaza nucleotide analogues were however routinely used in sequencing reactions which 
helped to prevent this phenomenon (Mizosawa et al., 1986).
Sequencing reactions can be performed using either single or double stranded DNA 
using the methods described in manufacturers manuals {e.g. Promega T7pol sequencing 
kit). DNA sequencing using single stranded templates were found to be the most reliable 
method of producing clear, distinct bands and enabled 250-400 nt to be read from a 
single set of reactions.
Using the universal primer to sequence template will produce 200-400 nt of sequence 
from the region adjacent to the universal primer's binding site. A strategy is therefore 
required to sequence regions further away. One such method is to design 
oligonucleotides which will hybridise to regions of DNA that have already been 
sequenced. These can be used as primers in subsequent reactions to extend the sequence 
futher along the same strand. Oligonucleotides complimentary to sequence already 
obtained can be used to sequence the other strand in the reverse direction. In this way one 
can sequence a region of interest by "walking" along the template.
5 .2 .2  Construction of subclones used for DNA s e q u e n c i n g .
To determine in which direction the icd B ORF is reading the 0.8kb Barn HI /  Sal I 
fragment was introduced into the sequencing vectors M13mp 18 and 19 (section 4.2.6). 
When oligo-N (the oligonucleotide designed from the N-terminal protein sequence) was 
used as a primer in sequencing reactions only M13rtl8 produced sequence (section 4.2.6 
and figure 5.1a). Both templates were also sequenced using the universal (-40) 
sequencing primer and the DNA sequence then extended sequentially with
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oligonucleotide primers until the whole fragment had been sequenced on both strands 
(see Figure 5.1a).
The presence of a Bam  HI site internal to the icd B gene enabled the insert to be 
cloned in two parts. Digestion of pRTB2 with Bam  HI and Xba I produced two 
fragments derived from the 2.9 kb insert. One of the fragments (1.55 kb) had one Xba I 
staggered end and one Bam  HI staggered end. Its ligation into M13mpl9, which had 
been linearised with the same restriction enzymes, produced the sub clone M13rt21 (see 
figure 5.1b). The second fragment (0.8 kb) had Bam HI staggered ends at both termini 
and was introduced into the Bam  HI site of M13mpl8. Its introduction in both 
orientations produced the two subclones M13rt24 and M13rt24b.
The entire 2.7 kb Eco RV/Sma I fragment from pRTB2 was also subcloned into 
M13mpl8 and 19 using the Kpn I and Xba I restriction sites which flank this region in 
pRTB2. These recombinants (M13rt 20 and 21) were also used for sequencing. Figure 
5.1b summarises all of clones used for sequencing and figure 5.1a shows the 
oligonucleotides used on each template. The DNA sequence is shown in figure 5.3.
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Figure 5.1. Summary of M13 subclones and oligonucleotides used for 
sequencing the S.coelicolor gene, icd  B.
(a)
The entire region of DNA sequenced is shown in here. Only the relevant restriction 
sites used for creating the subclones are shown (for a more comprehensive map see 
figure 4.4). The start codon for the icd B gene and direction of transcription is indicated 
by the arrow to the right of the Eco RV site. Single stranded DNA sequencing was 
performed using several oligonucleotides as primers. The length and direction of 
sequence obtained from each oligonucleotide is indicated. Labeling refers to the 
oligonucleotide and subclone used in the sequencing {eg. 2 1 o ll indicates that 
oligonucleotide 11 was used in sequencing reactions with the subclone M13rt21).
(b), (c) and (d).
Fragments of DNA containing part (or all) of the icd B gene and surrounding regions 
were introduced into M13mp 18 and 19 for sequencing with oligonucleotides (see section 
5.2.2. for description). The position of each of the clones relative to the 2,560 bp region 
sequenced is shown here. Arrows labeled with numbers indicate which Ml 3 subclones 
sequence in which direction {eg. the subclone M13rt 18 was used to sequence the coding 
strand of the icd B gene and M13rt 19 used to sequence the non-coding strand).
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5.3 Discussion.
5 . 3 . 1  Analysis of Open Reading Frames (ORFsL
The high guanosine plus cytosine (G+C) content of streptomycete DNA imposes an 
extreme bias on the distribution of nucleotides in each of the three positions of a codon 
within a coding sequence. This is most extreme in the third base of codons, which is the 
position that allows the greatest degeneracy. Approximately 90% of all codons within 
streptomycete coding regions containing a guanosine or a cytosine in this position whilst 
70% contain G/C in the first position and 50% in the second (Bibb et al., 1984). Non 
coding regions do not contain such a restrictive bias with the frequency of G+C being 
distributed in a random manner. It is therefore relatively easy to distinguish an ORF in a 
region of DNA by looking for this non-random distribution of nucleotides (Bibb et al., 
1984).
A computer program that performs this sort of analysis is provided in the "GCG" 
package as a program called "CODONPREFERENCE" (Devereaux, 1984). It calculates 
the mean G+C content in each of the three positions within a window of specified size. 
The window is moved sequentially along the DNA sequence and the results are usually 
plotted as three separate graphs representing the G+C content for each codon position, 
refered to as "phases". If the region contains a real ORF then the plot should show one of 
the phases to have a medium G+C content (c.70%), one that will have a low G+C 
content (c.50%) and a third that will have a high G+C content (c.90%). This well defined 
order (ie. -Medium-Low-High-Medium-Low-High-) not only indicates the presence of an 
ORF but also the direction in which it is transcribed and translated.
As a consequence of such a rigid distribution of the G+C content, a bias is also 
imposed on the codons used by streptomycetes. Synonomous codons containing Gs or 
Cs (especially at the third position), are used in extreme preference to those containing As 
and Ts. The frequency of codons within a potential ORF (PORF) should therefore follow 
the codon usage table that was compiled from 67 streptomycete genes (Figure 5.5a) and 
provides a further way of testing where a PORF is likely to encode a protein. The 
"CODONPREFERENCE" program also draws a plot (figure 5.3 for each phase of the 
sequence that provides a measure of how closely the codon usage of the predicted frames 
correlates with a codon usage table.
Non coding regions of DNA will produce predicted amino acid sequences with a 
more random codon usage than coding regions and would therefore be expected to use 
every codon with almost equal preference. This in turn means that non-coding regions
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will use rare codons with a higher frequency than coding regions. The presence of a large 
number of rare codons in a putative coding region will therefore indicate that it is 
probably false. These are also highlighted by the program "CODONPREFERENCE" 
(figure 5.3)
Analysis of the "CODONPREFERENCE" plot produced for the region suurounding 
the icd B gene, shows that there is a region of DNA which shows extreme G/C bias and a 
codon usage similar to that used in streptomycetes in general. This indicates that this 
region seems to contain a true ORF. The nucleotide composition in phase 3 shows the 
high frequency of Gs and Cs that occur typically in the third position of a codon, whilst 
phases 1 and 2 show the medium and low frequency expected for the first and second 
bases of a codon respectively. This pattern shows that the direction of translation is from 
left to right (frame 1) as the sequence is written in figure 5.3. The paucity of rare codons 
observed in this frame would seem to confirm the presence of an ORF in this frame. The 
effect of such a high G+C content on the codon bias of the gene can be clearly seen, with 
the codon usage trace following the trace of the G+C bias almost exactly.
5 . 3 . 2  Translation start and stop codons,
Analysis of the DNA sequence (Figure 5.2), shows that there is a GTG start codon at 
position 198, which is consistent with the predicted start position indicated by the frame 
analysis program (Figure 5.3). The frequency with which GTG codons are used as a 
start codon is far higher in streptomycete genes than in E.coli, being used 18% of the 
time as compared to only 3% in E.coli (Seno and Baltz, 1989). The amino acid sequence 
deduced from the nucleotide sequence (Figure 5.2) had an N-terminus identical to the 
sequence determined by direct sequencing of the protein (figure 3.19) except that the first 
amino acid of the protein corresponded to the second codon of the ORF. The N-terminal 
formyl-methionine must therefore have been removed post-translationaly from the 
nascent polypeptide.
The first translation stop codon in the correct frame was found to be a TGA codon at 
position 2422 in Figure 5.2, which is at a position consistent with the loss of codon bias 
(indicated by figure 5.3). Translation of the 2,223 nucleotide region between these start 
and stop codons would result in a protein of 741 amino acids with a molecular weight of 
79,916. This agrees quite well with the molecular weights determined by both gel 
filtration and denaturing SDS-PAGE (see section 3.2.3). This confirms that the whole 
gene is contained within this region (and therefore within plasmids pRTB 1, 2 and 3) and 
that the protein is indeed a large monomeric protein encoded by a single gene.
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gen e .
a) Entire DNA sequence obtained from single stranded sequencing of the clones shown 
in figure 5.1 (section 5.2.1).
b) The translation of the putative ORF upstream of icd B is shown starting at base 3 and 
has been translated to the first stop codon at base 93. The possible terminator structure for 
this PORF is marked A (see figure 5.8).
c) The amino acid sequence for icd Bis shown starting from nucleotide 198 and 
finishing at the first stop codon at 2421. The possible terminator structure for this gene is 
marked B (figure 5.7) and the four possible promoters for icd E a^re marked I, II, III 
and IV (figure 5.5).
d) The translation of the putative ORF downstream of icd Bis shown starting at the 
possible start codon at base 2423 and has been translated to the end of the sequence. The 
-35 region of the putative promoter is labeled as V and the -10 region as VI.
All amino acid sequence has been derived from translation of the DNA sequence using the 
GCG programme “TRANSLATE” with each amino acid written below the first base of 
the appropriate codon. Putative ribosome binding sites for icd B and the putative 
downstream ORF are marked RBS. Possible translation s ta rt and stop codons are 
shown in bold.
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10 30 50 ,-35  I I
GGATCCCGTCGCCCGCCCGGACGGTCGCGCTCCAGCAGGGGGCCGTGGTCCTGCCGCAGC 
I P S P A R T V A L Q Q G A V V L P Q Q
70 -1 0  I I  ____ *  _ 90A  * *____ 110
a ) AGCGGGCGGGCGAGGACGTCGTCCCGCTCCCCTGAGCGCGGCGTGGCCGGAATCTGGGTG
b)  R A G E D V V P  L P - 35 I V - 10
130___________ - 2 5 .  I I I  1 5 Q ________ 170
a ) CGACCCCTGTCGAGCCGGGGACGGTCACGAGATATCTTGATGTCGAGCAATGTTGCAGAC 
I V  -3 5  I  -1 0  I
RBS 190 210 230
a ) GTGGAGCGGAGCACCCGGTGACTGACTCGACCATCATCTATACACACACTGACGAGGCCC 
C) V T D S T I  I Y T H T D E A P
250 270 290
a ) CGGCCCTGGCGACGTATTCGTTCCTGCCGGTGGTCCGGGCGTACGCCTCGCAGGCGGGTG 
C)  A L A T Y S F L P V V R A Y A S Q A G V
310 330 350
a ) TCGCGGTCGAGACCCGCGACATCTCGCTGGCCGGCCGCATCATCGCCCTGTTCCCGGAGT 
c )  A V E T R D I S L A G R I  I A L F P E Y
370 390 410
a ) ACCTCACCGAGGACCAGCGCATCCCGGACGCCCTCGCGGAGCTGGGCGAGCTGGCCAAGA 
C)  L T E D Q R I P D A L A E L G E L A K T
430 450 470
a ) CGCCCGCCGCCAACATCATCAAGCTGCCGAACATCTCGGCGTCCATCCCGCAGCTCAAGG 
C)  P A A N I  I K L P N I  S A S  I P Q L K A
490 510 530
a ) CCGCCGTCGCCGAGTTGCAGGGCCAGGGCTACGCGCTGCCGGCCTACCCGGACGACCCGA 
C)  A V A E L Q G Q G Y A L P A Y P D D P K
550 570 590
a ) AGACCGACGAGGAGCGCGACATCCGCGCCCGCTACGACAAGGTCAAGGGCTCCGCGGTCA 
C) T D E E R D I R A R Y D K V K G S A V N
610 630 650
a ) ACCCGGTCCTGCGCGAGGGCAACTCCGACCGGCGCGCCCCGGCGTCGGTGAAGAACTACG 
C)  P V L R E G N S D R R A P A S V K N Y A
670 690 710
a ) CCAAGACCCACCCGCACCGCATGGGCGCCTGGACCGGCGAGTCCAAGACCAACGTGGCGA 
C)  K T H P H R M G A W T G E S K T N V A T
730 750 770
a ) CCATGGGCGAGAACGACTTCCGCTCCACCGAGAAGTCCGCGGTGATCGCCGAGGACGGCA 
C)  M G E N D F R S T E K S A V I A E D G T
790 810 830
a ) CCCTGCGGATCGAGCTGGTCGGCGACGACGGCACCACCACCGTGCTGCGCGAGTCGGTGC 
c )  L R I E L V G D D G T T T V L R E S V P
850 870 890
a ) CGGTGAAGAAGGACGAGGTCGTCGACGCCTCCGTACTGCGCGTCGCCGCCCTGCGCGAGT 
C)  V K K D E V V D A S V L R V A A L R E F
910 930 950
a ) TCCTCACCGCGCAGGTCGCCCGCGCCAAGGCCGAGGGCATCCTCTACTCGGTGCACCTGA 
C)  L T A Q V A R A K A E G I L Y S V H L K
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970 990 1010
a ) AGGCCACGATGATGAAGGTCTCCGACCCGATCATCTTCGGCCACGTGGTCCGCGCCTTCT 
C)  A T M M K V S D P  I  I F G H V V R A F F
1030 1050 1070
a ) TCCCGAAGACCTTCGCCCAGTACGGCGACGTGCTCGCCAAGGCCGGCCTCACCCCGAACG 
C)  P K T F A Q Y G D V L A K A G L T P N D
1090 1110 1130
a ) ACGGCCTGGGCGGCATCTACAAGGGCCTGGAGTCCCTGCCCGAGGGCGCCGAGATCAAGG
c )  G L G G I Y K G L E S L P E G A E I K A
1150 1170 1190
a ) CGTCCTTCGACGCCGAGCTGGCCGAGGGCCCGGAGCTGGCCATGGTCGACTCCGACAAGG 
C)  S F D A E L A E G P E L A M V D S D K G
1210 1230 1250
a ) GCATCACCAACCTGCACGTGCCCTCGGACGTCATCATCGACGCGTCCATGCCGGCCATGA 
C)  I T N L H V P S D V I  I D A S M P A M I
1270 1290 1310
a )  TCCGCACCTCCGGTCACATGTGGGGCGCGGACGGCGGCGAGCACGACGCCCTCGCCGTGA
c )  R T S G H M W G A D G G E H D A L A V I
1330 1350 1370
a ) TCCCGGACTCCTCGTACGCCGGTGTGTACCAGGCCGTCATCGAGGACTGCCGCGCCAACC 
C)  P D S S Y A G V Y Q A V I E D C R A N R
1390 1410 1430
a ) GGCCGCTTCACGACCCCTCCACCATGGGTTCGGTCCCGAACGTCGGCCTCATGGCGCAGA 
C) P L H D P S T M G S V P N V G L M A Q K
1450 1470 1490
a ) AGGCCGAGGAGTACGGCAGCCACGACAAGACCTTCGAGATCCCCACCACGGGCACCGTCC 
C)  A E E Y G S H D K T F E I P T T G T V R
1510 1530 1550
a ) GCCTGGTCGCACGACCGCGGGCAACGCGGGTGCTGGAGCAGACGGTCTCCGCCGGTGACA 
C)  L V A R P R A T R V L E Q T V S A G D  I
1570 1590 1610
a ) TCTTCCGCGCCTGCCAGACCAAGGACGCGCCGATCCGCGACTGGGTGAAGCTGGCCGTCA 
C)  F R A C Q T K D A P  I R D W V K L A V T
1630 1650 1670
a ) CCCGCGCGCGCGCCACCGGCGACCCGGCCGTCTTCTGGCTGGACGAGGGCCGCGCCCACG 
C)  R A R A T G D P A V F W L D E G R A H D
1690 1710 1730
a ) ACGCCAACCTGATCGCCAAGGTCAAGCAGTACCTGTCGGAGCACGACACCGAGGGCCTGG 
C)  A N L I A K V K Q Y L S E H D T E G L D
1750 1770 1790
a ) ACATCCGGATCCTCGACCCGGTCGAGGCGACCAAGCTGTCGGTGGAGCGCATCCGCCGCG 
C)  I R I L D P V E A T K L S V E R I R R G
1810 1830 1850
a ) GCGAGAACACCATCTCGGTCACCGGCAACGTGCTGCGCGACTACCTGACCGACCTGTTCC 
C)  E N T I S V T G N V L R D Y L T D L F P
1870 1890 1910
a ) CGATCCTGGAGCTGGGCACCAGCGCCAAGATGCTGTCGGTCGTCCCGCTGATGGCGGGCG 
C)  I  L E L G T S A K M L S V V P L M A G G
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1930 1950 1970
a ) GCGGCCTCTTCGAGACCGGTGCCGGCGGTTCGGCCCCGAAGCACGTGCAGCAGCTGGTCA 
C)  G L F E T G A G G S A P K H V Q Q L V K
1990 2010 2030
a ) AGGAGGACTACCTGCGCTGGGACTCGCTCGGTGAGTTCTTCGCCCTGGTGCCGTCCCTGG 
C)  E D Y L R W D S  L G E F F A L V P S L E
2050 2070 2090
a ) AGAAGTACGCCGAGGCCACGGGCAACGGCAAGGCCAAGGTTCTCGCCGACACCCTCGACC 
C)  K Y A E A T G N G K A K V L A D T L D R
2110 2130 2150
a ) GCGCCACGGCGACGTTCCTCAACGAGGACAAGTCCCCGACCCGCCGCGTCGGCGGCATCG 
C)  A T A T F L N E D K S P T R R V G G I D
2170 2190 2210
a ) ACAACCGCGGCAGCCACTTCTACCTGTCCCTGTCTGGGCGCAGGGAGCTGGCGAAGCAGA 
C)  N R G S H F Y L S L S G R R E L A K Q T
2230 2250 2270
a ) CCGACGACGCGGACCTGGCCAAGGCCTTCGCCCCGCTCGCCGAGACGCTCACCGCGAGCG 
C)  D D A D L A K A F A P L A E T L T A S E
2290 2310 2330
a ) AGCAGAAGATCGTCGAGGAGCTGAACGCCGTCCAGGGCAAGCCGGCCGAGATCGGCGGCT 
C)  Q K I V E E L N A V Q G K P A E  I G G Y
2350 2370 2390
a ) ACTACCAGCCCGACCCGGCCAAGGCCGCCAAGATCATGCGCCCGTCGACCACCTGGAACG 
C)  Y Q P D P A K A A K I M R P S T T W N E
2410 2430 v B » *__  2450
a ) AGGCGCTGGCGTCCCTCGCCTGATCCTCGGGAGCCCCGCGCACCCCACGGGCACCCCGTT
c )  A L A S L A -3 5  V
2470 2490 2510 RBS
a ) TCCGTTCGGCGGAGGCGGGGTGTCCGTCTGTCTGCCGTCCCCCGACCTCCGGAGCACTCC
d ) - 10 VI
2530 2550
a ) TCATGACCGACGCCCCCGCCTCGTTCGCACTCGTCCCGGG
d ) M T D A P A S F A L V P
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5 . 3 . 3  Identification of Putative Ribosome Binding Sites (RBSsI.
A conserved sequence of nucleotides is usually found just upstream of the start codon 
of many E.coli genes, that is normally required for efficient translation. It is 
complementary to at least part of the 3' end of the 16S rRNA, a constituent of the 30S 
ribosmal subunit complex required to initiate translation (Shine and Dalgamo, 1974). 
This sequence therefore provides a site which the 30S complex can recognise and bind to 
(helping it to distinguish between GUGs, UUGs and ATGs that are acting as start 
codons and those that encode amino acids internal to the coding region).
However exceptions have been cited where mRNA molecules have no RBS and yet 
are efficiently expressed. For instance the mRNA that is transcribed from the prm  
promoter of the XC1 gene has no mRNA upstream of the start codon leaving no room 
for a normal SD ribosome binding site (Ptashne, 1976). This has also been found for 
theaph gene (neomycin resistance) from Streptomyces fradiae. When transcribed from 
the PI promoter, it also lacks "leader" mRNA. Such transcripts seem to be translated 
efficiently anyway at the appropriate times of the life cycle (Janssen et al., 1989). Janssen 
has also reported the removal of Shine-Delgamo sequences from E.coli genes (with 
reporter genes fused downstream) which have also been efficiently translated. It therefore 
seems that SD-sequences are not an absolute requirement for efficient translation raising 
questions as to the actual role that RBSs play (Janssen, ISBA conference 1991).
The sequence below shows a DNA sequence which is excactly complementary to the 
16S ribosomal RNA from S.lividans and represents an ideal ribosome binding sequence 
for streptomycetes (Bibb and Cohen, 1982).
5’- AGAAAGGAGGTGATC -3’
Most sequenced streptomycete genes have been found to posses an upstream region 
of DNA that is similar to this sequence in a manner analogous to the Shine-Delgamo 
sequence found for most E.coli genes. Most of these SD sequence are found 1-18 bases 
away from the start codon (with an average of 10 from the G highlighted in bold above) 
and contain 4-12 matches to the above sequence (average of 6, Seno and Baltz 1989).
Analysis of the appropriate region upstream of the S.coelicolor icd B gene has 
revealed three possible RBSs (see figure 5.4). Sequence B could be expected to act as a 
RBS, being as similar to the ideal sequence (with a total of 5 matches) as many of the 
other streptomycete genes and having a distance from the start codon (9 nt) very close to 
the mean for streptomycetes. Sequence A, which is further away (13nt from the start 
codon), has 7 matches to the ideal sequence. The third sequence (sequence C) also has 7
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Figure 5.3 Analysis of the region of sequenced DNA for ORFs.
The computer program "CODONPREFERENCE" was used to analyse the region of 
DNA sequenced (see figure 5.2 and section 5.31). The plot is divided into three sections, 
each representing one of the three forward frames of the sequence. The first section 
shows the data calculated for frame 1, the second section for frame 2 and the third section 
for frame 3.
Each section contains two graphs. The upper of the two traces shows the G+C 
content for the third nucleotide of codons in each frame (ie. the fraction of codons within 
a window of 25 containing a G or a C in the third position).
The second of the two traces indicates how well the codon bias for the sequence 
follows the codon usage for the organism in general (comparisons were made to the 
codon usage table shown in figure 5.6a). The mean 'P' value for codons within the 
window size chosen (in this case a size of 25 codons) is plotted. Every synonomous 
codon is given a 'P' value that indicates how frequently the codon is used compared to 
one of the other synonomous codons. A 'P' value of greater than 1 indicates that the 
codon is used more frequently than would be expected in a random sequence (with the 
same nucleotide composition) and a value of less than 1 indicates that it is used less 
frequently than in a random sequence (see GCG reference manual for details).
Rare codons were also highlghted in these traces by placing a mark on the horizontal 
axis of each trace. Rare codons were defined in this case as those codons with a codons 
with a ’P' value of less than 0.1.
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matches but overlaps with the start codon. As it is possible for ribosomes to bind to and 
translate mRNA with no leader sequences (see above), it is possible that this sequence 
could be functional.
It is impossible to tell from sequence analysis alone which of these sequences act as 
the functional RBS for the icd B gene, or if more than one is involved. It is possible that 
more than one is functional, although what function this would serve is unclear. Further 
studies would be required to solve this question maybe by using techniques such as 
footprinting (using the ribosome complex to protect mRNA) or by studying the effect of 
mutants created by site directed mutagenesis {eg. Janssen et al.t 1989).
5 . 3 . 4  Identification of putative promoter sequences.
It was described in section 1.1.3 how RNApol and promoter heterogeniety in 
streptomycetes play a key role in the differential control of gene expression. The 
relationship between promoter structure and gene function and the level and times of 
transcription is, however, still unclear. Such relationships will only be solved by the 
study of more promoters. It was therefore of interest to examine the upstream sequences 
of the icd B gene and compare it to known promoters as a first step in the study of the icd 
B promoter region.
Seno and Baltz (1989) compiled a consensus sequence from those streptomycete 
promoters that had been identified experimentally and found that the sequence is less 
representative than the E.coli counterpart. This is because promoter sequences from 
streptomycetes are variable, probably allowing for differential control of genes via 
control of transcription. However attempts to correlate gene funtion to the type of 
promoters used were unsuccessful (see section 1.1.3).
The DNA sequence upsteam of the icd B gene was examined by eye to look for 
sequences similar to known streptomycete promoters. Two sequences were identified that 
show some poor similarities to the -10 and -35 consensus sequences from both 
streptomycetes and E.coli (see Figure 5.5 a). Sequence I shows 50% identity to both 
consensus sequences with the gap between the -10 and -35 sequences being close to 
average. The close proximity to the RBS would require transcription to start straight after 
the last base of the -10 sequence (see Figure 5.2). Although this is unusual I have already 
described one example in streptomycetes (Janssen et al., 1989) where mRNA has been 
transcribed with no leader sequence at all.
1 2 6
Chanter 5. DNA sequencing and analysis o f icd B.
Sequence II would be more likely to act as a promoter. Although it only shows 42% 
identity to the E.coli sequence it shows 58% identity to the streptomycete sequence and 
lies further away from the putative RBS. A region was also found with 100% identity to 
7 of the nucleotides in the -35 region of gin AP2 (Wray and Fisher, 1988) although no 
similarity was found to the -10 region of this promoter, (see figure 5.5 b). Yet another 
region was identified which matches the -10 region from the aph DPI promoter in 8 out 
of 9 nucleotides (streptomysin resistance, Disder et al., 1987 a and b) but shows no 
similarity to the -10 region of this promoter (Figure 5.5 c).
As described in section 1.1.3 more than one of these sequences may act as a promoter 
since there are now several examples of genes with multiple promoters. If this were the 
case then it may indicate that IDH is expressed at more than one stage of the lifecycle.
Unfortunately it is impossible to tell which, if any, of these putative promoters are 
functional as they have been identified solely by sequence similarities. It is possible that 
the real promoter lies further upstream from the sequence information available to us. 
Some promoters have been found to lie greater than 150 nucleotides upstream of the 
RBS. For example the PI promoter of gin A lies 173 nt away from the RBS (Wray and 
Fisher, 1988) and aph D P2 is found 403 nt upstream (Distler et al., 1987a). Analysis of 
the frame upstream of the icd B gene (section 5.3.7) may even suggest that the icd B is 
expressed as one of the distal genes within an operon, in which case there would be no 
promoter within the region of DNA sequenced.
These possibilities can be resolved only by further experiments. High resolution S1 
mapping could be used to identify the point from which the mRNA is transcribed. The 
appropriate region upstream of this point (ie. at distances of approximately 10 and 35 
nucleotides upstream of the mRNA start point) could then be examined to check for 
similarity to known promoter sequences. To check that any sequence(s) identified are 
functional as promoters, in vitro site directed mutagenesis could be performed to see if 
mutations will affect rates of transcription (e.g. Bibb et al., 1985 and Janssen et al., 
1989). Footprinting experiments could also be performed, using the various 
streptomycete RNApol holoenzymes to protect the DNA (Buttner and Brown, 1985).
1 2 7
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a )  1 7 7  AGACGTGGAGCGGAGCACCCGGTGACTGAC 2 0 6
b )  1 8 2  tGGAGcgGAgC--------------------------------- 1 9 2
c )  1 8 8 ------------------------G G A G C acccg---------------------- 1 9 7
d) 1 9 3 ---------------------------------- A cccG G TGAcT------ 2 0 3
Figure 5.4 Three potential ribosome binding sites (RBSs) have been 
identified just upstream  of the S.coelico lor icd  B gene.
a) Shows the sequence of the region up and down stream of the icd B the translation 
start site (see figure 5.3). The GTG start codon is shown in bold.
b), c), d). The three potential RBSs are highlighted. The bases that show similarity to the 
streptomycete RBS consensus sequence (AGAAAGGAGGTGATC) are shown in 
CAPITAL letters (see section 5.3.3). The position of the first and last base in each 
sequence are shown, with the numbers that correlating to those used in figure 5.3.
a) -35 -10
E.coli_______consensus TTGACA TATAAT
Streptomycete consensus TTGA CA TAGG AT
I 157 T T G A t g - ( 1 8 ) -  c A G a c g - ( 2 1 ) - G T G - 1 9 8
II 51 c T G c C g -  ( 1 1 )  -  g A G G A c -( 1 0 6 ) -G T G -1 9 8
b)
gin AP2 (-35) GGTCACG
III 1 4 3  -GGTCACG- ( 4 6 )  -G T G -1 9 8
c )  IV  V
9 7 -a g C G C G G C G tg g c c g g a a tc tG G G T G C g A -1 2  4
TTCCCGGCG-------------------------GGGTGCTAC
tyl F aphDPl
Figure 5.5 Possible prom oter sequences upstream  of icd  B.
The region upstream of the icd B translation start codon was examined for possible 
promoter sequences by comparing the DNA sequence to promoters from several other 
genes (reviewed by Seno and Baltz, 1989). Several sequences were identified that show 
some similarity to the promoters indicated below.
a) Shows the consensus sequences for the -10 and -35 regions of the E.coli and 
streptomycete promoters. The nucleotides most conserved between different promoters 
are shown in bold. Two different sequences were identified (labeled as I and II, also see 
figure 5.2) that showed some similarities to one or the other of the promoter consensus 
sequences.
b) A sequence was identified that possesses 100% identity to the -35 region of the 
second promoter (P2) for gin A. Nucleotides highlighted in bold indicate the similarity 
of this sequence to the -35 region of the E.coli promoter consensus sequence (figure 
5.5a).
c) The region of DNA sequence shown here contains a 5nt sequence that is similar to the 
-35 region of the tyl F promoter (labeled as region IV). 13nt downstream from this 
possible -35 region there is a sequence (labeled as region V) that is identical to the -10 
region of the aph DPI promoter except for one mismatch. Sequence identities are shown 
in CAPITALS.
Numbers not in brackets indicate the position of bases with respect to figure 5.3. 
Numbers in brackets indicate the number of nucleotides separating different regions.
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5 .3 .5  A potential transcrip tional term inator for icd  B.
Terminator structures are required in order to signal the position at which the RNApol 
should stop transcribing DNA. Such signals are most commonly found in E.coli, in the 
form of a rho independent terminator, which is a sequence of DNA that has the ability to 
form a stable stem and loop structure (Rosenberg and Court, 1979). Very similar 
sequences are also found in many streptomycete genes, although in the case of the hyg 
gene the mRNA appears to terminate at the 5' side of the stem rather than on the 3' side 
which is the normal position (Zalacain, 1986).
A search for such a terminator structure around the 3* region of the streptomycete icd 
B gene was performed using the GCG program "TERMINATOR", which identifies 
structures using the method of Brandel and Trifonov, (1984 a and b). When this program 
is run with a stringency of 3.5 it is reported that 95% of all possible rho independent 
terminators are identified. The program identified only one potential terminator structure 
downstream of the icd B gene (see figure 5.7). The first base involved in binding in the 
stem of this structure, is found to be 6 nt away from the TGA stop codon and is therefore 
in the position expected for a true terminator structure.
5 .3 .6  Codon usage.
It has been suggested that if a particular tRNA species is present in limiting amounts, 
then the use of codons using this tRNA within a coding region would help to limit the 
expression of the gene. Such codons would be expected to occur only in genes for which 
this control of translation is required and would therefore occur less frequendy than other 
synonomous codons used for incorporation of the same amino acids. In this way the 
codon usage of a gene would be able to affect the efficiency with which it is expressed 
(McCarthy and Gualerzi, 1990).
Such a situation has indeed been found in S.coelicolor. The TTA codon is very rare 
in streptomycetes and has to date been found only in genes that are involved in the 
regulation of development, antibiotic synthesis or resistance (Leskiw et al., 1991b). In 
fact mutations in the bid A gene that encodes for tRNA^u prevent the organism from 
sporulating and producing antibiotics but have no visible effect on its vegetative growth 
(Lawlor et al., 1987). The complete dependence of some genes on the presence of 
tRNAj|^ for expression was shown by the work of Leskiw et al. (1991a). They 
converted the TTA codon found in car B to a CTC codon (which also encodes for 
leucine). The car B gene was then found to express in bid A mutants in the absence of 
tRNAleu.TrA
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a) Codon usage table compiled from 67 streptomycete genes.
G A T C
Gly 19 Glu 81 Val 39 Ala 33 G
G Gly 10 Glu 19 Val 2 Ala 4 A
Gly 8 Asp 4 Val 4 Ala 3 T
Gly 64 Asp 96 Val 56 Ala 59 C
Arg 6 Lys 95 Met 0 Thr 30 G
A Arg 1 Lys 5 He 3 Thr 3 A
Ser 3 Asn 4 lie 5 Thr 2 T
Ser 28 Asn 96 lie 92 Thr 65 C
Trp 100 End 14 Leu 3 Ser 26 G
T End 83 End 3 Leu 0 Ser 3 A
Cys 13 Tyr 5 Phe 1 Ser 1 T
Cys 87 Tyr 95 Phe 99 Ser 39 C
Arg 36 Gin 93 Leu 55 Pro 52 G
C Arg 5 Gin 7 Leu 0 Pro 2 A
Arg 7 His 6 Leu 2 Pro 3 T
Arg 46 His 94 Leu 39 Pro 43 C
b) Codon usage table for the icd B gene from S.coelicolor.
G A T C
Gly 2 Glu 100 Val 36 Ala 27 G
G Gly 0 Glu 0 Val 2 Ala 2 A
Gly 14 Asp 0 Val 2 Ala 0 T
Gly 84 Asp 100 Val 60 Ala 71 C
Arg 2 Lys 100 Met 100 Thr 20 G
A Arg 0 Lys 0 lie 0 Thr 2 A
Ser 0 Asn 0 lie 0 Thr 4 T
Ser 9 Asn 100 lie 100 Thr 75 C
Trp 100 End Leu 2 Ser 42 G
T End 100 End Leu 0 Ser 0 A
Cys 0 Tyr 10 Phe 0 Ser 2 T
Cys 100 Tyr 90 Phe 100 Ser 47 C
Arg 16 Gin 100 Leu 70 Pro 85 G
C Arg 2 Gin 0 Leu 0 Pro 0 A
Arg 0 His 0 Leu 2 Pro 0 T
Arg 79 His 100 Leu 27 Pro 15 C
Figure 5.6. Comparison of codon usage in the icd  B gene to that used by 
streptomycete genes in general.
a) The DNA sequences from 67 streptomycete coding regions were provided by Dr M 
Bibb from which a codon usage table was compiled using the program "xxxxxxxxxx" 
(provided as part of the GCG package). This table is therefore more representative than 
the table published by Seno and Baltz (1989), which was compiled from only 27 genes. 
However the new table was found to be very similar to the Seno and Baltz table, with the 
only significant difference being in the stop codons.
b) The frequency with which each codon is used in the icd B gene of S.coelicolor is 
shown in this table for comparison to the codon usage table shown in a).
The first nucleotide of a codon is shown in the first column of the tables above, the 
second nucleotide of a codon is shown in the top row and the third nucleotide shown in 
the last column. Cross referencing all three codon positions shows which amino acid is 
encoded and the frequency (expressed as a percentage) with which the codon is used to 
code for that amino acid.
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C G 
C — G 
G - C  
A A 
G -  C 
G -  C 
G — c
2 4 1 7  5 ' -CGCCTGATCCTC CACGGGCA-3' 2 4 5 3
Figure 5.7 Possible term inator structure for the icd B gene.
Just downstream from the TGA stop codon (shown in bold type) for the icd B 
gene there is a sequence which has been identified as a potential rho independent 
terminator (see region B in figure 5.3).
c c
T ”  G 
G — C 
C — G
71 5-CGAGGACGT TGGCCGGAA 1 1 2 - 3 '
Figure 5.8 Possible term inator structure upstream  of the icd B gene.
A sequence that is capable of forming a rho independent terminator has been 
identified upstream of the icd B start codon. It may form a terminator structure for a 
putative upstream ORF. The putative stop codon for this PORF (shown in bold type) 
would be included within the structure.
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McCarthy and Gualerzi (1990) have suggested that the presence of rare codons would 
have the most effect if they were situated near to the 5f end of a gene, where a stalled 
ribosome could also affect the initiation of further transcription. In 7 out of the 11 genes 
containing TTA the codon occurs within the first 50 codons, allowing for such a steric 
interference at the ribosome binding site.
Other rare codons, such as CTA and TTT, could be expected to play a similar role. 
However these codons occur randomly both in genes required for vegatative growth and 
those used for other functions. It is therefore unlikely that they play a role in the control 
of either metabolic or morphological differentiation (Leskiw et al., 1991b). It is possible 
however that they may play a role in limiting the amount of transcription rather than the 
timing of it.
The complete absence of TTA codons so far in DNA sequences of genes involved in 
primary metabolism made it of interest to check the codon usage of the S.coelicolor icd B 
gene. As IDH is almost certainly an absolute requirement for vegetative growth it would 
not be expected to contain any TTA codons, if the dogma postulated by Leskiw were to 
stand true. It would be expected that there will be few, if any, other rare codons in what 
is likely to be gene that is expressed to a reasonably high level. Comparison of the codon 
usage tables in Figure 5.6 shows that this is indeed the case with several codons, 
especially those with a high A+T content, not being used at all. This is consistent with the 
view of Leskiw that no vegatative genes in streptomycetes will contain TTA codons. It 
would be of interest to find out what the effect would be of introducing such a codon into 
a gene such as icd B that does not normally possess one.
Although the evidence of Leskiw et al. (1991b) would indicate that the level of 
tRNA^u could be used to differentially control genes at different times of the lifecycle, 
recent work by M.Bibb (John Innes Institute, Norwich, personal communication) has 
indicated that this tRNA species is in fact present throughout the lifecycle. This indicates 
that any such control by the bid A product is more complex thqn first thought, perhaps 
requiring other regulatory elements in order to exert its effect.
5 . 3 . 7  Possible ORFs up and downstream of the icd  B gene.
Analysis of the codon usage and nucleotide composition in the region upstream from 
the GTG start codon of the icd B gene shows that another ORF may exist at this point 
(Figure 5.3). However due to the short length of this region-it is difficult to tell from this 
data alone in which direction the possible open reading frame (PORF) would be 
transcribed. This region was therefore translated in all six possible reading frames and the 
amino acids sequences used to screen databases using the GCG computer program
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"FASTA". No significant similarities to other proteins were identified. This may not be 
surprising because of the short length of sequence available and the fact that the extreme 
ends of proteins are often not well conserved.
The absence of rare codons in frame 1 (of the sequence shown in figure 5.2; phase 3 
in figure 5.3) would however suggest that the upstream sequence could produce a PORF 
that is reading in the same direction as icd B and in the same frame. The only possible 
TGA stop codon is at position 93-95 and lies within a region (see Figure 5.2) that could 
form a terminator like structure (see figure 5.8).
Figure 5.3 shows that there may be another ORF downstream of the icd B gene 
(indicated by ORF indicator in phase 3). The absence of any strong G/C or codon usage 
bias in this region does not necessarily preclude this possibility, as the extreme N- 
terminal and C-terminal ends of proteins do not show the biases typical of the rest of an 
ORF. This is illustrated well by the lack of codon and G/C bias at the extreme ends of the 
icd B coding region, (shown by examination of figure 5.3). The only possible start 
codon found in this region was an ATG triplet at position 2523-2525. At the optimum 
distance away from this ATG (9 nt upstream of ATG) there is also a sequence that 
contains 4 of the residues that are often conserved within Shine-Dalgamo type RBSs (see 
Figure 5.9). The region between the putative start codon and the stop codon of the icd B 
gene was therefore examined for possible promoter sequence(s). A stretch of DNA 
sequence was revealed that resembles the gin A-P2 -35 sequence and a vph PI -10 
sequence (see Figure 5.10). This region begins just 3nt downstream of the putative icd B 
terminator structure.
Further sequence information could help decide if these PORFs are in fact real. 
Sequence similarities to another known protein(s) could indicate whether the PORFs are 
capable of encoding for a protein.
It was interesting to find that there is a possible ORF just upstream of the icd B gene 
and another just downstream. The proximity of these two PORFs to the icd B ORF 
suggests that one or both of them may form part of an operon with icd B. SI mapping 
would therefore be required to determine the ends of the mRNA.
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RBS AAGGAGGT
2508- acctccGGAGcactcctcATGacc -2527
Figure 5.9 Possible ribosome binding site for the PORF downstream of 
ic d .
A PORF was found just downstream of the icd B gene with a start codon at position 
2522 (see figure 5.3). A search for a possible RBS upstream of this start codon revealed 
a sequence that showed some similarity to the consensus RBS (see section 5.3.3). The 
S.coelicolor sequence is shown below the consensus sequence with identical matches 
highlighted in CAPITALS.
Y YI
2 4 4  9 -G G g C A C c c c g t t t c c g t tC G G C G G  - 2 4 7 2
GGTCAC-------------------------- CGGCGG
gin A (-35) vph (-10)
Figure 5.10 Possible promoter for the putative ORF found downstream 
of icd B .
A PORF was found just downstream of the icd B gene with a start codon at position 
2522 (see figure 5.3). A search for a possible promoter sequence upstream of this start 
codon revealed a sequence that showed some similarity to the -35 region of the gin A 
promoter (labeled as region V).12nt downstream from this there is a sequence that is 
identical to the -10 region of the vph promoter (labeled as region VI). Numbering 
indicates the position of bases in figure 5.3.
The S.coelicolor sequence is shown below the consensus sequence with identical 
matches highlighted in CAPITALS.
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5.3 Summary.
A region of DNA that covers 2,406 bp has been sequenced. This has been found to 
contain an ORF that could code for a protein of 741 amino acids with a molecular weight 
of approximately 80,000. This indicates that a gene has been cloned that encodes for a 
protein large anough to be the IDR
Comparison of the N-terminal amino acid sequence, predicted from the DNA 
sequence, to the N-terminal sequence of the native protein, showed that they are identical. 
This confirms that the gene has been cloned, that encodes the protein subjected to N- 
terminal sequencing. Post-translational modification must have occurred to remove the N- 
terminal formyl methionine since this initiation amino acid is absent from the N-terminal 
sequence of the native protein.
Several possible RBSs and promoters have been identified in the appropriate 
positions upstream of the start codon although their functional significance has yet to be 
proved. A possible terminator has also been identified 6 nt downstream of the stop 
codon. The icd B gene possesses a codon usage very similar to the mean codon usage for 
streptomycetes.
Analysis of the DNA up and downstream of the icd B gene has revealed the presence 
of a possible ORF in each region. If real, both would be transcribed in the same direction 
as icd B.
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6.1 Introduction,
The IDH of S. coelicolor is the first large, type IIIDH, for which the entire peptide 
sequence has been deduced. Analysis of the sequence may provide some insight into the 
relatedness and differences between the type I and II enzymes. Some of the possibilities 
that may be revealed by sequence analysis are given below.
a) The S. coelicolor IDH (and maybe type II IDHs in general), could have been 
derived from the fusion of two identical (or almost identical) gene sequences of the type I 
class. This could lead to the production of a type II monomeric protein that is, to all intents 
and purposes, virtually identical to a type I homodimer. In this case one would expect to 
find repetition in the amino acid sequence of the enzyme from S. coelicolor .
b) A similar fusion could have occurred between two gene sequences that were quite 
different to those that encode the type I monomer. If these sequences were similar then one 
would expect to find repetition in the amino acid sequence of the enzyme from S. 
coelicolor (ie. equivalent of a fused homodimer) If the sequences were different to each 
other then repetition in amino acid sequence would not be expected {ie. equivalent of a 
fused heterodimer). However in both cases one might expect the presence of two NADP+ 
and two isocitrate binding sites, although it may not be possible to identify them at the 
primary sequence level alone.
c) The EDH from S. coelicolor could be very similar to the type I enzymes but with 
extra sequences distributed throughout the protein. These extra sequences might be present 
to substitute for regions which are responsible for subunit/subunit interactions in a 
homodimer and that might be required to allow the enzyme to assume the correct 
conformation for activity. This would assume that the the type II IDHs have evolved from 
the type I IDHs or from an ancestor that was common to both types. Alternatively the type 
I IDHs could have evolved from the type II enzymes; the ability to form a dimer could 
have obviated the necessity for some of the sequence found in the type II IDHs. In these 
cases one would expect to find only one NADP+ and one isocitrate binding site in the IDH 
from S. coelicolor.
d) The IDH from S. coelicolor might be completely different to any of the IDH 
sequences known so far or may possess only some small regions of similarity that have a 
functional significance (eg. an NADP+ or isocitrate binding site). This in itself would be 
interesting, maybe giving more insight into residues required for the function of IDH. 
With this arrangement it is possible that the enzyme could possess one or two binding sites 
for both NADP+ and isocitrate.
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Thorsness and Koshland (1987) had pointed out that the NADP+ dependent IDH from 
(E. coli NADP-IDH) had no significant sequence conservation to any other 
dehydrogenase with the exception of the functionally similar isopropylmalate 
dehydrogenases (IMDHs), which use NAD+ as a cofactor.
It is also clear from examination of the three dimensional structure of the E. coli 
enzyme that none of these IDHs or IMDHs have a classical Rossmann fold type nucleotide 
binding site (Rossmann et. al., 1974). Examination of the protein sequence also shows 
that they do not possess either of the consensus sequences often quoted for NAD+/NADP+ 
dependent enzymes (Scrutton et al., 1991 and Wierenga et al., 1988).
It was therefore also of interest to find out if the S. coelicolor enzyme possesses one 
of the classical NAD+(P) binding sites. Alternatively it might possess a nucleotide binding 
site more similar to that of the IMDHs, or possibly no recognizable binding site at all. 
Attempts were also made to see if any conservation could be found for isocitrate binding 
sites.
Since this study was performed two other IDH sequences have become available 
which have confirmed some of the findings discussed in this chapter and are mentioned 
further in section 6.3.1., 6.3.2 and figure 6.7.
fL1  Results and Discussion.
(L2x1 Search, .for consensus sequences*
The Apple Macintosh program "MacPattem" was used to search for consensus 
sequences in the S. coelicolor enzyme sequence. The most relevant ones are described 
below.
6.2.1.al Lactate dehydrogenase (LDH1 consensus.
The consensus shown below is based around a histidine that is known to be required 
for the catalytic mechanism (Abad-Zapatero et.al., 1987).
[LrVMA]-G-[EQ]-H-G-[DN]-[ST]
-where the residues labeled in brackets show the variation at individual sites.
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6.2.1.1?) IDH/IMDH consensus sequence.
This consensus was based on the region around the only histidine that was absolutely 
conserved amongst all of the IMDHs and the E. coli IDH. This residue was assumed to 
have a catalytic role based on the information available from LDH and shows a little 
resemblance to the LDH consensus sequence. This region has now been found to contain 
the bulk of the residues that contribute towards the binding of NADP+ (Hurley et.al., 
1991).
E-[AP]-x-H-G-[ST]-A-P-x-x-[AEl 
-where the ’x' can be any amino acid.
NOTE: This sequence is provided within the Apple Macintosh computer 
program "MACPATTERN" as shown above. However examination of the 
alignment of the IMDHs and the IDH of E. coli (shown by Hurley et.al.,
1989), shows that this sequence has been entered into the program incorrectly.
The final residue highlighted in the sequence above (£) should be printed as a 
G.
No matches to either of these consensus sequences were found in the S. coelicolor 
enzyme using this program.
6.2.1.c) Nucleotide binding consensus sequences.
A modification of the NAD+ binding site of Rossmann et al. (1974) was proposed by 
Wierenga et al. (1986) and Scrutton et al. (1990), for the nucleotide binding site of some 
NADP+ dependent enzymes. The "FIND" program (supplied with the GCG package) was 
used to search for both of these consensus sequences in the S. coelicolor IDH sequence. 
A sequence identical to the NADP+ binding site of Scrutton et al. was found as shown 
below. The numbers correspond to the first and last residues of the S. coelicolor 
sequence.
NAD+ Consensus 
NADP+ Consensus 
A region of the S. coelicolor 
IDH sequence.
None of these consensus sequences are found in any of the other sequences available 
(ie. the yeast and E. coli IDHs and the IMDHs). One cannot attach too much significance 
to this as there are no further obvious similarities to the rest of the proposed consensus 
sequences.
G -X -G -X -X -G  
G -X -G -X -X -A  
580 -G - A - G - G - S - A -  585
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6 .2 ,2  Comparison of the^S. coelicolor enzyme to the other IDHs and
IMDHs,
6.2.2.a) Comparisons of sequences using "DOTPLOT".
It is possible that there are only small regions of similarity between the S. coelicolor 
IDH and the other IDHs and IMDHs and that the proteins are otherwise dissimilar. 
Dotplots are a convenient way to compare such proteins as every region of one protein is 
compared to every region of another. The method used by Maizel and Lenk (1981) was 
used (supplied in the GCG package as a program called "COMPARE"). A comparison 
between the two proteins is made within a window of specified size. If the number of 
residues within this window equals or exceeds a specified threshold level (the stringency) 
then a match is scored. A window from one of the proteins is compared to every register 
of the second protein. The window is then moved successively by one amino acid at a time 
along the first sequence and the analysis repeated. In this way every register of one protein 
is compared to every register of the other and can reveal small regions of similarity, even if 
insertions or deletions are present in one of the proteins relative to the other.
Results are then displayed using the program "DOTPLOT" in which matches are 
represented by a dot placed in the appropriate position of a graph between two sequences. 
The dot is placed in a position corresponding to the middle of the matching window. Lines 
on the graphs representing regions of similarity therefore need to be extended by half a 
window length at each end, to deduce the actual coordinates of the matching residues.
When comparing the S. coelicolor sequence to the other IMDH and IDH sequences 
several window sizes were tried with different stringencies. A window size of 30 and a 
stringency of 15 to 17 were found to yield the best results. This reduced the amount of 
non-specific background matches, whilst leaving the most relevant matches more or less 
intact. The effect of such alterations are shown in figure 6.1. The validity of these 
conditions were tested by comparing the E. coli IDH to two of the IMDHs which are 
known to be similar. IMDH from Bacillus subtilis and Thermus thermophilus were used 
in all of the comparisons in this study because they are, respectively, the most and least 
similar in comparisons to the E. coli IDH (Hurley et al. 1989), providing a yard-stick for 
other comparisons (see figure 6.2 h and j).
It can be seen from these plots, that the E. coli IDH shows some regions of 
considerable similarity to each of the IMDHs and E. coli IDH. Similar plots were 
produced by comparing the yeast enzyme to the IMDHs. These plots suggest that all of the 
sequences are to some extent similar to each other. This is particularly true for the region 
marked 'B' which is common to all of the plots.
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F igu re  6.1 Com par ison  of  the IDH sequence f rom  S. coelicolor  to the 
IM D H  sequence  f rom T.thermophilus  using " D O T P L O T S " .
The amino acid sequence of the IDH from S. coelicolor was compared to the amino 
acid sequence of the IMDH from T.thermophilus. The effect of altering the stringency 
parameter (using the "COMPARE" program) is shown using a window size of 30. Data 
was displayed using the "DOTPLOT" program.
Plot a) Was performed using a stringency of 15.
Plot b) Was performed using a stringency of 16.
Plot c) Was performed using a stringency of 17.
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F ig u re  6.2 Com par ison  of  some IDH and  IM D H  sequences  using 
" D O T P L O T S " .
The amino acid sequences of the IMDHs from T.thermophilus and B.subtilus were
com pared to the amino acid sequences of the IDHs from S.cerevisiae, E. co li and S. 
coelicolor , using the computer program "COMPARE" with a window size of 30. Results 
were displayed using the program "DOTPLOT". The stringency used for each plot is 
shown below in square brackets.
a)S. coelicolor IDH vs. B. subtilis IMDH b)S. cerevisiae IDH vs. B. subtilis IMDH 
[15] [16]
c)S. coelicolor IDH vs. T. thermophilus d)S. cerevisiae IDH vs. T. thermophilus 
IMDH [16] IMDH [16]
e)S. coelicolor IDH vs. E. coli IDH [16] f)S. cerevisiae IDH vs. E. coli IDH [16] 
g )S. coelicolor IDH vs. S. cerevisiae h)£. coli IDH vs. B. subtilis IMDH [16]
IDH [15]
i)S. coelicolor IDH vs. S. coelicolor IDH j)£ . coli IDH vs. T. thermophilus IMDH 
[17] [16]
S.coelicolor
S.coelicolor 
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Moreover, a similar region was also seen in a comparison of the yeast enzyme to the 
EDH from S . coelicolor (see plot g). This coincides with region 'B' of the yeast enzyme 
that is common to both IMDHs and the E. coli IDH. One would therefore expect to find 
this same region of similarity in comparisons between the S. coelicolor IDH and the 
IMDHs.
Examination of the plots between the IMDHs and the S. coelicolor enzyme confirms 
this, producing a staggered region of similarity, also labeled 'B' in plots a) and c). It is 
interesting to note that although the S. coelicolor EDH is similar to the yeast enzyme and 
both IMDHs, and the E. coli IDH shows similarity to the IMDHs and the S.cerevisiae 
enzyme, there is no obvious similarity between the E. coli and S. coelicolor enzymes.
Figure 6.2 shows that the region common to all of these proteins corresponds to the 
approximate region 310-330 of the E. coli sequence. This lies next to the region 
containing the bulk of the NADP+ binding residues in the E. coli IDH (Hurley et al. 
1991). It is therefore possible that this region is also an NADP+ binding site in the 
enzymes from S.cerevisiae and S. coelicolor . The approximate positions of the 
equivalent common region of the other proteins are also shown below.
Approximate Position
Enzvme of Region B.
T. thermophilus IMDH 260-280
B.subtilus IMDH 260-280
E. coli IDH 330-350
S. cerevisiae IDH 310-330
S. coelicolor IDH 570-590
6.2.2.b) Comparison of sequences using "BESTFIT".
To investigate these similarities further, the algorithm of Smith and Waterman (1981) 
was used to test if these protein sequences could be aligned. The algorithm is supplied as 
part of the GCG package as a program called "BESTFIT". It makes optimal alignments 
between two sequences, of as long a length as possible, with the best "quality” score 
possible, by inserting gaps within the sequences. Scoring is performed by comparing the 
similarity between amino acids within a window based on a similarity table (provided in 
the GCG package) with a penalty for any gaps that are added. It is possible to assess the 
relevance of such alignments by comparing the scores produced from the alignments of ten 
randomised sequences (using the program 'BESTFIT/RAN'). These sequences are 
produced from the shuffling of the query sequences. A "quality score" that is significantly 
larger than the "mean random score" would indicate an alignment of significance.
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"BESTFIT" alignments were first performed between the yeast IDH sequence, the E. 
coli IDH and the IMDHs. In each case an alignment was made which was similar to the 
alignment produced between the E. coli IDH and the IMDHs (see section 6.2.3 for the 
alignments between the E. coli IDH and the IMDHs). The scores for these alignments (eg. 
144.9 for the alignment between IDHs from yeast and E. coli ) were less than the 
equivalent scores between the E. coli IDH sequence and the IMDHs (eg. 166.2 for the 
alignment between IMDH from T.thermophilus and the IDH from E. c o li). However 
comparison to the randomised scores (eg. 129.0 for the alignment between IDHs from 
yeast and E. coli) suggest that the alignments were in fact significant. The data for every 
alignment are shown in figure 6.3.
Comparisons were therefore also carried out between the yeast enzyme and that from 
coelicolor , as dotplots had suggested a small amount of similarity. When many gaps 
were added the entire sequence of the yeast enzyme lined up to virtually the whole of the 
S. coelicolor enzyme (figure 6.4). Although a fair degree of significance is indicated by 
comparing the 'quality score' to the 'randomised score' (see figure 6.3a), it is possible that 
much of the line-up is spurious. If the alignment was really significant then the S. 
coelicolor enzyme has numerous extra sequences distributed throughout the protein but 
is otherwise similar. These extra sequences could enable the protein to fold in some way 
that enables it to function as a monomer, negating the requirement of a second subunit or 
the inserted sequences may have another function (see section 6.1c).
As the yeast IDH shows sequence similarity to the IMDHs and also to the S. coelicolor 
IDH, one would expect the S. coelicolor enzyme to show sequence similarity to the 
IMDHs, as already suggested by the dotplots. This was indeed found to be the case. 
Alignments of the two IMDH sequences to the S. coelicolor IDH were virtually identical, 
with the whole of the IMDH sequences being aligned to the last three quarters of the C- 
terminal end of the S. coelicolor IDH. These alignments are not shown because much of 
this alignment could be spurious as the "BESTFIT" program attempts to line up the whole 
of the S. coelicolor protein sequence to the much smaller IMDH sequences. This could 
have obscured any significant alignments and has probably led to the low score shown in 
figure 6.3.
The alignments at the C-terminal ends of the proteins were, however, very similar to 
those between the yeast enzyme sequence and all the other IDH/IMDH sequences. The 
alignments at the C-terminus was also similar to the alignments between the E. coli IDH 
and the IMDHs. This region also corresponds to the common region (region "B") 
suggested by the dotplots, which lies next to several residues involved in NADP+ binding 
in the E. coli IDH. Alignment over this region could therefore have a functional 
significance.
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With both dotplot and bestfit analysis, every combination of comparisons between the 
various proteins produced a line-up over this same area. The only exception to this is the 
direct comparison of the IDH from E. coli with that from S. coelicolor, even though the 
other line-ups suggested that a similarity of some degree would be expected.
An evolutionary relationship between the proteins could therefore be suggested from 
this, although one that is only very distant. The S. coelicolor and E. coli proteins could 
have diverged in different directions to such an extent that there is no obvious sequence 
similarity left between them. If the IMDHs and the S.cerevisiae IDH were to lie 
somewhere between these two, in evolutionary terms, then one might expect to see the sort 
of poor sequence similarity that has been found. This similarity, if true, is unexpected as it 
would imply an evolutionary relationship between type I and type II IDHs.
6.2.2c) Comparison of the C-terminal regions of proteins using "BESTFIT".
Because the programme "BESTFIT" attempts to line up the whole length of of two 
proteins, it is possible that much of the alignments between the S. coelicolor IDH and 
other proteins are spurious and have created the low scores shown in figure 6.3a (section 
6.2.2c). Bestfit analyses were therefore repeated, this time using only the sequence 
flanking this C-terminal area of interest which includes Region 'B'. Figure 6.3b 
summarises the scores for the comparisons between all of the proteins and indicates that all 
these alignments are significant with the exception of the line up between the E. coli and 
S. coelicolor IDHs. Figure 6.5 however shows that the E. coli!S. coelicolor 
comparison shows some similarities to the other alignment
From these data it could be concluded that there is significant sequence similarity 
between all of the proteins over a region that includes many of the residues required for 
NADP+ binding in the E. coli IDH. This suggests that an NAD(P)+ binding site common 
to all of the proteins has been found. Attempts were therefore made to line up all of these 
sequences together to try to deduce which residues were common to all of the enzymes. 
These residues may have a catalytic function.
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49 IALFPEYLTEDQRIPDALAELGELAKTPAANIIKLPNISASIPQLKAAVA 98 
: . : : . I .. I I I . : : . :  . : I . : I .
1 MSMLSRRLFSTSR___LAAFSKI......................KVKQPW 27
99 ELQGQGYALPAYPDDPKTDEERDIRARYDKVKGSAVNPVLREGNSDRRAP 148
1 1 : 1 : : .  I : I I : I . : I I
28 ELDGDEMT................. RIIWDKIKKKLILPYL......... D 52
149 ASVKNYAKTHPHRMGAWTGESKTNVATMGENDFRSTEKSAVIAEDGTLRI 198 
. . : |  I .  . . I : | : : .  I.  I .  :
53 VDLKYYDLSVESRDA..TSDKITQDAAEAIKKYGVGIKCATITPDEARVK 100
199 ELVGDDGTTTVLRESVPVKKDEWDASVLRVAALREFLTAQVARAKAEGI 248
I : . . : : . | | | : : . : .  I : I ------- |
101 EFNLHK..... MWKSPNGTIRNILGGTVFREPIVIPRIPRLVPR. WEKPI 144
249 LYSVHLKATMMKVSDPIIFGHWRAFFPKTFAQYGDVLAKAGLTPNDGLG 298 
: . : I • : . I . . I . : I I . : : I :
145 IIGRHAHGDQYKATDTLIPGP............................GSLE 169
299 GIYKGLESLPEGAEIKASFDAELAEGPELAMVDSDKGITNL.HVPSDVII 347 
: I I . : .  : I . : . I . . : I I : .  I . : I . . : I . . : I
170 LVYKPSDPTTAQPQTLKVYDYK.GSGVAMAMYNTDESIEGFAHSSFKLAI 218
348 DASMPAMIRTSGHMWGADGGEHDALAVIPDSSYAGVYQAVIEDCRANRPL 397 
I . : : : . I . . : : : I . : : : : I . I . I
219 DKKLNLFLSTKNTILKKYDG...........RFKDIFQEVYE  24 9
398 HDPSTMGSVPNVGLMAQKAEEYGSHDKTFEIPTTGTVRLVARPRATRVLE 447
I I I I : : :
250 ............... AQYKSKFEQLGIHYE................ HRLID 2 69
44 8 QTVSAGDIFRACQTKDAPIRDWVKLAVTRARATGDPAVFWLDEGRAHDAN 4 97 
: I .
270 DMV. .AQMIKS........................................KGG 281
4 98 LIAKVKQYLSEHDTEGLDIRILDPVEATKLSVERIRRGENTISVTGNVLR 547 
: I : I . I . 1 : 1 .
282 FIMALKNY........................................DGDVQS 295
548 DYLTDLFPILELGTSAKMLSWPLMAGGGLFETGAGGSAPKHVQQLVKED 597 
I . : . :  | . | : |  I I : : . .1 . :  . . : I I . . . : I . . .  I : :
2 96 DIVAQGFGSLGL .MTSILVTPDGKTFESEAAHGTVTRHYRKYQKGE 340
598 YLRWDSLGEFFALVPSLEKYAEATGNGKAKVLADTLDRATATFLNEDKSP 647
. : I : : . : I I : . : I I : I ----- : I : . I : . I I . : . : I
341 ETSTNSIASIFAWSRGLLKRGELDNTPALCKFANILESATLNTVQQDGIM 390
648 TRRVGGIDNRGSHFYLSLSGRRELAKQTDDADLAKAFAPLAETLTASEQK 697 
I : : I I . I : . . .1 I . I I . :
391 T  KDLALACGNNERS . AYVTTEEFLDAVEKR 419
698 IVEELNAVQ 70 6 
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Figure 6.4 Alignment between the IDHs from S. coelicolor and 
S.cerevisiae  mitochondia using "BESTFIT".
S.cerevisiae sequence is shown on the bottom line and the S. coelicolor sequence on 
the top line. Numbers refer to the First and last amino acid at in each line. Identical matches 
are marked with a line ( | ). Matches with a score of greater than 0.5 are marked with a 
colon ( : )  and those that match with a score of greater than or equal to 0.1 are marked with 
a full stop ( . ) ,  using the scoring table provided with the GCG package.
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281 I AD AF LQQILLRP AE YD VIACMNLNGD YIS D ALAAQVGGIGIAPGANIGD 330 Eco x Tth 
. . I I :  : : :  .11 : I I : . . I : I I . : : :  I . . I : : I : I : I . : I
213 YVDAMAMHLVRSPARFDVWTGNIFGDILGNLRADLPGSLGLLPSASLGR 2 62
331
263
ECALFEATHGTAPKYAGC DKVNPGSIILSAEMMLRHMGWTEAADLIVKGM 380
I I I I I I . I I I
GTPVFEPVHGSAPDYAGK 3R. NPTAAILSAAMMLEQL . . . . RPGGLARKV 307
381 EGAINAKTVTYDFERLMDGAKLLKCSEFGDAIIENM 416
1:1 I I . :  . . . : : I .................. I :
308 EDA. .AKALLETPPPDLGGS. . .EARAFTATVLRHL 338
511 TEGLDIRILDPVEATKLSVERIRRGEN.TISVTGNVLRDYLTDLFPILEL 559 S c o  x Tfch
• I • • I : •  : I I I I : : I . I . : I : : I
201 GRGYPDVALEHQYVDAMAMHLVRSPARFDVWTGNIFGDILGNLRA. .DL 248
5 60 GTSAKMLSV '/PLMAGGGLFETGAGGSAPKHVQC LVKEDYLRWDSLGEFFA 60 9
. I
2 49 PGSLGLLPSlASLGRGTPVFEPVH. GSAPDYAGK ,GRNPTAAILS 290
610 LVPSLEKYAEATGNGKAKVLADTLDRATATFLNEDKSPTRRVGGIDNRGS 659 
. I I . .  : : .11 • : : I . . : I : . I . . : I I : . I :
291 AAMMLEQL.................... RPGGLARKVEDAAKALLE . . . TPPPDLGGSEARA. 329
660 HFYLSLSGRRELA 672 
: . • . I . I I
330 ...FTATVLRHLA 339
501 KVKQYLSEHDTEGLDIRILDPVEATKLSVERI. RRGENTISVTGNVLRDY 549 S e o  x B a u  
: . I . . : : : .  I : . :  . . .  . : :  I . . :  . :  | | : | : :  | .
200 RLWREVAEDVAQEFPDVKLEHMLVDNAAMQLIYAPNQFDVWTENMFGDI 24 9
550 LTDLFPILELGTSAKMLSWPLMAGGGLFETGAGGSAPKHVQQtVKEDYL 599
I . I . : I . . I II. . I
250 LSDEASM. . LTGSLGMLPS ASLSSSGLHLFEPVHGSAPDIAGK 3MANPFA 297
600 RWDSLGEFFALVPSLEKYAEATGNGKAKVLADTLDRATATFLNEDKSPTR 649 
I : : : : I I . I . I . : : : . Mi l .
2 98 AILSAAMLLRTSFGLEEEAKAVEDAVNKVLAS................... 329
650 RVGGIDNRGSHFYLSLSGRRELAKQTDDADLAKAFAPLAETLTASEQKIV 699
: | . |  I . . . . I  . 1 . 1 1 .
330 ........................GKRTRDLARSEEF.........SSTQAIT 34 9
700 EELNAVQGKPAEIGG 714
I I : • I  I : -
350 EEVKAAIMSENTISN 364
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500 AKVKQYLSEHDTEGLDIRILDPVEATKLSVERIRRGENTISVTGNVLRDY 549 Sco x Sn a  
. . I I : . . . : .  I : I . I .
270 DMVAQMIKSKGGFIMALKNYD........................ GDVQSDI 297
: . :  I . 1:1 II 
2 98 VAQGFGSLGLMTS
550 LTDLFPILELGTSAKMLSVIVPLMAGGGLFETGAG.GSAPKHVd^LVKEDY 598
: : : I I I . : I : I . . . : I . . .  I : : 
ILVTPDGKTFESEAAHGTVTRHYRKYOKGEE 341
599 LRWDSLGEFFALVPSLEKYAEATGNGKAKVLADTLDRATATFLNEDKSPT 648
. : I : : . : I I : . : I I : I   : I : . I : . I I . : . : I I
342 TSTNSIASIFAWSRGLLKRGELDNTPALCKFANILESATLNTVQQDGIMT 391
649 RRVG.GIDNRGSHFYLSLSGRRELAKQTDDADLAKAFAPLA 688 
392 KDLALACGNNERSAYVT....TEEFLDAVEKRLQKEIKSIE 428
16 IRILDPVEATKLSVERIRRGENTISVTGNVLRDYLTDLFPILELGTSAKM 565 Sco x Er .n  
I I I . : . . .  I : I . : I . : . . I : I I : . I : : I . : :
275 IVIKDVIADAFLQQILLRPAEYDVIACMNLNGDYISDALAAQVGGIG. . I 322
566 LSV^PLMAGGGLFETGAGGSAPKHVC2LVKEDYLRWDSLGEFFALVPSLE 615 
I I I :.  I . I I I . . .  I 
323 APG ANIGDECALFE . ATHGTAPKYAG 3....................... D 349
616 KYAEATGNGKAKVLADTLDRATATFLNEDKSPTRRVGGIDNRGSHFYLSL 665
350 KVNPGSIILSAEMMLRHMGWTEAA. . . .DLIVKGMEGAINAKTVTY. . . . 391
6 66 SGRRELAKQTDDADLAKAFAPLAETLTASEQKIVEEL 702 
I : I . I I . . .  :: I : I : :
392 . . . .DFERLMDGAKLLKC....... SEFGDAIIENM 416
Figure 6.5 Comparison of the C-terminal region of the IDH from 
S.coelicolor  to other IDHs and IMDHs.
The programme "BESTFIT" was used to line up the C-terminal region (amino acids 
500-714) of the S.coeicolor IDH sequence to some other protein sequences. This region 
(shown boxed) is suspected to contain an NADP binding region over the putative NADP 
binding sites. Identical matches between amino acids in the alignments are marked with a 
line ( | ). Matches with a score of greater than 0.5 are marked with a colon ( : )  and those 
that match with a score of greater than or equal to 0.1 are marked with a full stop ( .) .
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6*2,3 Sequence alignment of_the_IPHs / IMDHs.
Bestfit data between the yeast IDH, E. coli IDH and the IMDHs were very similar and 
produced alignments across the whole of each sequence (individual alignments not 
shown). This suggests that the S.cerevisiae enzyme is similar to each of the proteins 
across the whole of its length and not just over the putative NADP+ binding sites. 
Attempts were therefore made to first line up all of these sequences to each other using the 
GCG program, ,,PILEUP,,.
As expected an alignment was produced that agrees well with those produced by the 
individual "BESTFIT” comparisons. Figure 6.6 shows these alignments. However one of 
the gaps introduced by the program was moved to a different position. The gap was 
moved so that it would lie over the region that encodes a clasp-like domain in the E. coli 
IDH. This clasp-like domain consists of two p-sheets that are known to be absent in the 
IMDH from T.thermophilus (Miyazaki et al., 1992) and the IDH from the same organism 
(Imada et al., 1991) and from the NAD-IDH from yeast (Cupp and McAlister-Henn, 
1991) (see section 1.2.5). Residues identical in the yeast enzyme and at least two other 
sequences were highlighted along with the residues from E. coli that are known to 
contribute to the binding of substrate and co-factor or are involved in catalysis. There are 
also many conservative matches throughout the sequence, confirming the report by Hurley 
et al. (1991) that the S.cerevisiae IDH has sequence similarity to the E. coli enzyme. This 
would seem to suggest that this eukaryotic NADP-IDH can also be classified as a type-I 
IDH.
Such identities are even more apparent when one examines the residues that lineup 
with the E. coli sequence at positions required for NADP+ or isocitrate binding. Figure 
6.7c, shows the almost complete conservation of the residues required for 
isocitrate/isopropylmalate binding, which was first noticed by Hurley et al. (1991) 
between the IMDHs and the IDHs. Figure 6.7.a, shows that there is also a large amount of 
sequence conservation over those residues required for NAD(P)+ binding which had not 
previously been noticed.
Attempts to include the S. coelicolor sequence in this alignment were not very 
successful as the "PILEUP” tried to line up the whole length of the S. coelicolor protein. 
Much of the protein is certain to be dissimilar to the rest of the proteins due to the extra 
sequence and could produce some spurious alignments. The various alignments produced 
by the bestfit analysis over the putative NAD+(P) binding site (figure 6.4) were therefore 
used to compile figure 6.7b). It can be seen that only a few residues show conservation 
when compared to those shown in figure 6.7a).
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Complete conservation is seen though over the region 584-589, which coincides with 
the main cluster of NAD+(P) binding residues in the other sequences. An attempt was 
therefore made to derive a consensus sequence that could describe this conservation. No 
attempt was made to make a similar consensus for the isocitrate binding residues, since 
they are too distant from each other and at variable distances, making it difficult to identify 
residues that might be significant.
6 . .h 4  N A D ( P ) +  c o n s e n s u s  s e q u e n c e .
The obvious conservation (shown in figure 6.7a and b) between the residues required 
for NAD(P)+ binding, indicates that a consensus could be derived that is present in most 
of the sequences used in this analysis (consensus no. 1 below).
1) S-(26-27 X)-L-G-(17-19 X)-H-G-[STJ-A-(2 X)-[YH]-(5-12 X)-N-(37-47 X)-D-(2-5 X)-[RG]
x= any amino acid, eg. (26-27x) =26 to 27 amino acids 
[Residues in square brackets indicate variability ]
This consensus can be used to screen by eye putative NAD+(P) binding sites in other 
proteins. Its use for analysis by computer (using a program such as "BEST" or "FASTA") 
would be more difficult because of the variability in size of the gaps between the residues. 
Such variability is likely to be even more extreme in less conserved proteins. The 
consensus can be shortened to include only the core region in the middle of this 
consensus. Further modification to include other conserved residues in the proximity of 
this core region was also included to give the consensus below (consensus no. 2 below).
2) E -  [AP] -  ( 1 - 2 X )  -  H -  G -  [ST]  -  A -  P -  X -  [YH]
3)  E -  [AP] -  x -  H -  G -  [ST]  -  A -  P - X -  X -  [AQ]
Note that the consensus sequence provided by the MacPattem program is 
incorrect (see section 6.2.1b). The corrected sequence is shown here in 
sequence 3.
It can be seen that this consensus is essentially the same as the sequence provided in 
the Apple-Macintosh computer program, "MACPATTERN" (see section 6.2.1b and 
consensus no. 3 above). Modifications to include the S.cerevisiae and S. coelicolor 
sequences have led to a more degenerate sequence which allows greater flexibility if a 
scoring system is used. For instance the T.thermophilus IMDH and the E. coli IDH 
sequence conform to the consensus perfectly, whilst the B. subtilis IMDH has one 
mismatch. S.cerevisiae and S. coelicolor IDHs conform less well, scoring six out of
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1 * 50
B s u   MKKRIA LLPGDGIGPE VLESATDVLK
T t h   MKVA VLPGDGIGPE VTEAALKVLR
ECO MESKWVPAQ GKKITLQNGK L N V PEN PIIP  YIEGDGIGVD VTPAMLKWD
S e e  .............................................. MSMLS RRLFSTSRLA AFSKIKVKQP WELDGDEMT
51 97
B s u  . SVAERFNHE F E F E Y G L I..................... GGAAI DEHHNPLPEE TVAACKNADA
T t h  .A LD EA.EG G  P T Y E V F P F ..................... GGAAI D A .S A P F P E P  TRKGVEEAEA
ECO AAVEKAYKGE R KISW M EI. .  . YTGEKSTQV YGQDVWLPAE TLDLIREYRV
S e e  RIIWDKIKKK LILPYLDVDL KYYDLSVESR DATSDKITQD AAEAIKKYGV
98 + + + 139
B s u  ILLGAVGGPK WDQNLSELRP EKGLLSIRKQ LDLFANLRPV KVFESLSDRS
T t h  VLLGSVGGPR LGRPSPQDPP GDGASFLKEK PDLFANLRPA KVFPGLERLS
ECO AIKGPLTTPV G G G IR S L N V A .................LRQE LDLYICLRPV RYYQGTP. . S
S e e  GIKCATITPD EARVKEFNLH K  MWKSP NGTIRNILGG T V F R E P IV IP
140 + + 182
B s u  PLK K E Y ID .N  VDFVIVRELT GGLYFGQPSKRYVNT
T th  PL K E E IA R .G  VDVLIVRELT GGIYFGEP_____ RG
ECO P V K H . . P E . L  TDMVIFRENS EDIYAGIEWK ADSADA.................EKVIKFLRE
S e e  RIPRLVPRWE K PIIIG R H A H  GDQYKATDTL IPGPGSLELV YKPSDPTTAQ
232
182 +
B s u  EG EQEAVDTLFY KRTEIERVIR EGFKMA.ATR KGKVTSVDKA
T t h  MS EAEAWNTERY SKPEVERVAR VAFEAA. RKR RKHWSVDKA
ECO EMGVKKIRFP EHCGIGIKPC SEEGTKRLVR AAIEYAIAND RDSVTLVHKG
S e e  PQTLKVYDYK GSGVAMAMYN TDESIEGFAH S S F K L A I.D K  KLNLFLSTKN
232 281
B s u  NVLESSRLWR EVAEDVAQEFP....................................................................DVKLEHML
T th  NVLEVGEFRR KTVEEVGRGYP....................................................................DVALEHQY
ECO NIMKFTEGAF KDWGYQLARE EFGGELIDGG PWLKVKNPNT GK EIVIKDVI
S e e  TILKKYDGRF KDIFQEVYEA QYKSKFEQ.........................................LGIHYEHRL
282 ! * ! ! ! ** 331
B s u  VDNAAMQLIY APNQFDVW T ENMFGDILSD EASMLTGSLG M LPSASLSSS
T t h  VDAMAMHLVR SPAR FDV W T GNIFGDILGN LRADLPGSLG L L PSA SL .G R
ECO ADAFLQQILL RPAEYDVIAC MNLNGDYISD ALAAQVGGIG IA PG A N I.G D
S e e  IDDMVAQMIK SKGGF. IMAL KNYDGDVQSD IVAQGFGSLG LMTSILVTPD
332 * *** * ** 371
B s u  GLHLFEP . . V HGSAPDI.................... AGKGMANP FAAIL. . SAA MLLRTSFGLE
T th  GTPVFEP . . V HGSAPDY.................... AGKG.RNP TAAIL . . SAA MML.EQLRPG
E co ECALFEA. . T HGTAPKY....................AGQDKVNP G S IIL ..S A E  MMLR. HMGWT
S e e  GKT.FESEAA HGTVTRHYRKY QKGEETSTNS IASIFAWSRG LLKRGELDNT
372 ** * 413
B s u  E E . . . .AKAV EDA.VNKVLA SGKRTRDLA. . .RSEEFS..................... STQAI
T th  GL____ ARKV EDA.AKALL. . ETPPPDLG. . .GSEARA.....................FTATV
ECO EA_____ADLI VKG.MEGAIN AKTVTYDFE. . .RLMDGAKL LKCSEFGDAI
S e e  PALCKFANIL ESATLNTVQQ DGIMTKDLAL ACGNNERSAY VTTEEFLDAV
Figure 6.6 A lignm ent o f  the yeast IDH sequence to the E . c o li  IDH and IMDH 
seq u en ces .
The programme "PILEUP" from the GCG package was used to produce an alignment of the four 
sequences shown.
See = IDH homS.cerevisiae mitochondria, Eco = IDH from E. c o l i .
Tth = IMDH from T. thermophilus , Bsu = IMDH from B. subtilus.
(+ ) = amino acids contributing to binding o f isocitrate in E. coli sequence. ( ! )  Amino acids 
involved in coordinating Mg^+ (* )  = amino acids contributing to binding of NADP in E. coli 
sequence.Numbering labels the residues of the E. coli IDH sequence (Hurley et al., 1991).
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b)
E.coli B.subt T.therm. S.cerev T.therm. S.cerev S.coeli S.coel- S.coel- S.coel-
IDH IMDH IMDH IDH IDH NAD-IDH E.coli B.sub T. therm. S.cerev
R-292 A-233 S-224 S-278 R-230 S-233 R-533 R-533 R-533 E-508
1-320 L-261 L-252 L-305 L-258 L-262 T-561 A-563 A-563 L-557
G-321 G-262 G-253 G-306 G-259 G-263 S-562 K-564 K-564 E-558
H-339 H-281 H-271 H-326 H-276 H-281 G-583 G-583 G-583 G-583
G-340 G-282 G-272 G-321 G-277 G-282 G-584 G-584 G-584 G-584
T-341 S-283 S-273 T-328 S-278 S-283 S-585 S-585 S-585 S-585
A-342 A-284 A-274 V-329 A-279 A-284 A-586 A-586 A-586 A-586
Y-345 1-287 Y-277 H-332 H-282 1-287 H-589 H-589 H-589 H-589
V-351 A-293 R-282 T-344 1-288 A-293 Y-617 K-595 W-601 W-601
N-352 N-294 N-283 N-345 N-289 N-294 A-618 E-596 D-602 D-602
Y-391 R-334 P-320 K-392 T-329 R-333 F-661 D-676 R-649 R-649
D-392 D-335 D-321 D-393 D-330 - E-670 D-677 R-650 R-650
R-385 R-338 G-324 G-399 V-333 - K-673 L-680 G-653 D-655
£ 1
E.coli B.subt T.therm S.cerev T.therm S.cerev
IDH IMDH IMDH IDH IDH NAD-IDH
N-115 L-086 D-082 N-104 N-100 N-100 T.therm. -  T.thermophilus
S-113 S-084 P-080 E-101 S-098 S-98 B.subt = B . subtilis
R-119 R-096 K-092 K-109 R-103 R-104 S.cerev = S.cerevisiae
R-129 R-106 R-102 L-119 R-113 R-114
R-153 R-134 R-130 R-148 R-135 R-135 All IDHs shown are NADP
Y-160 Y-141 Y-137 Y-155 Y-143 Y-142 dependent except for
K-230 K-192 K-183 K-229 K-190 K-189 S.cerev. NAD-IDH which is
D-283 D-214 D-215 D-269 D-222 - NAD dependent.
D-307 D-238 D-239 D-292 D-246 D-248
D-311 D-242 D-243 D-296 D-250 D-252
Figure 6.7 Sum m ary of residues suspected to be involved in the 
binding of NADP and isocitrate.
a) Residues known to be important in the binding of NADP in E. coli IDH are shown 
in the first column . Those residues that line up with the E. coli sequence in figure 6.6 
are shown for the IMDHs and S.cerevisiae IDH. Numbers represent the position of 
amino acids in each protein.
Sequences for S.cerevisiae NAD-IDH and the T.thermophilus NADP-IDH have 
recently been published and have been aligned with the E. coli IDH sequence. Using 
the alignments published by the respective authors (see section 6.3.2) residues lining 
up with the NADP binding residues were included in this table.
b) Comparison of the S. coelicolor IDH sequence to the other sequences produced 
different alignments (see figure 6.5). For each different alignment, the residues lining 
up with those proposed to be involved in NADP binding (inferred from figure.6.7.a) 
are shown.
c) Residues known to be important in the binding of isocitrate in E. coli are shown. 
Those residues that line up with the E. coli sequence are shown for the IMDHs and 
S.cerevisiae IDH. Numbers represent the position of amino acids in each protein and 
are derived from the alignment in figure 6.6.
Sequences for S.cerevisiae NAD-IDH and the T.thermophilus NADP-IDH have 
recently been published (see section 6.3.1). Those residues required for isocitrate 
binding in the E. coli sequence have been reported to also be conserved in these 
enzymes.
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eight possible matches. Although consensus 2 is only a minor modification of the 
sequence in "MACPATTERN", it was obtained independently during this work. It utilised 
the data of Hurley et al. (1991) which has highlighted its importance in NAD(P)+ binding. 
The consensus provided as part of "MACPATTERN" was assumed to have a some sort of 
catalytic role but was not considered for use as a consensus for nucleotide binding.
Such a consensus has indicated that all of these proteins do have an NAD(P)+ binding 
site that can be identified at the primary sequence level. The conservation is not totally rigid 
however, especially outside the main cluster of binding residues. Recent publication of the 
sequence for the NAD dependent IDH from S.cerevisiae and for the NADP dependent 
IDH from T. thermophilus has shown that these sequences also possess a putative 
NAD(P)+ binding consensus sequence.
6 .2 .5 . Com parison of the S. coelicolor enzyme to itself.
As outlined in section 6.1. a) and b) , it is possible that the S. coelicolor enzyme 
could have evolved from the fusion of two identical genes to form a monomeric protein 
that has two identical halves. It was also discussed (section 6.1b) that the S. coelicolor 
enzyme may possess two NADP binding sites, even if the enzyme is not produced by the 
fusion of two genes.
In the first situation one might expect to find two regions of extensive similarity to 
other IDHs/IMDHS which would be revealed in the dotplots described in section 6.2.2a. 
In the second situation one may expect to find two small regions of similarity to the other 
proteins, representing two NADP binding sites (presuming that both NADP binding sites 
are similar). Neither situation was found indicating that the S. coelicolor IDH has not 
evolved from the fusion of two identical genes and that it only possesses one IDH/IMDH- 
like NAD(P)+ binding site.
6 .2 .6  D atabase searching.
To test whether the S. coelicolor IDH was similar to any other proteins that have been 
sequenced several methods were used to screen various databases. The algorithm of 
Pearson and Lipman, "FASTA", was used as well as the more sensitive DAP algorithm of 
to screen the appropriate peptide sequence databases (e.g. PIR and SWISSPROT). 
TFASTA was also used to screen the more extensive DNA sequence databases. This 
algorithm is basically the same as the FASTA method but the DNA sequences in the 
database are first translated in all six reading frames before making the comparison. None 
of the searches identified any proteins with a significant sequence alignment.
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6.3 Conclusions.
6 . 3 . 1  Relationships between the S.cerevisiae  and E. coli IDHs and the 
IM DHs.
As discussed in section 1.2.5 the IMDHs and the E. coli IDH are related in both 
function and amino acid sequence. Comparison of the S.cerevisiae IDH to both classes 
produced a sequence alignment that resembles the alignment of the E. coli enzyme to the 
IMDHs.
NAD dependent IDHs from E. coli, pig heart and yeast, all have similar subunit 
compositions and molecular weights. Haselbeck and McAlister-Henn (1991) have also 
reported the similarity between the N-termini of the pig heart and yeast enzyme. Cross 
reaction of antibodies between the porcine and E. coli IDHs also indicates that they are 
related. One could infer from this that the E. coli and yeast enzymes must therefore be 
related in some way, a suggestion also made by Hurley et al. (1991).
From these data it would therefore appear that the yeast mitochondrial enzyme is in fact 
a member of the class I, 80 kDa, dimer type of IDH, of which the only previous examples 
have been in bacteria. Mitochondria are believed to have evolved from prokaryotes, 
probably providing an explanation for this, although it could be that the classification of 
NADP+ dependent IDHs can be broadened to include those enzymes from eukaryotes.
Since the work described in thesis was completed other IDH sequences have become 
available. It was reported that the sequence for the NADP-IDH from T.thermophilus and 
the NAD-IDH2 subunit from yeast, show conservation with the residues required to bind 
isocitrate in E. coli (Miyazaki et al., 1992 and Cupp and McAlister-Henn, 1992 
respectively). The degree of conservation (33% identical) found for the yeast NAD-IDH2 
was particularly surprising since this enzyme has a different quartemary structure and 
different coenzyme specificity to the type I IDH. These sequences have been included in 
figure 6.7c to illustrate the conservation over the substrate binding site for all of the 
IDH/IMDHs.
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6 . 3 . 2  NAD(P)+ hinding sites.
A sequence relationship between all of the proteins studied was first noticed when a 
region of similarity was identified that was common to all of them. Close analysis of this 
region showed that significant alignments over this region could be made for almost every 
pair of proteins. This region contains within it 13 out of the 14 residues required for 
NADP+ binding, although the main region of sequence conservation surrounds a cluster of 
6 amino acids within a 7 amino acid region (residues 339-345 for the E. coli enzyme).
Figure 6.7 shows that there is some variability in the amino acids at each position, 
although the degree of conservation is very noticeable. For most positions there is a 
conservative or identical amino acid between at least two of the proteins and often there are 
also conserved residues in the proximity of these regions (figure 6.6). A consensus 
sequence was therefore made to represent each sequence as fully as possible.
Both the NAD-IDH2 S.cerevisiae (Cupp and McAlister-Henn, 1991) and the NADP- 
IDH from Thermus thermophilus (Miyazaki et al., 1992) have sequences that conform to 
this consensus sequence, corroborating its validity as a consenus for this type of enzyme.
6 .3 .3  Relationship between the S. coelicolor IDH and the other 
p r o te in s
Other than the sequence similarity over the putative NADP+ binding site, no other 
obvious regions of possible conservation could be found. Exactly why the S. coelicolor 
IDH (and type-II enzymes in general) is twice as big as the type-I IDHs (as discussed in 
section 6.1) remains a question to be answered.
Alignment of the whole of the S. coelicolor sequence to that of S.cerevisiae required 
the insertion of a great many gaps making it probable that at least some of the alignment 
was insignificant. However if it were true it would suggest that the S. coelicolor protein 
is very similar to the yeast IDH but with several extra lengths of sequence distributed 
throughout the sequence. This leads to the conclusion that type I IDHs (of which the 
S.cerevisiae IDH could be included as a member) and type II IDHs (of which the S. 
coelicolor IDH is as a member) are related. However other sequences will need to be 
found that produce similar alignments before the significance of the alignment in figure 6.4 
can be decided.
1 5 5
Chapter 6. Analysis of the amino acid sequence of IDH from S.coelicolor.
Dotplot analysis ruled out the possibility of the S. coelicolor enzyme having evolved 
from the duplication and fusion of a single gene. There was little sequence similarity 
between the N-terminal and C-terminal halves of the protein.
In summary , it can be concluded that the S.cerevisiae IDH is more closely related to 
the IMDHs and the E. coli IDH than was previously suspected. From alignments 
produced between these enzymes a consensus could be found that is quite different to the 
classical -GXGXX(A/G)- consensus that normally indicates a nucleotide binding fold.
IDH from S. coelicolor shows no extensive sequence similarity to any of these 
proteins but does appear to be partially conserved over the putative NADP+ binding site 
Most similarity is seen to the yeast mitochondrial IDH and alignments with this protein 
may indicate an evolutionary relationship.
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7.1 Introduction.
The TCA cycle plays an important role in the production of many precursors in many 
organisms. In streptomycetes some of these precursors are used for the biosynthesis of 
antibiotics making this cycle of commercial interest. In E.coli grown on acetate as a sole 
carbon source, one of the TCA cycle enzymes, IDH, has been shown to play a key role 
in controlling the flux of carbon between the glyoxylate bypass and the TCA cycle. It is 
assumed that EDHs may play a similar role in streptomycetes grown on acetate or oils, 
making this enzyme an obvious target for study in these organisms. Control of flux, 
possibly mediated by IDH, may also have an effect on secondary metabolism, as both the 
glyoxylate bypass and the TCA cycle are likely to compete with polyketide biosynthetic 
pathways for available acetyl-CoA.
Cloning the gene that encodes IDH would provide a means of altering the levels of 
IDH {eg. by over or under expression of the cloned gene) allowing the effects on cell 
growth and antibiotic biosynthesis to be observed. The aim of this project was therefore 
to clone the gene by "reverse genetics", a method which first requires purification of the 
enzyme. During the development of the purification procedure some of the physical and 
biochemical properties of the enzyme were studied.
When the gene had been cloned the nucleotide sequence was determined and 
analysed. Comparison of the predicted amino acid sequence of the enzyme to other 
proteins was also performed and the conclusions that were reached are discussed in this 
chapter.
Zj.2 Classification of the S .coelicolor  IDH as a "Type I I” IDH.
It was suggested by Fukanaga et al. (1988) that bacterial IDHs can be classified into 
two groups. One group consists of dimeric enzymes with subunit molecular weights of 
c.45 kDa and, where data are available, have similar N-terminal amino acid sequences. 
Antibodies raised against one of the members of this group (IDH-I from Vibrio spp. 
ABE-1) have been found to cross react with two other members from the same group 
(namely IDH from E.coli and S.typhimurium ), but do not cross react with members 
from the second group (see below).
The second group of enzymes are monomeric with molecular weights of around 
80,000 and, until recently, had only two members; Azotobacter vinelandii EDH and IDH- 
II from Vibrio spp. Studies of the IDH from S.coelicolor showed that this enzyme could 
also be classified as a member this group. Not only was the S.coelicolor IDH a
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monomeric protein with a molecular weight of around 80 kDa but it also had an N- 
terminal sequence 69% identical to the IDH II from Vibrio spp. Like the IDH-II from 
Vibrio spp. it also showed no cross reaction with an anti-E.coli IDH antiserum. It was 
therefore suggested that this group of monomeric enzymes should be called the "type II" 
IDHs (after the IDH-II from Vibrio spp.) and that the group typified by the Vibrio spp. 
IDH-I be called the "type I" IDHs.
As this thesis was being prepared the R.vannielii IDH was reported also to have an 
N-terminal amino acid sequence and subunit size similar to the Vibrio spp. IDH-II. The 
similarity to the N-terminal amino acid sequence of the enzyme from S.coelicolor is also 
striking (63% identical) even though the R.vannielii enzyme has been found to possess 
dual coenzyme specificity. This gives credence to the classification of all monomeric 
enzymes into a group distinct from the type I IDHs. It is possible that the IDH from 
S.coelicolor (and maybe type II IDHs in general) also has dual coenzyme specificity, but 
experiments were not performed to look for the low levels of NAD dependent IDH 
activity found for the IDH from R.vannielii.
1x1 Com parison of IDH sequences from various sources.
Genes for several IDHs (E.coli NADP-IDH, T.thermophilus NADP-IDH, 
S.cerevisiae mitochondrial NADP-IDH and S.cerevisiae mitochondrial NAD-IDH2) 
have now been cloned and sequenced which has allowed the comparison of the enzymes 
at the level of amino acid sequence . It was perhaps of no surprise to learn that the E.coli 
and T.thermophilus IDHs were very similar as they can both be classified as type I 
IDHs. More surprising was the fact that the amino acid sequence for the IDH2 subunit 
(from the yeast mitochondrial NAD dependent IDH) was also very similar to the E.coli 
sequence (33% identical; Cupp and McAlister-Henn, 1991). Not only do the enzymes 
have a different cofactor specificity, but it has also been suggested that the yeast IDH is 
an octameric enzyme made from two non-identical subunits (see section 1.2.4.4 and 
Keys and McAlister-Henn, 1990). It is also controlled allosterically unlike the E.coli 
enzyme. Despite this, the similarity in amino acid sequence is obvious, with most of the 
residues required for isocitrate binding being identical between both the E.coli NADP- 
IDH and yeast NAD-IDH2 (Cupp and McAlister-Henn, 1991). These identities are 
summarised figure 6.7.
Cupp and McAlister-Henn (1991) also noticed similarity in the amino acid sequences 
between peptides from each of the three NAD-IDH subunits from pig and the NAD-IDH2 
subunit from yeast, as well as with the E.coli NADP-IDH sequence. This would seem to 
indicate a common evolutionary origin for each of the subunits from the different
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enzymes, even though the pig heart NAD-IDH has a quaternary structure which is 
different from either of the other enzymes (see section 1.2.4.4).
This similarity in sequence was also surprising as it was expected that the reaction 
mechanisms of the NAD and NADP dependent IDHs would be significantly different. 
This was suggested by the fact that no reports have been made of an NAD-dependent 
IDH being inhibited by glyoxylate plus OAA, although this phenomenon is common 
feature of all NADP dependent IDHs (Nimmo, 1986). The inhibition by glyoxylate plus 
OAA may therefore somehow interfere with the interactions between the 5'-carboxyl of 
NADP (that is not present in NAD) and the enzyme.
As each of the pig NAD-IDH subunits have amino acid sequences which are similar 
to each other, as well as to the NAD-IDH2 subunit from yeast, it would be interesting to 
find out if the two yeast subunits (EDH1 and IDH2 from NAD-IDH) are also similar to 
each other. Keys and McAlister-Henn (1990) reported that the two subunits are 
immunologically distinct and have different N-terminal amino acid sequences. However it 
is possible that similarities can be found between the IDH1 and IDH2 subunit sequences 
(even though this is not suggested by immunological experiments) as antibodies raised 
against one protein do not usually cross react with another unless the proteins are at least 
50% identical.
Haselbeck and McAlister-Henn (1991) had reported that there was no significant 
homology between the NADP-IDHs from yeast and E.coli despite the fact that they are 
both 80 kDa homodimers and that neither is subject to allosteric control. As part of the 
work described in this thesis the yeast and E.coli NADP dependent IDHs were compared 
to each other, as well as to two NAD dependent IMDH sequences (section 6.2.3 and 
6.3.1). The alignments produced suggested that the E.coli and yeast NADP-IDHs are in 
fact similar at the amino acid sequence level. It was therefore suggested from the amino 
acid sequence information, coupled with the similarity in subunit size, that the yeast 
mitochondrial NADP-IDH can be classified as a type I IDH, despite its eukaryotic 
origins. This is perhaps not too surprising as mitochondria are believed to have evolved 
from prokaryotic origins. The similarity of the pig NADP-IDH amino acid sequence 
(from peptide sequence) to the NADP-IDH from yeast, may suggest that this IDH is also 
related.
From sequence comparisons it therefore appears that subunits for NADP dependent 
IDHs from both eukaryotes and prokaryotes are related to each other and also to each of 
the subunits from NAD dependent IDHs. The obvious similarity of the IMDHs to the 
E.coli and yeast NADP-IDHs (sec 1.2.5) suggests that even these enzymes are related. It 
therefore seems that each type of enzyme has evolved using the same type of subunit, but
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that as the enzymes diverged each type of subunit acquired specialist functions. The 
degree of similarity between the NAD+ and NADP4- dependent enzymes was unexpected
In E.coli IDH both subunits are involved in catalysis and both are subject to control 
by phosphorylation. Other type-I enzymes may have similar mechanisms for control and 
catalysis, since virtually all of the residues required for isocitrate and Mn2+ binding are 
conserved in the T.thermophilus IDH and yeast NADP-IDH (figure 6.7).
Equilibrium dialysis experiments on yeast and pig heart NAD-IDHs have shown that 
the number of substrate and effector binding sites per active enzyme is less than the 
number of subunits (Keys and McAlister-Henn, 1990 and Huang and Colman, 1990). 
Subunits could have become specialised so that some could be involved in catalysis 
whilst others could be involved in binding effectors and exerting allosteric control. For 
instance it is conceivable that the ancestral NADP binding site could have evolved into an 
AMP binding site for some of the subunits. Although the NAD-IDHs from these two 
organisms have some similar properties, the IDH from yeast has been reported to be a 
octamer, based on initial studies of other euferyotic NAD-IDHs such as that from pig 
heart (Keys and McAlister-Henn, 1990). However the pig heart NAD-IDH has recently 
been re-axamined and reported to be a tetramer (Huang and Colman, 1990). It is 
therefore possible that the yeast NAD-IDH is also a tetramer.
Attempts to align the NADP-IDH from S.coelicolor to the NAD dependent IMDHs 
and the NADP dependent IDHs from yeast and E.coli are also discussed in this thesis. 
The similarity of many of the proteins is low indicating that the type II IDHs are quite 
different to the other enzymes, although a distant relationship could be suggested by the 
alignments between the S.cerevisiae and S.coelicolor NADP-IDHs. If this relationship 
is significant then the S.coelicolor IDH (and maybe type II IDHs in general) has evolved 
with extra sequences distributed throughout the protein. These extra sequences could 
substitute for regions which would be responsible, in type I IDHs, for subunit-subunit 
interactions and in forming the correct enzyme configuration. If such a relationship does 
exist between the yeast and streptomycete IDHs then one could conclude that type II 
IDHs are distantly related to type I IDHs in general, since it was earlier suggested that the 
yeast NADP-IDH is probably also related to the E.coli IDH.
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1A  Identification of a putative novel nucleotide binding site.
When comparing the amino acid sequences of various IDHs and IMDHs a sequence 
was found that is very similar to and contained within all of the other proteins compared. 
This region coincides with the region in the E.coli IDH that contains many of the 
residues required for binding NADP (Hurley et al., 1991). It was therefore suggested 
that all of the proteins analysed during this work have similar NAD(P) binding sites. 
Comparisons of the recently published sequences for the NAD-IDH from yeast and the 
NADP-IDH from T.thermophilus have been included in figure 6.7a and would seem to 
confirm the conservation of NAD(P) binding residues in the EDH and IMDH type 
enzymes.
Miyazaki et al. (1992) noticed that a region of the T.thermophilus IDH showed 
sequence similarity to isopropylmalate isomerase, as well as to several IMDHs. They 
concluded that this region must be therefore be involved in isopropylmalate or isocitrate 
binding in the appropriate enzymes, as the two similar substrates seemed to be the only 
common link between the enzymes. However the region identified by Miyazaki et al. 
(1992) aligns with the region that, in the E.coli EDH, is involved in the binding of 
NADP (Hurley et al., 1991). The alternative explanation for a region of conservation is 
that the isomerase and IMDHs have a common evolutionary origin. However this 
possibility also seems unlikely, as there is no other similarity reported between the 
isomerase and dehydrogenase sequences (Andreadis et al., 1984).
A consensus sequence for this putative NAD(P) binding site was therefore proposed 
in section 6.2.4, describing the common sequence found in all of the proteins analysed. It 
is clear that the proposed consensus is different to the any of the other NAD(P) binding 
sites (discussed in section 1.3). The diagram below illustrates that the proposed 
IDH/IMDH-NADP binding sites are quite different to the other NAD(P) binding sites. 
However there are some features of these binding sites that are conserved.
For instance the glycine at position 3 in the alignment above is conserved in all of the 
sequences, suggesting that this amino acid may have a functional role. Indeed the residue 
at this position in the W^erenga, LDH-type nucleotide binding site is required to allow the 
close approach of the 5' pyrophosphate group of NAD(P) to the a-helix, aB. A similar 
role was also proposed for this residue in FNR type binding folds. Another common 
feature is also found between the NAD(P) binding sites of the LDH type enzymes, the 
FNR enzyme and the E.coli IDH; all make use of a positively charged dipole, found at 
the N-terminus of an a-helix, to stabilise interactions between the protein and the 
negatively charged 5' pyrophosphate of NAD(P).
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1 2 3 4 5 6
Wterenga NAD G -X -G -X -X -G
consensus
Wterenga NADP G -X -G -X -X -A
consensus
Spinach FNR G - T - G - I - A - P
E.coli IDH T -H -G -T -A -P
B.subtilis IMDH V -H -G -S -A -P
T.thermophilus IMDH V -H -G -S -A -P  
S.coelicolor IDH A -G -G -S -A -P
In conclusion it can be said that there is no consensus sequence that can be used to 
describe all NAD(P) binding sites. However some sequence similarities and inferred 
structural similarities have been noticed between nucleotide binding sites from different 
enzyme families. This is likely to reflect functional constraints on the types of residues 
required rather than an evolutionary relationship.
2*5 Future work.
Now that the IDH fromS.coelicolor has been successfully purified and the gene 
encoding this enzyme cloned and sequenced, there are numerous experiments that can be 
performed at both the biochemical and genetic levels. It has been shown that the enzyme 
of S.coelicolor is a type II IDH based on quartemary structure, subunit size, N-terminal 
amino acid sequence and immunological properties. Compared to the type I IDHs, little is 
known about how type II IDHs function or how they are controlled.
To gain an insight into the role (if any) that IDH plays in controlling metabolism in S. 
coelicolor, it will be neccesary to measure the level of IDH activity at different times of 
the life cycle and under different growth conditions. There would be a special interest in 
any differences found in the levels of IDH activity found between mycelia harvested 
during the growth and antibiotic production phases and any differences found for mycelia 
grown on media with glucose compared to acetate as the sole carbon source.. Any change 
found in the total cellular IDH activity, could be due to alterations in the activity of the 
enzyme (by covalent modification or allosteric effectors), or could be due to changes in 
the quantity of IDH protein.
Changes in the level of protein synthesis could be detected using an antiserum raised 
against the S.coelicolor IDH. Alternatively the antiserum raised against the type II IDHs 
from R.vinelandii (Leyland and Kelly, 1991) or Vibrio spp. ABE-1 (Ishii et al., 1987) 
could probably be used. The cloned icd B gene could be used as a specific probe for 
measuring the levels of IDH mRNA thereby detecting any changes in the rate of
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transcription. Any changes in protein synthesis not accounted for by fluctuating 
transcription levels would probably be accounted for by changes in the rate of translation.
From the data presented in this work (and that of Leyland and Kelly, 1991), it was 
found that certain metabolites (such as OAA) have an effect on the activity of the IDHs 
from both S.coelicolor and R.vinelandii. The relevance of such effects needs to be 
addressed further by measuring the intracellular concentrations of these metabolites and 
observing the inhibitory effects of the metabolites on IDH activity at these concentrations.
The putative multiple promoters identified during this work may play a role in 
controlling the levels of transcription at different stages in the life cycle and/or under 
different growth conditions. However it is possible that other functional promoters lie 
elsewhere and that some or all of the sequences identified are non-functional. The 
functional promoter(s) could be identified by searching for promoter sequences upstream 
of the transcription start point(s). The mRNA start point(s) could be identified by 
experiments such as SI mapping or primer extension mapping. Determination of both 
ends of the transcript that contains the coding information for IDH could also help to 
resolve whether icd B is part of an operon (ie. whether the transcript is long anough to 
encode other proteins up and/or downstream of icd B).
The validity of putative ORFs up and downstream of the icd B gene could also be 
investigated by sequencing further up and downsream of icd B. This is of particular 
interest since it was found that the gene encoding citrate synthase lies immediately 
upstream of the icd gene in B.caldotenax (Catherine Wild, personnal communication) 
perhaps suggesting some sort of concerted regulation.
A 30 fold over-expression has recently been achieved in the heterologous host, S. 
lividans (P.Chapman, Institute of Genetics, Glasgow University). The 5 kb Pst I insert 
from pRTBl was ligated into the multicopy number streptomycete vector pIJ486 
(Hopwood et al., 1985) and introduced into S.lividans. The strain grew more slowly 
than the wild type strain, probably due to the pressure of overproduction rather than an 
effect caused by the activity of the S. coelicolor IDH.
It would now be interesting to observe the effect on cell growth and antibiotic production, 
of over and under-expressing the S.coelicolor IDH in the native host. It is likely that 
overexpression will have little effect on this host either. However complete loss of all 
IDH activity (using a disrupted copy of the cloned icd B gene in genomic replacement 
experiments) is likely to make the strain auxotrophic for glutamate or proline, analogous 
to the situation for E.coli icd mutants. It is possible that if such mutants are provided 
with supplements, then the strain will grow but may have altered levels of antibiotic 
biosynthesis.
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More subtle changes in IDH activity could be made by introducing the cloned gene 
into an S.coelicolor icd B mutant, on a plasmid that allows controllable expression of the 
gene. Alternatively it may be possible to express the antisense strand of the icd B gene in 
a controllable manner. Antisense mRNA will bind to sense mRNA preventing further 
translation.
It would also be interesting to observe the effect of expression of the S.coelicolor 
gene in the E.coli icd mutant (especially during growth on acetate) as E.coli may not be 
able to control the activity of the heterologous enzyme by the phosphorylation mechanism 
used to control its own IDH. This would probably require modification of the icd B 
promoter sequence(s) to enable expression of the gene by the E.coli RNApol. 
Expression of the E.coli gene in a streptomycete icd B mutant (both with and without the 
E.coli IKP) could also prove interesting, perhaps providing further insights into how the 
enzymes from both organisms are controlled.
The number of NADP and isocitrate binding sites per monomer is unknown for the 
S.coelicolor IDH or indeed any of the type II IDHs. It would be interesting to determine 
this property, as it is conceivable that the type II enzymes may possess more than one 
NADP binding site. Equilibrium dialysis experiments could be used to determine the 
number of binding sites for isocitrate and indeed the number of binding sites for any 
effectors that may be identified.
Analysis of the amino acid sequence for the IDH from S.coelicolor has revealed a 
region that may be involved in the binding of NADP. Several experiments could be 
performed to try and confirm or disprove this suggestion. Modifiction of the enzyme 
using chemicals that specifically modify different amino acids could help to identify 
residues required for enzyme activity. Protection against such modification by the 
presence of NADP bound to the enzyme could indicate which residues are adjacent to or 
within the NADP binding site. Similar experiments could be performed to also identify 
residues involved in isocitrate binding. Another method would be to substitute specific 
amino acids thought to be involved in NADP binding for amino acids with different 
properties. This could be achieved by introducing specific mutations into the cloned icd B 
gene by site directed mutagenesis. Any change in the ability of the enzyme to bind NADP 
would provide evidence that the amino acid changed site is involved in coenzyme 
binding.
The ultimate method for identifying the NADP binding site would be by determining 
the position of NADP within the three-dimensional structure of the enzyme using 
techniques such as X-ray crystallography. Production of sufficient quantities of pure
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protein should be relatively easy now that the enzyme has been overexpressed in S. 
lividans. Determination of the crystal structure would also be of interest for comparison 
to the structure of type I IDHs (based on the E.coli IDH). It is possible that the core 
structure of the type II IDH is similar to that of the type I IDHs with intervening 
sequences being required for the correct folding and activity of the enzyme as a 
monomer.
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